{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 90,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "%matplotlib inline"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 88,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import requests\n",
    "import json\n",
    "import io\n",
    "import matplotlib.pyplot as plt\n",
    "import numpy as np"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# GDC endpoint"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 77,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "b'diagnoses.0.days_to_recurrence,demographic.submitter_id,diagnoses.0.treatments.1.treatment_id,diagnoses.0.morphology,submitter_id,diagnoses.0.treatments.0.treatment_intent_type,diagnoses.0.primary_diagnosis,id,diagnoses.0.treatments.0.state,diagnoses.0.treatments.1.created_datetime,diagnoses.0.treatments.1.treatment_or_therapy,diagnoses.0.age_at_diagnosis,demographic.year_of_birth,diagnoses.0.days_to_last_known_disease_status,diagnoses.0.days_to_last_follow_up,demographic.gender,diagnoses.0.classification_of_tumor,diagnoses.0.progression_or_recurrence,case_id,diagnoses.0.treatments.0.updated_datetime,diagnoses.0.state,diagnoses.0.treatments.1.updated_datetime,diagnoses.0.tumor_stage,demographic.demographic_id,diagnoses.0.submitter_id,demographic.race,diagnoses.0.last_known_disease_status,diagnoses.0.site_of_resection_or_biopsy,diagnoses.0.treatments.0.submitter_id,diagnoses.0.diagnosis_id,diagnoses.0.treatments.0.treatment_or_therapy,demographic.year_of_death,diagnoses.0.created_datetime,diagnoses.0.tissue_or_organ_of_origin,state,diagnoses.0.tumor_grade,diagnoses.0.treatments.0.created_datetime,diagnoses.0.treatments.0.therapeutic_agents,demographic.ethnicity,diagnoses.0.treatments.1.state,disease_type,diagnoses.0.treatments.1.submitter_id,demographic.created_datetime,diagnoses.0.treatments.1.treatment_intent_type,diagnoses.0.prior_malignancy,demographic.updated_datetime,primary_site,diagnoses.0.treatments.1.therapeutic_agents,diagnoses.0.updated_datetime,demographic.state,diagnoses.0.treatments.0.treatment_id\\r\\n,TCGA-DD-AADM_demographic,d2011ad3-bbca-5f2a-a646-4c39ab7f6e50,8170/3,TCGA-DD-AADM,,\"Hepatocellular carcinoma, NOS\",62c02da8-e4b4-4294-9923-8992d187fc7b,released,,no,21349,1954,,,male,not reported,not reported,62c02da8-e4b4-4294-9923-8992d187fc7b,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:20:26.737322-05:00,stage ii,77e26aa8-0a52-5a54-bdfb-03fad63e7383,TCGA-DD-AADM_diagnosis,asian,not reported,Liver,TCGA-DD-AADM_treatment_1,d6e8d7a3-555c-5438-be59-c4306d4a8d5e,no,2012,,Liver,released,not reported,2019-04-28T13:20:26.737322-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AADM_treatment,,,no,2019-04-28T13:20:26.737322-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:42.289685-05:00,released,fa555b9e-bfc5-5c0e-9e23-c71a219985cc\\r\\n,TCGA-MR-A520_demographic,e4c42bee-c60c-55e3-ab8a-b0466b7800d3,8170/3,TCGA-MR-A520,,\"Hepatocellular carcinoma, NOS\",25e893ad-a0fd-45ae-9aa9-9bcd7c2ec8e5,released,2019-04-28T13:16:22.558732-05:00,no,21398,1954,,229,male,not reported,not reported,25e893ad-a0fd-45ae-9aa9-9bcd7c2ec8e5,2019-04-28T13:16:22.558732-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,1e4ee582-0af2-5e5d-9d92-fafda2d5c5b1,TCGA-MR-A520_diagnosis,white,not reported,Liver,TCGA-MR-A520_treatment,cbb396f4-c2de-5a4e-bbd6-2da38fa272c5,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-MR-A520_treatment_1,,,no,2019-04-28T13:16:22.558732-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:53.093878-05:00,released,e318f368-87c5-5de7-8ca3-c799aeeb0cdd\\r\\n,TCGA-DD-AAW2_demographic,a4ac4bf7-2759-5302-91d3-a0b1d7324c02,8170/3,TCGA-DD-AAW2,,\"Hepatocellular carcinoma, NOS\",03df105e-a005-4577-bfdb-9644758d778e,released,2019-04-28T13:14:08.134677-05:00,yes,25420,1940,,1855,male,not reported,not reported,03df105e-a005-4577-bfdb-9644758d778e,2019-04-28T13:14:08.134677-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,d844d7ce-a5a4-5cf7-9d9a-d4b02b3a1a30,TCGA-DD-AAW2_diagnosis,asian,not reported,Liver,TCGA-DD-AAW2_treatment,03275ef7-8af5-5719-a2f6-f2bdb9c71935,yes,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AAW2_treatment_1,,,no,2019-04-28T13:14:08.134677-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:05.743590-05:00,released,9bd0e639-14db-5b89-b0a4-f4784e34bc2e\\r\\n,TCGA-2Y-A9GZ_demographic,2e637e2b-6f22-5a1c-91cf-c925926755a0,8170/3,TCGA-2Y-A9GZ,,\"Hepatocellular carcinoma, NOS\",0e8c3831-def9-4efa-9f93-8942072d6a77,released,,no,30082,1925,,,female,not reported,not reported,0e8c3831-def9-4efa-9f93-8942072d6a77,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:14:41.005191-05:00,stage ii,27836d7b-262e-5d2b-b00f-a7f483f52cda,TCGA-2Y-A9GZ_diagnosis,white,not reported,Liver,TCGA-2Y-A9GZ_treatment_1,0e331006-5173-541d-890b-f2bb4fc4c235,yes,2009,,Liver,released,not reported,2019-04-28T13:14:41.005191-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-2Y-A9GZ_treatment,,,no,2019-04-28T13:14:41.005191-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:35.448559-05:00,released,fae58ba4-ab4b-5145-8e0f-be4a51af8e7d\\r\\n,TCGA-LG-A6GG_demographic,6fe0674b-d337-5cc1-8132-67a443930c31,8170/3,TCGA-LG-A6GG,,\"Hepatocellular carcinoma, NOS\",c618da6d-3c66-4a6a-8832-3526a3b75410,released,2019-04-28T13:26:16.469340-05:00,no,28871,1934,,387,female,not reported,not reported,c618da6d-3c66-4a6a-8832-3526a3b75410,2019-04-28T13:26:16.469340-05:00,released,2019-05-03T14:06:23.922205-05:00,stage ii,ffb78614-fb86-5019-ac97-955440623d3b,TCGA-LG-A6GG_diagnosis,white,not reported,Liver,TCGA-LG-A6GG_treatment,f3bb0715-b668-5105-bba6-04b62400fbed,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-LG-A6GG_treatment_1,,,yes,2019-04-28T13:26:16.469340-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:53.093878-05:00,released,4d1b37ee-01fd-5145-8848-1ab507e09597\\r\\n,TCGA-ED-A82E_demographic,f7af8469-90ad-538f-ae2b-aa538780c0e4,8170/3,TCGA-ED-A82E,,\"Hepatocellular carcinoma, NOS\",a96b67ba-6180-4b80-8792-877860421ca0,released,,no,22234,1953,,408,female,not reported,not reported,a96b67ba-6180-4b80-8792-877860421ca0,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:24:30.022236-05:00,stage iiia,27bd99c2-8b82-5b2a-b17a-778d5faceb20,TCGA-ED-A82E_diagnosis,asian,not reported,Liver,TCGA-ED-A82E_treatment_1,78bd28cb-4dfd-5191-b57d-26d45188641c,no,,,Liver,released,not reported,2019-04-28T13:24:30.022236-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-ED-A82E_treatment,,,no,2019-04-28T13:24:30.022236-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:27.936420-05:00,released,b39f9eba-670e-565a-b986-183c9e6e7116\\r\\n,TCGA-UB-AA0U_demographic,f45e1a55-bebe-5e3a-a421-2a4f83f68dfa,8170/3,TCGA-UB-AA0U,,\"Hepatocellular carcinoma, NOS\",ae8d4b34-d40a-482d-9d45-23242843df00,released,2019-04-28T13:24:47.031068-05:00,no,21985,1953,,327,male,not reported,not reported,ae8d4b34-d40a-482d-9d45-23242843df00,2019-04-28T13:24:47.031068-05:00,released,2019-05-03T14:06:23.922205-05:00,stage ii,93208168-cbd2-5570-b9d5-2c76375534bd,TCGA-UB-AA0U_diagnosis,white,not reported,Liver,TCGA-UB-AA0U_treatment,5fe77a91-b880-56bf-b485-ee4a18082fcf,yes,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-UB-AA0U_treatment_1,,,no,2019-04-28T13:24:47.031068-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:38:16.668337-05:00,released,69cd6ef5-3ec7-51d1-81d8-7edfa3b68734\\r\\n,TCGA-G3-A6UC_demographic,475b233f-cb4d-5b10-b149-a7dcb14f1fab,8170/3,TCGA-G3-A6UC,,\"Hepatocellular carcinoma, NOS\",87aa894e-7676-40b7-9557-6541446d8cea,released,,no,23793,1947,,671,male,not reported,not reported,87aa894e-7676-40b7-9557-6541446d8cea,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:22:37.439768-05:00,stage iiib,3f8b4a68-30b4-5dc2-9f64-5710ee5b4724,TCGA-G3-A6UC_diagnosis,white,not reported,Liver,TCGA-G3-A6UC_treatment_1,6b727a88-5675-5e82-ba85-9497f8ca423c,no,,,Liver,released,not reported,2019-04-28T13:22:37.439768-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-G3-A6UC_treatment,,,yes,2019-04-28T13:22:37.439768-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:27.936420-05:00,released,0453c968-1b70-5fe6-aaf6-5c7a3306ee5b\\r\\n,TCGA-BC-A216_demographic,14b781f8-693f-5dfb-b8f8-ab36bc298115,8170/3,TCGA-BC-A216,,\"Hepatocellular carcinoma, NOS\",4bbdbe77-f3cb-4b64-9826-72debb734784,released,,no,22968,1946,,1351,female,not reported,not reported,4bbdbe77-f3cb-4b64-9826-72debb734784,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:18:54.354037-05:00,stage iiia,3f938cba-40bb-57dd-9a8d-e502a861925c,TCGA-BC-A216_diagnosis,white,not reported,Liver,TCGA-BC-A216_treatment_1,ac512a2f-0513-5d5f-b2ea-f351dd56ae09,no,,,Liver,released,not reported,2019-04-28T13:18:54.354037-05:00,,not reported,released,Adenomas and Adenocarcinomas,TCGA-BC-A216_treatment,,,no,2019-04-28T13:18:54.354037-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:35.448559-05:00,released,92b6c0e1-c6bc-50ec-aa21-f3c1b4821ca7\\r\\n,TCGA-MI-A75E_demographic,bb2736c2-24c4-541a-a002-6bb150325556,8170/3,TCGA-MI-A75E,,\"Hepatocellular carcinoma, NOS\",010d5817-9a3f-4a06-8643-653116c044ff,released,,no,22457,1952,,507,male,not reported,not reported,010d5817-9a3f-4a06-8643-653116c044ff,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:13:51.777199-05:00,stage iiic,27e342a5-79cf-5ea9-bf17-9b6b9eac6ab8,TCGA-MI-A75E_diagnosis,white,not reported,Liver,TCGA-MI-A75E_treatment_1,bcae9074-6ab3-5b77-9486-86f530ae0a5a,no,,,Liver,released,not reported,2019-04-28T13:13:51.777199-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-MI-A75E_treatment,,,no,2019-04-28T13:13:51.777199-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:53.093878-05:00,released,3aa684b0-f064-5bef-b1da-8eec30967b07\\r\\n,TCGA-G3-A25Z_demographic,a8184d23-1591-598d-aad2-fd7f102a2a40,8170/3,TCGA-G3-A25Z,,\"Hepatocellular carcinoma, NOS\",2f3d22ad-6917-4189-89d9-2a06c2d2de0a,released,2019-04-28T13:16:49.974196-05:00,no,21509,1952,,655,male,not reported,not reported,2f3d22ad-6917-4189-89d9-2a06c2d2de0a,2019-04-28T13:16:49.974196-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,21d2ce92-043a-562c-bec3-7ef95494da3b,TCGA-G3-A25Z_diagnosis,asian,not reported,Liver,TCGA-G3-A25Z_treatment,040435fd-4a64-5f10-b6b9-f419287da9be,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-G3-A25Z_treatment_1,,,no,2019-04-28T13:16:49.974196-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:27.936420-05:00,released,5e63027f-2085-5120-9c48-9ce3771e3341\\r\\n,TCGA-DD-AAD6_demographic,da9ba4d6-293a-5d31-9ccd-90974c9eeaa3,8170/3,TCGA-DD-AAD6,,\"Hepatocellular carcinoma, NOS\",418e79d1-51c7-4cef-a1b6-e291fb13c2a5,released,2019-04-28T13:18:02.261627-05:00,no,24185,1945,,672,male,not reported,not reported,418e79d1-51c7-4cef-a1b6-e291fb13c2a5,2019-04-28T13:18:02.261627-05:00,released,2019-05-03T14:06:23.922205-05:00,stage iiia,d996c17e-7683-5fcc-85a8-92b2aff2b9da,TCGA-DD-AAD6_diagnosis,asian,not reported,Liver,TCGA-DD-AAD6_treatment,0a46b854-ad69-5814-9ee2-e7251f8415ac,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AAD6_treatment_1,,,no,2019-04-28T13:18:02.261627-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:42.289685-05:00,released,7532446f-4e23-5b4d-b2cc-2d14f19c137c\\r\\n,TCGA-DD-A39V_demographic,bc8e0b1e-fdb1-5f3c-ba17-2b9850f7a49e,8170/3,TCGA-DD-A39V,,\"Hepatocellular carcinoma, NOS\",dd056692-4e2a-4e45-a4d0-357af9754f0e,released,2019-04-28T13:27:27.424412-05:00,no,28254,1923,,,male,not reported,not reported,dd056692-4e2a-4e45-a4d0-357af9754f0e,2019-04-28T13:27:27.424412-05:00,released,2019-05-03T14:06:23.922205-05:00,stage ii,282e3807-6835-52db-bb8d-f9b4b7857335,TCGA-DD-A39V_diagnosis,white,not reported,Liver,TCGA-DD-A39V_treatment,7c057e0a-5e49-5214-bee7-db7152cb2688,yes,2001,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A39V_treatment_1,,,no,2019-04-28T13:27:27.424412-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:19.490721-05:00,released,9ce3806d-9bb0-568c-90af-7a567b000301\\r\\n,TCGA-BC-A3KG_demographic,d3fbd640-1d6d-5287-a86a-ad048e4d6193,8170/3,TCGA-BC-A3KG,,\"Hepatocellular carcinoma, NOS\",75f43fca-200a-48b0-bb67-0693d7b91119,released,,no,25061,1943,,680,female,not reported,not reported,75f43fca-200a-48b0-bb67-0693d7b91119,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:21:27.313849-05:00,stage ii,b07159a5-c041-5962-aaf7-ff8f9b7889d3,TCGA-BC-A3KG_diagnosis,white,not reported,Liver,TCGA-BC-A3KG_treatment_1,3301db0f-ac03-5bd1-bd3f-b4373b1bcb4c,yes,,,Liver,released,not reported,2019-04-28T13:21:27.313849-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-BC-A3KG_treatment,,,no,2019-04-28T13:21:27.313849-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:35.448559-05:00,released,160d377f-e29b-55e0-a034-3535f48d9a21\\r\\n,TCGA-DD-A1EC_demographic,f20704ad-8aeb-544d-a47f-693fc103fdf1,8170/3,TCGA-DD-A1EC,,\"Hepatocellular carcinoma, NOS\",520a709a-87f6-4f3d-b2a2-9192e3b65c5b,released,2019-04-28T13:19:16.070813-05:00,yes,7363,1984,,602,female,not reported,not reported,520a709a-87f6-4f3d-b2a2-9192e3b65c5b,2019-04-28T13:19:16.070813-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,e2768e76-8431-5e60-98e3-c6cbbf0f0084,TCGA-DD-A1EC_diagnosis,white,not reported,Liver,TCGA-DD-A1EC_treatment,9a7ffda7-b281-5b8a-9657-6b66f8425768,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A1EC_treatment_1,,,no,2019-04-28T13:19:16.070813-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:19.490721-05:00,released,bb893238-0303-5d04-881b-78667891847d\\r\\n,TCGA-RC-A7SB_demographic,7f0b39f5-adfb-51f0-8213-687b7d95dfc7,8170/3,TCGA-RC-A7SB,,\"Hepatocellular carcinoma, NOS\",26d93d77-ab66-45aa-a162-98d091221afb,released,2019-04-28T13:16:27.066854-05:00,no,19698,1959,,588,male,not reported,not reported,26d93d77-ab66-45aa-a162-98d091221afb,2019-04-28T13:16:27.066854-05:00,released,2019-05-03T14:06:23.922205-05:00,stage ii,4a1b71ff-27ec-5448-b786-0ba6645a0bd5,TCGA-RC-A7SB_diagnosis,asian,not reported,Liver,TCGA-RC-A7SB_treatment,930e4890-9e7d-5b5b-a5a1-1b6fbb4ca62d,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-RC-A7SB_treatment_1,,,no,2019-04-28T13:16:27.066854-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:53.093878-05:00,released,ccdf1f2a-fb1e-55a0-875f-b65847ea9601\\r\\n,TCGA-XR-A8TD_demographic,b5511a48-3b59-575a-9627-5e7cfde75526,8174/3,TCGA-XR-A8TD,,\"Hepatocellular carcinoma, clear cell type\",574ba00b-fee6-4aab-ac01-6ffaf8fdc0c5,released,,no,17908,1963,,1030,female,not reported,not reported,574ba00b-fee6-4aab-ac01-6ffaf8fdc0c5,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:19:47.282794-05:00,stage iiib,20247c1a-b212-5b95-91a6-565b1fbd4096,TCGA-XR-A8TD_diagnosis,white,not reported,Liver,TCGA-XR-A8TD_treatment_1,b0596099-9d35-56a6-820e-d698db4d58ef,no,,,Liver,released,not reported,2019-04-28T13:19:47.282794-05:00,,hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-XR-A8TD_treatment,,,no,2019-04-28T13:19:47.282794-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:38:16.668337-05:00,released,4db4af1b-ea26-5d05-8d6f-c5a45a5ca950\\r\\n,TCGA-EP-A3RK_demographic,7f37cad4-ce75-5a7c-bd1c-fb1030dfed52,8170/3,TCGA-EP-A3RK,,\"Hepatocellular carcinoma, NOS\",f15279dd-5d12-460b-9bd1-b4f95681ca65,released,2019-04-28T13:28:13.734830-05:00,yes,26985,1939,,363,male,not reported,not reported,f15279dd-5d12-460b-9bd1-b4f95681ca65,2019-04-28T13:28:13.734830-05:00,released,2019-05-03T14:06:23.922205-05:00,stage iiia,4ae6eea5-99dd-5ded-b2b7-93753c29d2c4,TCGA-EP-A3RK_diagnosis,white,not reported,Liver,TCGA-EP-A3RK_treatment,2ef28518-924b-56a3-b02a-c0a32962c5fb,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-EP-A3RK_treatment_1,,,no,2019-04-28T13:28:13.734830-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:27.936420-05:00,released,3b1f506e-b45f-51a6-93ce-81c1b56520c0\\r\\n,TCGA-2Y-A9H0_demographic,f640d0bc-bcbf-518f-a6bb-b464572ce690,8170/3,TCGA-2Y-A9H0,,\"Hepatocellular carcinoma, NOS\",492ff93f-432b-4b73-8706-632fb2c83eb4,released,,no,18109,1955,,3675,male,not reported,not reported,492ff93f-432b-4b73-8706-632fb2c83eb4,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:18:49.526697-05:00,stage iiia,b16280ae-cb18-5f38-b296-0ae60ebeb550,TCGA-2Y-A9H0_diagnosis,white,not reported,Liver,TCGA-2Y-A9H0_treatment_1,f3436404-2c73-5216-a8e0-45776bb15b55,no,,,Liver,released,not reported,2019-04-28T13:18:49.526697-05:00,,hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-2Y-A9H0_treatment,,,no,2019-04-28T13:18:49.526697-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:35.448559-05:00,released,431e0018-b050-5b5d-bb79-bc3279b345e9\\r\\n,TCGA-DD-AACY_demographic,220a34de-1351-5db3-9edd-060908212f98,8170/3,TCGA-DD-AACY,,\"Hepatocellular carcinoma, NOS\",d884561b-5828-4c47-acd7-3f02e181b596,released,,no,22332,1949,,1450,male,not reported,not reported,d884561b-5828-4c47-acd7-3f02e181b596,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:27:24.746614-05:00,stage i,da13e505-2415-559f-a172-850857b8b7b2,TCGA-DD-AACY_diagnosis,asian,not reported,Liver,TCGA-DD-AACY_treatment_1,b878ec36-f05f-5cf7-bcc3-05faf93b4ee0,no,,,Liver,released,not reported,2019-04-28T13:27:24.746614-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AACY_treatment,,,no,2019-04-28T13:27:24.746614-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:42.289685-05:00,released,33a82c86-eaa8-58c1-932a-6365312c7868\\r\\n,TCGA-G3-A7M7_demographic,f5104981-d9b0-559c-bc4a-5fede4a515dd,8170/3,TCGA-G3-A7M7,,\"Hepatocellular carcinoma, NOS\",3d048a45-3d5d-4563-acc8-3c662861f18a,released,,no,24002,1948,,361,male,not reported,not reported,3d048a45-3d5d-4563-acc8-3c662861f18a,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:17:42.751928-05:00,stage i,c5af7d07-b7b7-5959-b58c-802a81477c2a,TCGA-G3-A7M7_diagnosis,white,not reported,Liver,TCGA-G3-A7M7_treatment_1,5b5f92ec-f125-525c-87d5-3aa01b397857,no,,,Liver,released,not reported,2019-04-28T13:17:42.751928-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-G3-A7M7_treatment,,,no,2019-04-28T13:17:42.751928-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:27.936420-05:00,released,75e1b36d-cffb-5c65-bec0-17e7f27cdcf4\\r\\n,TCGA-FV-A3R3_demographic,beabe03c-36b9-5aca-b913-cf892e3c07e7,8170/3,TCGA-FV-A3R3,,\"Hepatocellular carcinoma, NOS\",3dd7c93d-8194-44ee-8014-10dd81ef6441,released,2019-04-28T13:17:45.099869-05:00,no,14231,1974,,4,female,not reported,not reported,3dd7c93d-8194-44ee-8014-10dd81ef6441,2019-04-28T13:17:45.099869-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,2318dec3-951a-5b77-81f2-c9450a2597e7,TCGA-FV-A3R3_diagnosis,white,not reported,Liver,TCGA-FV-A3R3_treatment,75f75a1c-422e-5ad0-bcf4-0faaecd2283d,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-FV-A3R3_treatment_1,,,no,2019-04-28T13:17:45.099869-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:27.936420-05:00,released,891a4ec4-00cb-5c61-9052-e426fe54a527\\r\\n,TCGA-XR-A8TE_demographic,dd3a0e6f-5eb8-5fc4-a875-04bb6281b6be,8170/3,TCGA-XR-A8TE,,\"Hepatocellular carcinoma, NOS\",ec4b4d34-2576-4412-b036-7460e64f4398,released,,no,5862,1996,,925,male,not reported,not reported,ec4b4d34-2576-4412-b036-7460e64f4398,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:27:57.051772-05:00,stage iiia,7494f977-dab1-5c9e-a628-e1201aadf380,TCGA-XR-A8TE_diagnosis,white,not reported,Liver,TCGA-XR-A8TE_treatment_1,c244774d-e96a-54db-8b12-eefcd660b050,yes,,,Liver,released,not reported,2019-04-28T13:27:57.051772-05:00,,hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-XR-A8TE_treatment,,,no,2019-04-28T13:27:57.051772-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:38:16.668337-05:00,released,166921ed-5cf4-5676-ac3b-9359656f8c40\\r\\n,TCGA-DD-AAE0_demographic,13ba8d27-2a79-5d78-9c25-998ad6a1cb3e,8170/3,TCGA-DD-AAE0,,\"Hepatocellular carcinoma, NOS\",5e4136e4-ddd8-4faf-8a8e-5f836fd97f49,released,,no,16732,1968,,555,female,not reported,not reported,5e4136e4-ddd8-4faf-8a8e-5f836fd97f49,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:20:09.981608-05:00,stage iiia,3517cfd9-0068-5d49-b1ac-19fa85b12f74,TCGA-DD-AAE0_diagnosis,asian,not reported,Liver,TCGA-DD-AAE0_treatment_1,7062c598-f9bd-5242-be47-21ce5d50d10d,no,,,Liver,released,not reported,2019-04-28T13:20:09.981608-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AAE0_treatment,,,no,2019-04-28T13:20:09.981608-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:05.743590-05:00,released,64f2abe3-fc37-560d-b3e7-e0a19df52465\\r\\n,TCGA-DD-A11C_demographic,0c6b43df-dc04-5911-b332-f93bb65f9033,8170/3,TCGA-DD-A11C,,\"Hepatocellular carcinoma, NOS\",023a1ad1-fb16-437e-9806-5063b47f76bd,released,,no,25403,1937,,662,male,not reported,not reported,023a1ad1-fb16-437e-9806-5063b47f76bd,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:13:56.227072-05:00,stage i,77c18747-87e6-5d35-8f07-12a2950d7ed6,TCGA-DD-A11C_diagnosis,white,not reported,Liver,TCGA-DD-A11C_treatment_1,1d3adbb8-abe8-5fac-8c6b-a1fe482bbaa4,no,,,Liver,released,not reported,2019-04-28T13:13:56.227072-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A11C_treatment,,,no,2019-04-28T13:13:56.227072-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:58.071505-05:00,released,887d1b13-ac90-58e7-b142-dccce184a967\\r\\n,TCGA-CC-A9FW_demographic,f38ec6d8-1f29-5aee-b8a9-10e4f9f46cd0,8170/3,TCGA-CC-A9FW,,\"Hepatocellular carcinoma, NOS\",027322f0-d720-41f8-897c-a10e5c1424c5,released,2019-04-28T13:13:58.664163-05:00,no,24891,1945,,248,male,not reported,not reported,027322f0-d720-41f8-897c-a10e5c1424c5,2019-04-28T13:13:58.664163-05:00,released,2019-05-03T14:06:23.922205-05:00,stage iiia,2b571b77-cc4f-5c1c-b0b1-b07dea2e94cd,TCGA-CC-A9FW_diagnosis,asian,not reported,Liver,TCGA-CC-A9FW_treatment,fb9aba46-c99b-5687-9e62-a5447ab06324,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-CC-A9FW_treatment_1,,,no,2019-04-28T13:13:58.664163-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:58.071505-05:00,released,3f92d3a6-9246-5db0-8900-d074edb45bf1\\r\\n,TCGA-BW-A5NP_demographic,ce8e9e44-2a0b-5054-a394-33aecadacccd,8170/3,TCGA-BW-A5NP,,\"Hepatocellular carcinoma, NOS\",56a82a56-0241-4d3d-9de2-696b0c36df91,released,2019-04-28T13:19:42.515475-05:00,yes,9809,1984,,0,female,not reported,not reported,56a82a56-0241-4d3d-9de2-696b0c36df91,2019-04-28T13:19:42.515475-05:00,released,2019-05-03T14:06:23.922205-05:00,stage iv,0d1e527a-0b5e-5bed-aaac-0cd78f3700b6,TCGA-BW-A5NP_diagnosis,white,not reported,Liver,TCGA-BW-A5NP_treatment,a62e0e69-b21e-5c47-87d4-0802a321c05c,no,,,Liver,released,not reported,,,hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-BW-A5NP_treatment_1,,,no,2019-04-28T13:19:42.515475-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:58.071505-05:00,released,4bdb7727-68cd-5b6b-9222-4c26dcb18061\\r\\n,TCGA-UB-A7MC_demographic,4bb9bb43-c4f3-5735-887c-6a824d8a527a,8170/3,TCGA-UB-A7MC,,\"Hepatocellular carcinoma, NOS\",f82aff25-0725-48d1-aefd-d60800f7d1ab,released,,yes,21733,1954,,500,male,not reported,not reported,f82aff25-0725-48d1-aefd-d60800f7d1ab,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:28:28.286772-05:00,stage iiia,d33ae859-8513-5186-aa85-76b2be3ea75a,TCGA-UB-A7MC_diagnosis,white,not reported,Liver,TCGA-UB-A7MC_treatment_1,ede2c8ce-305f-5ab4-9523-7433ef204a35,no,,,Liver,released,not reported,2019-04-28T13:28:28.286772-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-UB-A7MC_treatment,,,no,2019-04-28T13:28:28.286772-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:53.093878-05:00,released,00045c7d-6e29-5aa4-b580-9e7e4a8df49d\\r\\n,TCGA-O8-A75V_demographic,6960831a-8c7c-5731-83cb-a7e2f12a6794,8170/3,TCGA-O8-A75V,,\"Hepatocellular carcinoma, NOS\",76cc9c06-0827-465e-bab3-5f4115295ebe,released,,no,19850,1959,,538,male,not reported,not reported,76cc9c06-0827-465e-bab3-5f4115295ebe,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:21:32.276495-05:00,stage i,9eacd8b9-c914-5700-be05-5f5c3370186a,TCGA-O8-A75V_diagnosis,not reported,not reported,Liver,TCGA-O8-A75V_treatment_1,3c4e5c70-5765-5351-a01f-0a0ef6c6b8ba,no,,,Liver,released,not reported,2019-04-28T13:21:32.276495-05:00,,hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-O8-A75V_treatment,,,no,2019-04-28T13:21:32.276495-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:53.093878-05:00,released,ca0b871f-8094-5d0b-b5a9-90b31607d57a\\r\\n,TCGA-DD-AADW_demographic,c42c3aef-9203-52b9-ae51-b3a040847f2d,8170/3,TCGA-DD-AADW,,\"Hepatocellular carcinoma, NOS\",1bcf1762-7926-45f6-a367-d45fc3af7bc3,released,,yes,17781,1965,,587,male,not reported,not reported,1bcf1762-7926-45f6-a367-d45fc3af7bc3,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:15:41.881037-05:00,stage i,b8155630-1e4c-5069-9d1a-6acb8904f279,TCGA-DD-AADW_diagnosis,asian,not reported,Liver,TCGA-DD-AADW_treatment_1,65079aa3-1f22-5aab-92cf-13129f2994c3,no,,,Liver,released,not reported,2019-04-28T13:15:41.881037-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AADW_treatment,,,no,2019-04-28T13:15:41.881037-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:05.743590-05:00,released,5e223092-3c32-534e-85ff-f39962e14c14\\r\\n,TCGA-DD-AACU_demographic,7273b719-b04c-5246-8923-7a30e2bf4650,8170/3,TCGA-DD-AACU,,\"Hepatocellular carcinoma, NOS\",88b6181c-1086-42df-8bb9-1069ec2dc675,released,,no,21606,1951,,1567,male,not reported,not reported,88b6181c-1086-42df-8bb9-1069ec2dc675,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:22:39.651562-05:00,stage i,1cc09bb2-b498-53bf-9fce-6000e18e74ac,TCGA-DD-AACU_diagnosis,asian,not reported,Liver,TCGA-DD-AACU_treatment_1,f7c67ede-3160-5100-ab99-8c1c36f3340a,no,,,Liver,released,not reported,2019-04-28T13:22:39.651562-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AACU_treatment,,,no,2019-04-28T13:22:39.651562-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:42.289685-05:00,released,3401be0d-e68b-59d4-9989-8b503b3ca74a\\r\\n,TCGA-BC-A8YO_demographic,9c23e7df-1c0c-5382-90aa-6471d31d7861,8170/3,TCGA-BC-A8YO,,\"Hepatocellular carcinoma, NOS\",f53a70d9-a774-4969-896e-2dcdd4d02a7a,released,,no,24189,1947,,562,female,not reported,not reported,f53a70d9-a774-4969-896e-2dcdd4d02a7a,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T09:25:11.061966-05:00,stage iiic,576f78bc-9328-59bc-a05a-fdfa2feb901c,TCGA-BC-A8YO_diagnosis,white,not reported,Liver,TCGA-BC-A8YO_treatment_1,4e8177dd-70fd-58ce-af54-9ef9226373be,yes,,,Liver,released,not reported,2019-04-28T09:25:11.061966-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-BC-A8YO_treatment,,,no,2019-04-28T09:25:11.061966-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:35.448559-05:00,released,25b08923-3377-52f2-aeea-046e8ecfaad2\\r\\n,TCGA-CC-A8HS_demographic,6c09a1b0-38fe-523d-a13f-9709f3916c49,8170/3,TCGA-CC-A8HS,,\"Hepatocellular carcinoma, NOS\",d18cd259-267e-47b5-9353-ad3454e048a0,released,2019-04-28T13:26:53.201692-05:00,no,6617,1995,,0,male,not reported,not reported,d18cd259-267e-47b5-9353-ad3454e048a0,2019-04-28T13:26:53.201692-05:00,released,2019-05-03T14:06:23.922205-05:00,stage iiic,58062257-4213-5eeb-aeb8-6698aa48b917,TCGA-CC-A8HS_diagnosis,asian,not reported,Liver,TCGA-CC-A8HS_treatment,303f6aae-2c37-58dc-91ca-aa379055595d,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-CC-A8HS_treatment_1,,,no,2019-04-28T13:26:53.201692-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:58.071505-05:00,released,4dd42c93-6ae2-58e9-99a7-bc85e1c429ef\\r\\n,TCGA-G3-A7M8_demographic,5aa27821-9025-5a44-9cc7-12931991b659,8170/3,TCGA-G3-A7M8,,\"Hepatocellular carcinoma, NOS\",01cc571c-a47c-4548-9c14-5e51c79b095b,released,2019-04-28T13:13:53.977493-05:00,no,11527,1982,,430,male,not reported,not reported,01cc571c-a47c-4548-9c14-5e51c79b095b,2019-04-28T13:13:53.977493-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,5969cfac-c458-5b85-9b9a-35c6b6e352ff,TCGA-G3-A7M8_diagnosis,asian,not reported,Liver,TCGA-G3-A7M8_treatment,3549dbc9-d6ad-545a-bb24-6c4c238e7449,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-G3-A7M8_treatment_1,,,no,2019-04-28T13:13:53.977493-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:27.936420-05:00,released,3592b23f-5715-5e0f-9677-3a228395c475\\r\\n,TCGA-K7-AAU7_demographic,b5427a67-b6e9-5061-ab40-6f0619d42dfd,8180/3,TCGA-K7-AAU7,,Combined hepatocellular carcinoma and cholangiocarcinoma,1eacfcc0-1d05-4441-b3d8-b0790e1c40f1,released,,no,22476,1952,,359,male,not reported,not reported,1eacfcc0-1d05-4441-b3d8-b0790e1c40f1,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:15:54.075130-05:00,stage ii,59b1e94b-3550-55a9-ab75-9ae2c14bdeed,TCGA-K7-AAU7_diagnosis,white,not reported,Liver,TCGA-K7-AAU7_treatment_1,722b65bb-6f6c-5cd9-897c-8eb3ea40e3da,yes,,,Liver,released,not reported,2019-04-28T13:15:54.075130-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-K7-AAU7_treatment,,,no,2019-04-28T13:15:54.075130-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:53.093878-05:00,released,77941f1b-7a0e-5dba-abf4-f595fcd0f5a7\\r\\n,TCGA-2Y-A9GU_demographic,0ae23cae-0896-50ec-8e69-3bafc57451e6,8170/3,TCGA-2Y-A9GU,,\"Hepatocellular carcinoma, NOS\",b27720a2-e240-413c-a0f1-0b1af3621de2,released,2019-04-28T13:25:06.080066-05:00,no,20187,1954,,1939,female,not reported,not reported,b27720a2-e240-413c-a0f1-0b1af3621de2,2019-04-28T13:25:06.080066-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,0250e97f-8d78-55a2-919c-4e7e1884c932,TCGA-2Y-A9GU_diagnosis,white,not reported,Liver,TCGA-2Y-A9GU_treatment,da49717f-e4d6-55bb-9760-573c3dae1b56,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-2Y-A9GU_treatment_1,,,no,2019-04-28T13:25:06.080066-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:35.448559-05:00,released,e7822130-c7a8-5b25-b4ab-889e2d15c206\\r\\n,TCGA-DD-A3A4_demographic,2a67254d-799c-5ee3-888b-a94a2d7e25e8,8170/3,TCGA-DD-A3A4,,\"Hepatocellular carcinoma, NOS\",ab35c9f9-3040-424d-a89f-dff3a1365bc6,released,,no,13739,1961,,,male,not reported,not reported,ab35c9f9-3040-424d-a89f-dff3a1365bc6,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:24:34.739163-05:00,stage iiia,4dee23bb-3958-531e-8e2d-9cbfb9176343,TCGA-DD-A3A4_diagnosis,white,not reported,Liver,TCGA-DD-A3A4_treatment_1,cb8c076e-ce34-5eb6-aef5-b419f3b73d98,yes,1999,,Liver,released,not reported,2019-04-28T13:24:34.739163-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A3A4_treatment,,,no,2019-04-28T13:24:34.739163-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:19.490721-05:00,released,ab6fa8bb-d0f1-5877-9de2-cfc015ac1c0e\\r\\n,TCGA-2Y-A9GT_demographic,c927c519-f7ac-57a1-a577-1f783f6372b8,8170/3,TCGA-2Y-A9GT,,\"Hepatocellular carcinoma, NOS\",31a2ecc5-2d45-4823-8187-dc701dd412a8,released,2019-04-28T13:16:54.813154-05:00,no,18768,1955,,,male,not reported,not reported,31a2ecc5-2d45-4823-8187-dc701dd412a8,2019-04-28T13:16:54.813154-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,fb0dcf32-8f65-5d78-9560-ae840f6adba2,TCGA-2Y-A9GT_diagnosis,white,not reported,Liver,TCGA-2Y-A9GT_treatment,aa68e079-743b-5635-85fd-ef21272b4582,no,2010,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-2Y-A9GT_treatment_1,,,no,2019-04-28T13:16:54.813154-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:35.448559-05:00,released,9a317b44-5ad2-555e-b47c-7e2146b5e970\\r\\n,TCGA-FV-A4ZP_demographic,adbb9ae1-956a-5e54-ab03-fd25bb6c2ec2,8170/3,TCGA-FV-A4ZP,,\"Hepatocellular carcinoma, NOS\",5c08008d-5ed4-4480-bd00-c8a2d8c787dc,released,,no,28771,1927,,1836,male,not reported,not reported,5c08008d-5ed4-4480-bd00-c8a2d8c787dc,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:19:59.673477-05:00,stage iiia,fc5b1ccd-59f2-5faf-8054-97bc28e3dcdf,TCGA-FV-A4ZP_diagnosis,white,not reported,Liver,TCGA-FV-A4ZP_treatment_1,9e59ba04-89b4-50a8-8009-d7dfecaecd9c,no,,,Liver,released,not reported,2019-04-28T13:19:59.673477-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-FV-A4ZP_treatment,,,yes,2019-04-28T13:19:59.673477-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:27.936420-05:00,released,df8f358b-5fa8-571d-af32-a02b8758b0e6\\r\\n,TCGA-CC-A5UC_demographic,a1bf42ac-bd1c-5edc-8f48-faa01247f329,8170/3,TCGA-CC-A5UC,,\"Hepatocellular carcinoma, NOS\",7e589ee1-ffcc-448a-a275-829ca26a597e,released,2019-04-28T13:21:54.053680-05:00,no,23156,1949,,0,male,not reported,not reported,7e589ee1-ffcc-448a-a275-829ca26a597e,2019-04-28T13:21:54.053680-05:00,released,2019-05-03T14:06:23.922205-05:00,stage iiia,fc93633a-5607-53f2-8163-40d05b49dc90,TCGA-CC-A5UC_diagnosis,asian,not reported,Liver,TCGA-CC-A5UC_treatment,b53aeeb5-a66d-5c93-8c58-4309b62e265d,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-CC-A5UC_treatment_1,,,no,2019-04-28T13:21:54.053680-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:58.071505-05:00,released,9818f9ce-06eb-5179-b557-0d143b4abe34\\r\\n,TCGA-DD-AACD_demographic,c676d933-1b03-5ae1-95dc-24fea6500136,8170/3,TCGA-DD-AACD,,\"Hepatocellular carcinoma, NOS\",41fb30aa-63b4-4cc6-a275-b77048612fa0,released,2019-04-28T13:18:04.564689-05:00,no,17828,1960,,,male,not reported,not reported,41fb30aa-63b4-4cc6-a275-b77048612fa0,2019-04-28T13:18:04.564689-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,fd0541d0-0fcd-5f3c-a973-d6e27531a397,TCGA-DD-AACD_diagnosis,asian,not reported,Liver,TCGA-DD-AACD_treatment,5c3b7639-2463-57ab-bdc4-b276206621a3,yes,2009,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AACD_treatment_1,,,no,2019-04-28T13:18:04.564689-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:42.289685-05:00,released,74713e86-2ab5-59cf-8a38-a160e35a3152\\r\\n,TCGA-DD-A4NO_demographic,22110c9d-1abf-515c-9e74-2d058f527a7c,8170/3,TCGA-DD-A4NO,,\"Hepatocellular carcinoma, NOS\",75f78c38-6854-4390-ad11-789b4e549d63,released,,no,24090,1942,,2245,male,not reported,not reported,75f78c38-6854-4390-ad11-789b4e549d63,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:21:29.803861-05:00,stage i,fd3d3e66-f884-5164-b348-c62eb71ac1cd,TCGA-DD-A4NO_diagnosis,white,not reported,Liver,TCGA-DD-A4NO_treatment_1,8510a8cb-27f3-511e-bc5c-9efa7bc7e4da,no,,,Liver,released,not reported,2019-04-28T13:21:29.803861-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A4NO_treatment,,,no,2019-04-28T13:21:29.803861-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:19.490721-05:00,released,21b377c8-e29c-5465-872e-a00e37c87925\\r\\n,TCGA-WQ-A9G7_demographic,c4fbe2f2-6247-5cfe-baa4-9f6d8815fe17,8170/3,TCGA-WQ-A9G7,,\"Hepatocellular carcinoma, NOS\",491a3734-dcb8-4779-b098-0b5567f13f87,released,2019-04-28T13:18:47.199757-05:00,no,,1942,,30,female,not reported,not reported,491a3734-dcb8-4779-b098-0b5567f13f87,2019-04-28T13:18:47.199757-05:00,released,2019-05-03T14:06:23.922205-05:00,not reported,fd83f686-1b43-5fc8-8228-17b35cd72dbd,TCGA-WQ-A9G7_diagnosis,white,not reported,Liver,TCGA-WQ-A9G7_treatment,30bd927f-c5fc-5ef9-bde4-8e09b28ef949,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-WQ-A9G7_treatment_1,,,no,2019-04-28T13:18:47.199757-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:38:16.668337-05:00,released,285291fa-2fb2-5cae-9bbe-08b11aef531d\\r\\n,TCGA-G3-A25V_demographic,9565a3d4-b366-5020-b9ba-f865b61fc545,8170/3,TCGA-G3-A25V,,\"Hepatocellular carcinoma, NOS\",f435ec00-0db8-46b4-96bf-890a9d931df3,released,2019-04-28T13:28:18.361103-05:00,no,25144,1942,,860,male,not reported,not reported,f435ec00-0db8-46b4-96bf-890a9d931df3,2019-04-28T13:28:18.361103-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,fed6db5e-680e-5f55-a22c-3567859b0ebc,TCGA-G3-A25V_diagnosis,white,not reported,Liver,TCGA-G3-A25V_treatment,f1d998f3-558b-5ffb-98a8-67ec6412fead,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-G3-A25V_treatment_1,,,no,2019-04-28T13:28:18.361103-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:27.936420-05:00,released,369e78ec-0ed5-5810-bc93-db8f9c14c332\\r\\n,TCGA-G3-AAV3_demographic,bff0b07f-ad69-5e9d-9c45-07b04f84148e,8170/3,TCGA-G3-AAV3,,\"Hepatocellular carcinoma, NOS\",efc865fd-7c74-4361-9d7a-eef923dbcd24,released,,no,21449,1955,,412,female,not reported,not reported,efc865fd-7c74-4361-9d7a-eef923dbcd24,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:28:08.941753-05:00,stage ii,82bba35a-4243-56cb-877c-0e964821816f,TCGA-G3-AAV3_diagnosis,white,not reported,Liver,TCGA-G3-AAV3_treatment_1,e8b595b5-362a-52fa-9922-e5d8abc7c79d,no,,,Liver,released,not reported,2019-04-28T13:28:08.941753-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-G3-AAV3_treatment,,,no,2019-04-28T13:28:08.941753-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:53.093878-05:00,released,2ff44133-dd20-59b1-9391-acbee5798790\\r\\n,TCGA-DD-A11D_demographic,f6811cde-dd6d-54f1-9a1d-ab1adc193bfb,8170/3,TCGA-DD-A11D,,\"Hepatocellular carcinoma, NOS\",0ef95351-0133-4f34-a59c-90934fb161f8,released,,no,21003,1949,,,female,not reported,not reported,0ef95351-0133-4f34-a59c-90934fb161f8,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:14:43.660878-05:00,stage i,37da8f10-1df1-5744-9241-3da1b200392f,TCGA-DD-A11D_diagnosis,white,not reported,Liver,TCGA-DD-A11D_treatment_1,cab20d99-084b-5327-9457-c7f7898a4254,yes,2010,,Liver,released,not reported,2019-04-28T13:14:43.660878-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A11D_treatment,,,no,2019-04-28T13:14:43.660878-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:58.071505-05:00,released,f5207d73-bec6-5e3e-87e4-b24351ee7b57\\r\\n,TCGA-CC-A7IJ_demographic,fbf8ed40-f21f-5991-a766-ec0f57a7cf02,8170/3,TCGA-CC-A7IJ,,\"Hepatocellular carcinoma, NOS\",e610a644-0504-445a-bba1-4bae360de4c1,released,2019-04-28T13:27:49.200552-05:00,no,20751,1957,,382,male,not reported,not reported,e610a644-0504-445a-bba1-4bae360de4c1,2019-04-28T13:27:49.200552-05:00,released,2019-05-03T14:06:23.922205-05:00,stage ii,381fe31b-90d1-569d-bfbc-3966f56d2df0,TCGA-CC-A7IJ_diagnosis,asian,not reported,Liver,TCGA-CC-A7IJ_treatment,8c4970f0-be36-52a0-8ea1-ffbf52371754,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-CC-A7IJ_treatment_1,,,no,2019-04-28T13:27:49.200552-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:58.071505-05:00,released,c4647594-e428-508f-b119-8c93aa311adc\\r\\n,TCGA-G3-A25S_demographic,ceaa1e19-f566-562d-af6c-b917e13be20d,8170/3,TCGA-G3-A25S,,\"Hepatocellular carcinoma, NOS\",b865dec4-f051-4fbe-9405-f832ff2010d7,released,,yes,23571,1945,,37,male,not reported,not reported,b865dec4-f051-4fbe-9405-f832ff2010d7,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:25:26.158600-05:00,stage i,38cf4300-3bb3-55a3-9099-841c41f967ac,TCGA-G3-A25S_diagnosis,white,not reported,Liver,TCGA-G3-A25S_treatment_1,69ffe9ca-d199-5f37-887c-57f08061164f,yes,,,Liver,released,not reported,2019-04-28T13:25:26.158600-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-G3-A25S_treatment,,,no,2019-04-28T13:25:26.158600-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:27.936420-05:00,released,3ff77e6b-c7e2-5b2f-a2ff-e61ae61f637b\\r\\n,TCGA-MI-A75C_demographic,97c5f2d8-e17b-599d-94a5-cdbae27f14f5,8170/3,TCGA-MI-A75C,,\"Hepatocellular carcinoma, NOS\",a6c0def6-7649-485a-a679-50dafb5eade5,released,2019-04-28T13:24:22.503486-05:00,no,23441,1948,,291,male,not reported,not reported,a6c0def6-7649-485a-a679-50dafb5eade5,2019-04-28T13:24:22.503486-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,394bad7e-9b3b-5c85-894f-58eea6fac217,TCGA-MI-A75C_diagnosis,white,not reported,Liver,TCGA-MI-A75C_treatment,eb334490-ebce-567c-92db-dc696caab74a,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-MI-A75C_treatment_1,,,no,2019-04-28T13:24:22.503486-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:53.093878-05:00,released,15a3047f-4bae-56ee-9259-04451671a960\\r\\n,TCGA-G3-A25Y_demographic,70a205ad-ac4e-5c67-ba60-f12644bfa070,8170/3,TCGA-G3-A25Y,,\"Hepatocellular carcinoma, NOS\",239b4298-b090-480a-a19f-9758a827aa30,released,2019-04-28T13:16:10.681380-05:00,no,19055,1954,,,female,not reported,not reported,239b4298-b090-480a-a19f-9758a827aa30,2019-04-28T13:16:10.681380-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,3bf5f38e-1bb6-5260-9956-4c2dc77b74b1,TCGA-G3-A25Y_diagnosis,asian,not reported,Liver,TCGA-G3-A25Y_treatment,b8a68ae8-8e6f-5822-9866-9eac83578b21,no,2007,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-G3-A25Y_treatment_1,,,no,2019-04-28T13:16:10.681380-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:27.936420-05:00,released,4dc8a81c-3c8f-5c3c-ad9c-a9d65aae46ad\\r\\n,TCGA-DD-AACP_demographic,b94c010d-4cef-564f-93fa-45e60a0dc6f8,8170/3,TCGA-DD-AACP,,\"Hepatocellular carcinoma, NOS\",7ad77384-0946-4fb5-9b10-bdc8a5fc8d87,released,2019-04-28T13:21:42.106397-05:00,no,23728,1945,,415,male,not reported,not reported,7ad77384-0946-4fb5-9b10-bdc8a5fc8d87,2019-04-28T13:21:42.106397-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,4ec81093-f821-571f-8872-87b6a12d8b48,TCGA-DD-AACP_diagnosis,asian,not reported,Liver,TCGA-DD-AACP_treatment,424ed2d9-be84-5357-bd00-99862aabe58f,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AACP_treatment_1,,,no,2019-04-28T13:21:42.106397-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:42.289685-05:00,released,f5b3eb78-ac5a-5ac9-8f0e-136807fa61be\\r\\n,TCGA-WJ-A86L_demographic,67798971-aa46-5dec-a5d5-466e267119ee,8310/3,TCGA-WJ-A86L,,\"Clear cell adenocarcinoma, NOS\",63d475ef-8f26-45ed-ae80-cfa87e68b2f5,released,,no,25018,1945,,345,female,not reported,not reported,63d475ef-8f26-45ed-ae80-cfa87e68b2f5,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:20:33.896518-05:00,stage i,322cc545-dec3-5db9-93fc-4203393e4e12,TCGA-WJ-A86L_diagnosis,white,not reported,Liver,TCGA-WJ-A86L_treatment_1,381164d4-736c-5efa-ba76-a670750e7022,no,,,Liver,released,not reported,2019-04-28T13:20:33.896518-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-WJ-A86L_treatment,,,no,2019-04-28T13:20:33.896518-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:38:16.668337-05:00,released,14131cc2-5348-5a93-8257-33ba44995a5e\\r\\n,TCGA-CC-5258_demographic,35bbfaed-f33b-5617-93d7-5001fb936365,8170/3,TCGA-CC-5258,,\"Hepatocellular carcinoma, NOS\",6a93206a-c25c-4e45-b0ba-0a21bd8253b6,released,2019-04-28T13:20:55.909893-05:00,no,17586,1962,,0,male,not reported,not reported,6a93206a-c25c-4e45-b0ba-0a21bd8253b6,2019-04-28T13:20:55.909893-05:00,released,2019-05-03T14:06:23.922205-05:00,stage ii,027260a1-5655-56ed-a457-af7bcfadbf59,TCGA-CC-5258_diagnosis,asian,not reported,Liver,TCGA-CC-5258_treatment,6d83c227-7a04-5c8b-958c-790f8cf5ec3d,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-CC-5258_treatment_1,,,no,2019-04-28T13:20:55.909893-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:58.071505-05:00,released,ecfceeea-3526-5e6b-a2bb-aec642c87df6\\r\\n,TCGA-5C-A9VH_demographic,cbf6f8a9-0da8-5b65-baac-046dfffce3a2,8170/3,TCGA-5C-A9VH,,\"Hepatocellular carcinoma, NOS\",60fcd491-0170-46c0-ab14-d71f88267a14,released,2019-04-28T13:20:17.305483-05:00,no,25608,1943,,322,male,not reported,not reported,60fcd491-0170-46c0-ab14-d71f88267a14,2019-04-28T13:20:17.305483-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,3c3dbd03-7acd-5b16-b034-c95d9f0596e3,TCGA-5C-A9VH_diagnosis,white,not reported,Liver,TCGA-5C-A9VH_treatment,64aa2eaf-575d-5b4b-b2d7-a6cca52114a7,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-5C-A9VH_treatment_1,,,no,2019-04-28T13:20:17.305483-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:35.448559-05:00,released,21f1153a-c25b-5e3a-a04e-b5f7c3bd4630\\r\\n,TCGA-DD-AACL_demographic,ed6d528b-838c-5a51-acd9-4e91b2f74014,8170/3,TCGA-DD-AACL,,\"Hepatocellular carcinoma, NOS\",3da3cfec-5464-4dd8-9757-a0cdfe3536f8,released,2019-04-28T13:17:23.122061-05:00,no,24355,1942,,58,female,not reported,not reported,3da3cfec-5464-4dd8-9757-a0cdfe3536f8,2019-04-28T13:17:23.122061-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,3c9431a8-2a70-57fe-a100-17bb1df35169,TCGA-DD-AACL_diagnosis,asian,not reported,Liver,TCGA-DD-AACL_treatment,ce07d155-73af-5a98-9f74-d29f1cfb286e,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AACL_treatment_1,,,no,2019-04-28T13:17:23.122061-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:42.289685-05:00,released,4b371915-15d0-5243-96f0-8e8cea13cd83\\r\\n,TCGA-ED-A7PY_demographic,49febf45-716f-5d78-a67a-d02abfa0ba42,8170/3,TCGA-ED-A7PY,,\"Hepatocellular carcinoma, NOS\",a396e048-5aa0-4d71-96bd-7f4fdf6934aa,released,2019-04-28T13:24:02.166403-05:00,no,7556,1993,,390,female,not reported,not reported,a396e048-5aa0-4d71-96bd-7f4fdf6934aa,2019-04-28T13:24:02.166403-05:00,released,2019-05-03T14:06:23.922205-05:00,stage ii,3cf0ae94-08db-51b5-aae3-571da3e649cb,TCGA-ED-A7PY_diagnosis,asian,not reported,Liver,TCGA-ED-A7PY_treatment,27aee0ed-c36f-5f21-8aca-df1e47271b46,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-ED-A7PY_treatment_1,,,no,2019-04-28T13:24:02.166403-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:05.743590-05:00,released,22fd35dd-f118-5484-b055-08dd736a1618\\r\\n,TCGA-BC-A10S_demographic,d96dbff7-8ca4-5035-9974-a3c72e0448a5,8170/3,TCGA-BC-A10S,,\"Hepatocellular carcinoma, NOS\",592ef526-176a-42e0-bbeb-fb62d369a343,released,2019-04-28T09:25:01.372569-05:00,no,29842,1918,,,male,not reported,not reported,592ef526-176a-42e0-bbeb-fb62d369a343,2019-04-28T09:25:01.372569-05:00,released,2019-05-03T14:06:23.922205-05:00,not reported,a61c2196-449e-53bb-97b9-32843ea4bb98,TCGA-BC-A10S_diagnosis,white,not reported,Liver,TCGA-BC-A10S_treatment,46ebb24b-2852-5c9c-93e2-1ed54e616804,no,2002,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-BC-A10S_treatment_1,,,no,2019-04-28T09:25:01.372569-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:35.448559-05:00,released,302bae4b-6b10-59bf-be24-537eba141fd1\\r\\n,TCGA-ED-A459_demographic,d814e751-83ba-5ed9-8fe8-58883fd5f73d,8170/3,TCGA-ED-A459,,\"Hepatocellular carcinoma, NOS\",56403463-1727-4c23-a709-de5f168c4073,released,2019-04-28T13:19:35.227030-05:00,yes,17402,1965,,910,male,not reported,not reported,56403463-1727-4c23-a709-de5f168c4073,2019-04-28T13:19:35.227030-05:00,released,2019-05-03T14:06:23.922205-05:00,stage ii,8160488a-d2ef-599e-a5df-f709bfefa6cc,TCGA-ED-A459_diagnosis,asian,not reported,Liver,TCGA-ED-A459_treatment,4474095e-586b-5809-8cda-128b621290ff,yes,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-ED-A459_treatment_1,,,no,2019-04-28T13:19:35.227030-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:05.743590-05:00,released,138043d4-12b8-5e1c-ab7a-0a80b90b48ae\\r\\n,TCGA-DD-A1EE_demographic,0adb4177-d2bd-5424-8265-cb55fd54d181,8170/3,TCGA-DD-A1EE,,\"Hepatocellular carcinoma, NOS\",654af137-70d9-4ee4-9f69-793e352d30f8,released,,no,26858,1933,,204,male,not reported,not reported,654af137-70d9-4ee4-9f69-793e352d30f8,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:20:38.695986-05:00,stage iiia,03c85898-40d4-555d-99c8-4a76600490e9,TCGA-DD-A1EE_diagnosis,white,not reported,Liver,TCGA-DD-A1EE_treatment_1,b5173e9f-0981-5bca-9f26-b6e9d0edd9ae,no,,,Liver,released,not reported,2019-04-28T13:20:38.695986-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A1EE_treatment,,,no,2019-04-28T13:20:38.695986-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:19.490721-05:00,released,ddd209be-ca18-53cc-80a2-32d868821126\\r\\n,TCGA-DD-A4NF_demographic,7906d2ba-5ef6-5172-be06-3ecd7ccd6b7e,8170/3,TCGA-DD-A4NF,,\"Hepatocellular carcinoma, NOS\",1043bc90-72c9-48c9-ae24-f617d0485e78,released,2019-04-28T13:14:53.118184-05:00,no,26330,1939,,942,male,not reported,not reported,1043bc90-72c9-48c9-ae24-f617d0485e78,2019-04-28T13:14:53.118184-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,b7216171-78d3-5ee6-a888-e09201f64e04,TCGA-DD-A4NF_diagnosis,white,not reported,Liver,TCGA-DD-A4NF_treatment,11cb420d-48e0-5fc2-9679-d651a3c8ea5d,yes,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A4NF_treatment_1,,,no,2019-04-28T13:14:53.118184-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:19.490721-05:00,released,efde49fe-4c38-570d-88af-fcc778eec5cd\\r\\n,TCGA-DD-A4NN_demographic,68113f4d-71d3-538d-b222-720f2bf15b39,8170/3,TCGA-DD-A4NN,,\"Hepatocellular carcinoma, NOS\",b96b7620-5506-4def-aff2-5e888eaf3ea5,released,,no,20548,1948,,,female,not reported,not reported,b96b7620-5506-4def-aff2-5e888eaf3ea5,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:25:32.352763-05:00,stage i,3d1d7c7e-cd89-5fb6-b52f-c4d9f4563ebc,TCGA-DD-A4NN_diagnosis,white,not reported,Liver,TCGA-DD-A4NN_treatment_1,457656a3-343c-5c87-8403-f8f1a9f16014,no,2006,,Liver,released,not reported,2019-04-28T13:25:32.352763-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A4NN_treatment,,,no,2019-04-28T13:25:32.352763-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:19.490721-05:00,released,3de976b0-3dc8-5c8f-a3de-aa7e9d29c52f\\r\\n,TCGA-DD-A3A6_demographic,fc18cfe5-ba14-52a8-a8d8-2fb296c85365,8170/3,TCGA-DD-A3A6,,\"Hepatocellular carcinoma, NOS\",c4c4820b-6f4c-4cdd-b233-4d22f5933fd9,released,,no,26319,1925,,,female,not reported,not reported,c4c4820b-6f4c-4cdd-b233-4d22f5933fd9,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:26:08.972925-05:00,stage ii,3d91cd54-9f1b-5418-ae1c-f1f73cb550c4,TCGA-DD-A3A6_diagnosis,white,not reported,Liver,TCGA-DD-A3A6_treatment_1,706e9fae-f413-519c-aaaf-5e93ce23a24c,no,2005,,Liver,released,not reported,2019-04-28T13:26:08.972925-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A3A6_treatment,,,no,2019-04-28T13:26:08.972925-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:19.490721-05:00,released,313a790c-3282-598c-86e6-f90a880b90fd\\r\\n,TCGA-GJ-A6C0_demographic,fa5f5673-9c53-54a4-a131-726dbd8aa50c,8170/3,TCGA-GJ-A6C0,,\"Hepatocellular carcinoma, NOS\",1b326242-4be6-4f05-b5fb-07ed76b49850,released,2019-04-28T13:15:36.839535-05:00,no,27626,1937,,,female,not reported,not reported,1b326242-4be6-4f05-b5fb-07ed76b49850,2019-04-28T13:15:36.839535-05:00,released,2019-05-03T14:06:23.922205-05:00,stage ii,3d95e096-69f9-5e13-9269-9cbdce7a5da8,TCGA-GJ-A6C0_diagnosis,white,not reported,Liver,TCGA-GJ-A6C0_treatment,1a7395d3-023b-5a04-bb54-f45319ffc757,no,2012,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-GJ-A6C0_treatment_1,,,no,2019-04-28T13:15:36.839535-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:53.093878-05:00,released,d223999e-ba1a-56ab-aa07-cd0d8f1d9da3\\r\\n,TCGA-DD-AACO_demographic,45cfb94f-b857-5ad0-b6be-8edce899dbcb,8170/3,TCGA-DD-AACO,,\"Hepatocellular carcinoma, NOS\",34413807-07be-4204-b095-5e1dd1ed87dc,released,,no,14796,1969,,1876,male,not reported,not reported,34413807-07be-4204-b095-5e1dd1ed87dc,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:17:06.463136-05:00,stage i,3e7f9709-dbef-532c-97cb-ec89fcdf6ca5,TCGA-DD-AACO_diagnosis,asian,not reported,Liver,TCGA-DD-AACO_treatment_1,0ac06103-46eb-50f1-8505-5a522143ea86,no,,,Liver,released,not reported,2019-04-28T13:17:06.463136-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AACO_treatment,,,no,2019-04-28T13:17:06.463136-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:42.289685-05:00,released,28212fc8-07b3-5c9d-8ac7-e6722ce6fe16\\r\\n,TCGA-DD-AAE6_demographic,d472d406-e51d-5a90-85cc-fce9d0b2172a,8170/3,TCGA-DD-AAE6,,\"Hepatocellular carcinoma, NOS\",a61f823b-9164-4bd6-92f4-0a8d8ff0f55e,released,2019-04-28T13:24:10.271719-05:00,no,21764,1953,,141,female,not reported,not reported,a61f823b-9164-4bd6-92f4-0a8d8ff0f55e,2019-04-28T13:24:10.271719-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,3e9c5cb1-e56f-5d81-be8b-44cde4793c8f,TCGA-DD-AAE6_diagnosis,asian,not reported,Liver,TCGA-DD-AAE6_treatment,3dc73fec-72df-5256-a450-ac01fac1a325,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AAE6_treatment_1,,,no,2019-04-28T13:24:10.271719-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:05.743590-05:00,released,04afe9bc-c4df-5405-9afe-26574822790c\\r\\n,TCGA-UB-A7MD_demographic,f362047f-df82-5003-adb6-c85051d3cd08,8170/3,TCGA-UB-A7MD,,\"Hepatocellular carcinoma, NOS\",c49b41bf-0025-4682-966b-cfe8fb2b2546,released,2019-04-28T13:26:06.433564-05:00,no,24717,1946,,,male,not reported,not reported,c49b41bf-0025-4682-966b-cfe8fb2b2546,2019-04-28T13:26:06.433564-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,e79911fd-8be2-5a55-958b-678cd8962e93,TCGA-UB-A7MD_diagnosis,black or african american,not reported,Liver,TCGA-UB-A7MD_treatment,a7cc7f19-7944-5c43-8846-1c9bf29cba44,no,2013,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-UB-A7MD_treatment_1,,,no,2019-04-28T13:26:06.433564-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:53.093878-05:00,released,6bceb6d5-fc2b-5ce1-b2ec-f08b4e880fdc\\r\\n,TCGA-CC-5259_demographic,e8427baa-d2b2-5b7f-8878-40f13e8ffe57,8170/3,TCGA-CC-5259,,\"Hepatocellular carcinoma, NOS\",7444eea6-90e8-42dd-a7b5-0afc6d96e1e8,released,2019-04-28T13:21:22.179911-05:00,no,21946,1950,,250,female,not reported,not reported,7444eea6-90e8-42dd-a7b5-0afc6d96e1e8,2019-04-28T13:21:22.179911-05:00,released,2019-05-03T14:06:23.922205-05:00,stage iiic,e819f86b-d08a-5244-b7d4-10be0f6d1496,TCGA-CC-5259_diagnosis,asian,not reported,Liver,TCGA-CC-5259_treatment,b42fd25a-fea2-5e1c-94d2-7b9c8e673d53,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-CC-5259_treatment_1,,,no,2019-04-28T13:21:22.179911-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:58.071505-05:00,released,bf203f71-eca5-595b-a8b1-be4fcd38f833\\r\\n,TCGA-KR-A7K2_demographic,8f26c49f-72f5-5aa5-bef5-c9fd6d5f4be4,8180/3,TCGA-KR-A7K2,,Combined hepatocellular carcinoma and cholangiocarcinoma,fbb398fe-2ba8-4845-8083-6533ecb4a52e,released,,no,23699,1949,,829,male,not reported,not reported,fbb398fe-2ba8-4845-8083-6533ecb4a52e,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:28:36.600765-05:00,stage i,e8751753-fb55-5c60-8144-da0b8977bfa2,TCGA-KR-A7K2_diagnosis,white,not reported,Liver,TCGA-KR-A7K2_treatment_1,7e610c5f-dced-5131-aa07-0d4ff9505c69,no,,,Liver,released,not reported,2019-04-28T13:28:36.600765-05:00,,not reported,released,Adenomas and Adenocarcinomas,TCGA-KR-A7K2_treatment,,,no,2019-04-28T13:28:36.600765-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:53.093878-05:00,released,9a53ec49-4d38-5c6d-a151-ccf9029eae8a\\r\\n,TCGA-ED-A7XO_demographic,08587143-8cf0-55be-b2a8-9bd33b4e4fdc,8170/3,TCGA-ED-A7XO,,\"Hepatocellular carcinoma, NOS\",20bb3855-66e2-46d4-b189-006b4b254c2e,released,,no,10828,1984,,427,male,not reported,not reported,20bb3855-66e2-46d4-b189-006b4b254c2e,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:15:58.754462-05:00,stage iiia,e8871f2b-e212-5e8e-89d6-cd6ea7c25e3e,TCGA-ED-A7XO_diagnosis,asian,not reported,Liver,TCGA-ED-A7XO_treatment_1,b488f949-942a-5cc6-a178-32cb645791b0,no,,,Liver,released,not reported,2019-04-28T13:15:58.754462-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-ED-A7XO_treatment,,,no,2019-04-28T13:15:58.754462-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:05.743590-05:00,released,199a9fda-e082-5ddb-9c80-27af195da7e5\\r\\n,TCGA-YA-A8S7_demographic,c6a9c5d2-fbbc-54a4-975e-2bea0eb331c0,8170/3,TCGA-YA-A8S7,,\"Hepatocellular carcinoma, NOS\",bb2069d3-e699-4a8a-bb61-b3c28b98a66b,released,2019-04-28T13:25:37.300500-05:00,yes,25188,1944,,,male,not reported,not reported,bb2069d3-e699-4a8a-bb61-b3c28b98a66b,2019-04-28T13:25:37.300500-05:00,released,2019-05-03T14:06:23.922205-05:00,stage iiia,e8c3b42b-ead6-5132-9a93-60c5ba00e78e,TCGA-YA-A8S7_diagnosis,white,not reported,Liver,TCGA-YA-A8S7_treatment,00d455d1-fd97-5e93-9225-d982f0ad3780,no,2013,,Liver,released,not reported,,,hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-YA-A8S7_treatment_1,,,no,2019-04-28T13:25:37.300500-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:38:16.668337-05:00,released,42777ab3-c8f5-5d78-82d5-7402a68eab8c\\r\\n,TCGA-FV-A496_demographic,d0250ac6-0b30-50f2-86e0-0ef22407445a,8170/3,TCGA-FV-A496,,\"Hepatocellular carcinoma, NOS\",8afa3140-dcbd-44c0-ab13-4ada6a0444d4,released,,not reported,30950,1928,,10,female,not reported,not reported,8afa3140-dcbd-44c0-ab13-4ada6a0444d4,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:22:51.212088-05:00,stage i,e916b516-078c-5749-8cf9-5dcc311f9ad6,TCGA-FV-A496_diagnosis,white,not reported,Liver,TCGA-FV-A496_treatment_1,b431dd84-8c64-5329-9e21-878c23127e06,not reported,,,Liver,released,not reported,2019-04-28T13:22:51.212088-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-FV-A496_treatment,,,no,2019-04-28T13:22:51.212088-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:27.936420-05:00,released,df7ace6e-3758-508b-bb6d-532bc4a24240\\r\\n,TCGA-DD-AAC8_demographic,08d90b3b-5cd0-5d0b-9357-ba9d81309012,8170/3,TCGA-DD-AAC8,,\"Hepatocellular carcinoma, NOS\",496beef9-80d9-4734-a23d-334ae1b6aaab,released,,no,26322,1936,,,male,not reported,not reported,496beef9-80d9-4734-a23d-334ae1b6aaab,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T08:58:28.393775-05:00,stage i,046d006e-0108-5780-a2f4-97c227f7ec09,TCGA-DD-AAC8_diagnosis,asian,not reported,Liver,TCGA-DD-AAC8_treatment_1,c3d386b9-94ed-5bce-b5ec-7d56a23ac9cb,no,2008,,Liver,released,not reported,2019-04-28T08:58:28.393775-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AAC8_treatment,,,no,2019-04-28T08:58:28.393775-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:42.289685-05:00,released,b9e5e085-a9c7-5165-a0d1-182840a14e6b\\r\\n,TCGA-UB-AA0V_demographic,892406cf-8e08-59ba-8c20-41c9ebb72281,8170/3,TCGA-UB-AA0V,,\"Hepatocellular carcinoma, NOS\",ea214f79-0f6b-403f-8693-c844bf4b77cb,released,2019-04-28T13:27:51.728883-05:00,no,25340,1944,,314,female,not reported,not reported,ea214f79-0f6b-403f-8693-c844bf4b77cb,2019-04-28T13:27:51.728883-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,403c4f79-e963-58ef-a156-4462a071e004,TCGA-UB-AA0V_diagnosis,white,not reported,Liver,TCGA-UB-AA0V_treatment,124adab3-3d19-5d75-ac6f-21660e45f733,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-UB-AA0V_treatment_1,,,yes,2019-04-28T13:27:51.728883-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:38:16.668337-05:00,released,111f0e7b-f2cb-5763-9a83-681e98dfe1fd\\r\\n,TCGA-DD-A1EJ_demographic,7e06f6cc-c8ab-58db-bcb9-f3e32d3adc80,8170/3,TCGA-DD-A1EJ,,\"Hepatocellular carcinoma, NOS\",52292ffc-0902-4d97-b461-20723987a177,released,2019-04-28T13:19:18.338331-05:00,yes,26009,1937,,887,female,not reported,not reported,52292ffc-0902-4d97-b461-20723987a177,2019-04-28T13:19:18.338331-05:00,released,2019-05-03T14:06:23.922205-05:00,stage iiic,40b9e642-18d5-5633-a7d9-9ccd013a24a2,TCGA-DD-A1EJ_diagnosis,white,not reported,Liver,TCGA-DD-A1EJ_treatment,6ae73e07-3dcb-56ad-ac46-3752cf20f759,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A1EJ_treatment_1,,,no,2019-04-28T13:19:18.338331-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:19.490721-05:00,released,ba842480-3ef3-5544-b3f4-6dbda2c440ce\\r\\n,TCGA-BC-A217_demographic,c0d85091-0e52-5ef8-beb9-7e05cb843c7b,8170/3,TCGA-BC-A217,,\"Hepatocellular carcinoma, NOS\",6dcfc418-ab28-4365-95ea-c1ae254f2341,released,,no,27411,1935,,421,female,not reported,not reported,6dcfc418-ab28-4365-95ea-c1ae254f2341,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:21:02.988662-05:00,stage ii,b73346d5-d95b-58e9-b067-bf36270e905d,TCGA-BC-A217_diagnosis,white,not reported,Liver,TCGA-BC-A217_treatment_1,4aaa3333-63e9-5d5b-8923-abd2e8a626ea,no,,,Liver,released,not reported,2019-04-28T13:21:02.988662-05:00,,not reported,released,Adenomas and Adenocarcinomas,TCGA-BC-A217_treatment,,,no,2019-04-28T13:21:02.988662-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:35.448559-05:00,released,24e968fa-b55b-5cee-aee7-c995b2f8253d\\r\\n,TCGA-DD-AADL_demographic,e666b8fb-c952-566b-a1f5-1d363cdc3439,8170/3,TCGA-DD-AADL,,\"Hepatocellular carcinoma, NOS\",a7f7e313-4636-4c54-b2b7-f5928a8368e4,released,,no,21512,1954,,636,male,not reported,not reported,a7f7e313-4636-4c54-b2b7-f5928a8368e4,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:24:25.037990-05:00,stage i,9d4a0347-6ca3-579e-8cc8-d057f8bac565,TCGA-DD-AADL_diagnosis,asian,not reported,Liver,TCGA-DD-AADL_treatment_1,83c2a7f4-14d6-5fa1-8129-b3b03011905f,no,,,Liver,released,not reported,2019-04-28T13:24:25.037990-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AADL_treatment,,,no,2019-04-28T13:24:25.037990-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:42.289685-05:00,released,d85163cf-1c96-5aed-972c-ea5757a92b7f\\r\\n,TCGA-ED-A8O5_demographic,4912876b-3904-5065-a895-4b16910a83f2,8170/3,TCGA-ED-A8O5,,\"Hepatocellular carcinoma, NOS\",2bea076b-c923-4a91-a37b-c6615fec021c,released,,no,21648,1954,,406,female,not reported,not reported,2bea076b-c923-4a91-a37b-c6615fec021c,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:16:34.942637-05:00,stage iiia,6b6114d3-25b4-5713-a697-1fc11b1e42a9,TCGA-ED-A8O5_diagnosis,asian,not reported,Liver,TCGA-ED-A8O5_treatment_1,4787ebfb-efdf-5a1e-9f6b-a4388a53a667,no,,,Liver,released,not reported,2019-04-28T13:16:34.942637-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-ED-A8O5_treatment,,,no,2019-04-28T13:16:34.942637-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:27.936420-05:00,released,21679b43-281f-5263-b567-a2c2c25fec6a\\r\\n,TCGA-UB-A7MF_demographic,ba7e49e6-14b8-51d0-bbce-7d1d74b79a48,8170/3,TCGA-UB-A7MF,,\"Hepatocellular carcinoma, NOS\",8eef926b-f316-4fdb-b84a-262010258feb,released,2019-04-28T13:23:03.570865-05:00,no,20815,1957,,,male,not reported,not reported,8eef926b-f316-4fdb-b84a-262010258feb,2019-04-28T13:23:03.570865-05:00,released,2019-05-03T14:06:23.922205-05:00,stage iiia,04756ffb-84bf-51cf-9253-16d3ba953211,TCGA-UB-A7MF_diagnosis,white,not reported,Liver,TCGA-UB-A7MF_treatment,b2f56f65-04d4-5cf8-ade9-4297ddba0313,no,2013,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-UB-A7MF_treatment_1,,,yes,2019-04-28T13:23:03.570865-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:38:16.668337-05:00,released,34a73d5a-76ad-5095-86ad-1c70dcf6688e\\r\\n,TCGA-DD-AACJ_demographic,747a33cd-9e51-5952-8eed-937d9626f1bf,8170/3,TCGA-DD-AACJ,,\"Hepatocellular carcinoma, NOS\",93afbfa1-4d03-4105-8dda-b095f0ab308a,released,,no,27528,1933,,2102,male,not reported,not reported,93afbfa1-4d03-4105-8dda-b095f0ab308a,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:23:16.232721-05:00,stage ii,2d300209-7018-5866-9ee5-4882e5291614,TCGA-DD-AACJ_diagnosis,asian,not reported,Liver,TCGA-DD-AACJ_treatment_1,1a3cb188-e868-56fa-9325-394f2e946da0,no,,,Liver,released,not reported,2019-04-28T13:23:16.232721-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AACJ_treatment,,,no,2019-04-28T13:23:16.232721-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:42.289685-05:00,released,2c51dbef-64d8-5ff0-964d-49bc5fa16469\\r\\n,TCGA-G3-AAV0_demographic,c096181e-22ac-5914-a05c-adf7b27d4ca3,8170/3,TCGA-G3-AAV0,,\"Hepatocellular carcinoma, NOS\",6e657705-8579-433b-af7a-b6155b599518,released,,no,21249,1955,,476,male,not reported,not reported,6e657705-8579-433b-af7a-b6155b599518,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T09:12:48.556882-05:00,stage i,40ebac27-81fe-5276-8695-9b45caea8305,TCGA-G3-AAV0_diagnosis,asian,not reported,Liver,TCGA-G3-AAV0_treatment_1,770fa850-0bb2-5664-b679-1298034607fd,no,,,Liver,released,not reported,2019-04-28T09:12:48.556882-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-G3-AAV0_treatment,,,no,2019-04-28T09:12:48.556882-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:27.936420-05:00,released,14fce117-0011-5135-a2a9-5cce0b7c0734\\r\\n,TCGA-XR-A8TG_demographic,5f49af80-0a97-579c-b466-7ea1ea9eb310,8170/3,TCGA-XR-A8TG,,\"Hepatocellular carcinoma, NOS\",1d7d5166-6582-4ea1-b242-37c2c3919a3c,released,2019-04-28T13:15:46.786864-05:00,no,21544,1954,,898,male,not reported,not reported,1d7d5166-6582-4ea1-b242-37c2c3919a3c,2019-04-28T13:15:46.786864-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,42817abc-6823-5ac2-a769-298c088f0e51,TCGA-XR-A8TG_diagnosis,white,not reported,Liver,TCGA-XR-A8TG_treatment,2a1e9a64-41ce-5ff3-a97c-0f86b11a42f0,yes,,,Liver,released,not reported,,,hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-XR-A8TG_treatment_1,,,yes,2019-04-28T13:15:46.786864-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:38:16.668337-05:00,released,4b5da898-0794-5780-bf4a-c6a689d9e572\\r\\n,TCGA-DD-AAEK_demographic,c2f43d9a-3a47-555f-a6a3-3885e0ee5fee,8170/3,TCGA-DD-AAEK,,\"Hepatocellular carcinoma, NOS\",6ea0ef82-694d-492d-95da-a3bc8de99149,released,2019-04-28T13:21:05.151751-05:00,no,18757,1959,,1067,male,not reported,not reported,6ea0ef82-694d-492d-95da-a3bc8de99149,2019-04-28T13:21:05.151751-05:00,released,2019-05-03T14:06:23.922205-05:00,stage ii,42932a4b-6c58-5ad3-bbff-40cc025a9e4c,TCGA-DD-AAEK_diagnosis,asian,not reported,Liver,TCGA-DD-AAEK_treatment,1e720889-8c29-55db-ae89-23d7032c206e,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AAEK_treatment_1,,,no,2019-04-28T13:21:05.151751-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:05.743590-05:00,released,1bea0b89-ba96-59da-97b9-f59e83400530\\r\\n,TCGA-DD-AACH_demographic,535e59a2-4074-544e-8a52-4840b0cb5b3e,8170/3,TCGA-DD-AACH,,\"Hepatocellular carcinoma, NOS\",219b067c-522f-4971-b0d0-86f9971d369d,released,,no,25544,1939,,,male,not reported,not reported,219b067c-522f-4971-b0d0-86f9971d369d,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:16:01.092280-05:00,stage ii,42ced4c3-e884-53ae-a032-b174fa20d4e9,TCGA-DD-AACH_diagnosis,asian,not reported,Liver,TCGA-DD-AACH_treatment_1,4bca8769-9ea3-5404-82db-2d8bcef48224,no,2008,,Liver,released,not reported,2019-04-28T13:16:01.092280-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AACH_treatment,,,no,2019-04-28T13:16:01.092280-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:42.289685-05:00,released,390a389c-ecb2-51c8-963b-1c37770f536d\\r\\n,TCGA-G3-A3CI_demographic,8f72d4f6-26d8-56ee-a3f1-1ebe2bc832cd,8170/3,TCGA-G3-A3CI,,\"Hepatocellular carcinoma, NOS\",b5465221-78fe-40a8-abec-bed600602dd4,released,2019-04-28T13:25:11.094621-05:00,not reported,26224,1940,,180,male,not reported,not reported,b5465221-78fe-40a8-abec-bed600602dd4,2019-04-28T13:25:11.094621-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,d38463b6-1caf-5612-81fc-5a858382d91f,TCGA-G3-A3CI_diagnosis,white,not reported,Liver,TCGA-G3-A3CI_treatment,0858751a-24ea-5608-944d-0a09774995a4,not reported,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-G3-A3CI_treatment_1,,,no,2019-04-28T13:25:11.094621-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:27.936420-05:00,released,287ea99f-1ade-57e8-b11c-a94d9d8da37e\\r\\n,TCGA-BC-A3KF_demographic,87afc6a8-5ec2-53ea-8c00-54ee73b29e2f,8170/3,TCGA-BC-A3KF,,\"Hepatocellular carcinoma, NOS\",07dd49fc-8a76-41e8-9eb3-107336f68701,released,2019-04-28T09:02:13.241645-05:00,not reported,24328,1945,,8,female,not reported,not reported,07dd49fc-8a76-41e8-9eb3-107336f68701,2019-04-28T09:02:13.241645-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,1d15a978-201a-5b3d-bf79-1861bbb4a95f,TCGA-BC-A3KF_diagnosis,white,not reported,Liver,TCGA-BC-A3KF_treatment,39545a2d-32a5-57e0-8380-a98dfbb45241,not reported,,,Liver,released,not reported,,,not reported,released,Adenomas and Adenocarcinomas,TCGA-BC-A3KF_treatment_1,,,no,2019-04-28T09:02:13.241645-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:35.448559-05:00,released,057b05d5-8895-54b4-b3a0-ddf20993b7b5\\r\\n,TCGA-DD-AADR_demographic,28b2a771-2712-5e7e-ad03-86fcf134db66,8170/3,TCGA-DD-AADR,,\"Hepatocellular carcinoma, NOS\",899d8ea5-49dc-4970-8848-ea6ea088a272,released,,no,21217,1951,,2028,male,not reported,not reported,899d8ea5-49dc-4970-8848-ea6ea088a272,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:22:44.258889-05:00,stage i,4306cb20-b0d3-5969-8785-f9401dcc6a46,TCGA-DD-AADR_diagnosis,asian,not reported,Liver,TCGA-DD-AADR_treatment_1,863f63e6-99be-531c-b47b-a12794799bd4,no,,,Liver,released,not reported,2019-04-28T13:22:44.258889-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AADR_treatment,,,no,2019-04-28T13:22:44.258889-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:05.743590-05:00,released,e5953b63-a8c6-5e04-b722-2cb794f9ee92\\r\\n,TCGA-FV-A3R2_demographic,648f8a7b-298a-5307-ab34-e287544ee7b4,8170/3,TCGA-FV-A3R2,,\"Hepatocellular carcinoma, NOS\",17833039-0d7e-47f0-90e6-8cabae94c124,released,2019-04-28T13:15:17.254685-05:00,yes,27530,1930,,,male,not reported,not reported,17833039-0d7e-47f0-90e6-8cabae94c124,2019-04-28T13:15:17.254685-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,43390a46-18b2-5d41-bbb0-b0fa6c07fae4,TCGA-FV-A3R2_diagnosis,white,not reported,Liver,TCGA-FV-A3R2_treatment,377a3ca9-565d-521d-8e4f-4bc903b501d9,no,2005,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-FV-A3R2_treatment_1,,,yes,2019-04-28T13:15:17.254685-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:27.936420-05:00,released,c0b9c23f-7323-5e0d-993c-a5cac4f6e6ca\\r\\n,TCGA-CC-A9FV_demographic,92dddf8d-d3aa-56fc-aedc-45804a674929,8170/3,TCGA-CC-A9FV,,\"Hepatocellular carcinoma, NOS\",c4e6527a-8f58-4f6b-93b1-04abb5680ed0,released,,not reported,21044,1956,,0,male,not reported,not reported,c4e6527a-8f58-4f6b-93b1-04abb5680ed0,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:26:11.469640-05:00,stage iiia,43b242b0-1c9a-55b9-9464-19bf863200bf,TCGA-CC-A9FV_diagnosis,asian,not reported,Liver,TCGA-CC-A9FV_treatment_1,39e48792-2781-53be-b977-19e7ac0a3125,not reported,,,Liver,released,not reported,2019-04-28T13:26:11.469640-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-CC-A9FV_treatment,,,no,2019-04-28T13:26:11.469640-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:58.071505-05:00,released,5065a843-4f2d-55d8-bfa1-8229d1575717\\r\\n,TCGA-G3-A25U_demographic,5ac0628e-eb52-52e1-96bd-218a2b58f815,8170/3,TCGA-G3-A25U,,\"Hepatocellular carcinoma, NOS\",b9835dc5-bf31-4541-a973-e8ca802d80ba,released,,no,23207,1944,,1636,female,not reported,not reported,b9835dc5-bf31-4541-a973-e8ca802d80ba,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:25:34.776900-05:00,stage i,43f5ec56-a144-51c0-bec7-3fae2d90e71c,TCGA-G3-A25U_diagnosis,asian,not reported,Liver,TCGA-G3-A25U_treatment_1,4a65e5a0-9428-509f-ae61-b274bc4e7a63,no,,,Liver,released,not reported,2019-04-28T13:25:34.776900-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-G3-A25U_treatment,,,no,2019-04-28T13:25:34.776900-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:27.936420-05:00,released,41d65c25-cb42-53db-a40d-eafe1738d0b5\\r\\n,TCGA-DD-A3A3_demographic,689e8856-5619-503a-9dfd-330eab43c631,8170/3,TCGA-DD-A3A3,,\"Hepatocellular carcinoma, NOS\",516c8594-2973-41e5-a5ce-76d177edfa48,released,2019-04-28T13:19:09.052475-05:00,not reported,16708,1954,,,male,not reported,not reported,516c8594-2973-41e5-a5ce-76d177edfa48,2019-04-28T13:19:09.052475-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,115b8a69-5641-5d2b-a225-9333ce309565,TCGA-DD-A3A3_diagnosis,asian,not reported,Liver,TCGA-DD-A3A3_treatment,77b36f6d-6dcb-54d7-9d8e-b0c02a8b62e8,not reported,2000,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A3A3_treatment_1,,,no,2019-04-28T13:19:09.052475-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:19.490721-05:00,released,c8734913-6072-5814-8106-4c5aa436bafc\\r\\n,TCGA-DD-AACC_demographic,f6363b60-2f08-555d-b53f-ae49420da6f9,8170/3,TCGA-DD-AACC,,\"Hepatocellular carcinoma, NOS\",ed8c0d53-5db0-4b77-95ec-15971926e313,released,,no,22499,1947,,,male,not reported,not reported,ed8c0d53-5db0-4b77-95ec-15971926e313,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:27:59.439131-05:00,stage i,7e162531-a8d4-5240-a01c-fa5698a32cdd,TCGA-DD-AACC_diagnosis,asian,not reported,Liver,TCGA-DD-AACC_treatment_1,f4d28b87-dbf4-56a0-8609-9623e62d3dd5,no,2012,,Liver,released,not reported,2019-04-28T13:27:59.439131-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AACC_treatment,,,no,2019-04-28T13:27:59.439131-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:42.289685-05:00,released,d01b2b71-da71-5dd6-a69c-c7af822f71cc\\r\\n,TCGA-DD-AACI_demographic,c3f85da6-43d0-5f0a-aef2-1cbbfb14c1e3,8170/3,TCGA-DD-AACI,,\"Hepatocellular carcinoma, NOS\",e6fa354e-ada7-41e0-8c8b-38520a5e6601,released,2019-04-28T09:25:15.879891-05:00,no,25236,1939,,1618,male,not reported,not reported,e6fa354e-ada7-41e0-8c8b-38520a5e6601,2019-04-28T09:25:15.879891-05:00,released,2019-05-03T14:06:23.922205-05:00,stage ii,c9add189-907b-5bc3-b4a4-19a86495a579,TCGA-DD-AACI_diagnosis,asian,not reported,Liver,TCGA-DD-AACI_treatment,39264c87-e1c3-5906-a34c-4db9767f76a8,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AACI_treatment_1,,,no,2019-04-28T09:25:15.879891-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:42.289685-05:00,released,422a3610-551f-500c-b6fd-6500ee29b4fa\\r\\n,TCGA-DD-AAVQ_demographic,99befad3-7d2f-5b9d-8771-d38067963aa8,8170/3,TCGA-DD-AAVQ,,\"Hepatocellular carcinoma, NOS\",80e7742f-abbe-4f11-b4e4-c999dc1bd459,released,,no,13911,1969,,2728,male,not reported,not reported,80e7742f-abbe-4f11-b4e4-c999dc1bd459,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:22:08.436556-05:00,stage i,ab9d5866-bb73-52e9-9009-7220fc071db4,TCGA-DD-AAVQ_diagnosis,asian,not reported,Liver,TCGA-DD-AAVQ_treatment_1,b240ea14-e514-5cda-a051-b531165b6758,no,,,Liver,released,not reported,2019-04-28T13:22:08.436556-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AAVQ_treatment,,,no,2019-04-28T13:22:08.436556-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:05.743590-05:00,released,eab0ab83-f532-587f-b77a-729ca78237f1\\r\\n,TCGA-BC-A10U_demographic,0daad81b-336e-5a44-9d3b-06de833bb922,8170/3,TCGA-BC-A10U,,\"Hepatocellular carcinoma, NOS\",23103931-cc29-4f89-ae9c-79d53401ecea,released,,no,25305,1931,,,male,not reported,not reported,23103931-cc29-4f89-ae9c-79d53401ecea,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T08:36:47.504617-05:00,not reported,9d5bb55c-9078-5fe7-9b62-e181bcae6a52,TCGA-BC-A10U_diagnosis,white,not reported,Liver,TCGA-BC-A10U_treatment_1,0bcae4a4-2b6b-5b68-ae6d-fc5ed358bdae,no,2002,,Liver,released,not reported,2019-04-28T08:36:47.504617-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-BC-A10U_treatment,,,no,2019-04-28T08:36:47.504617-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:35.448559-05:00,released,4f127b23-b5ee-5474-8426-53a25e1f5359\\r\\n,TCGA-DD-A119_demographic,48d48758-76ce-5818-98de-1f403edce635,8170/3,TCGA-DD-A119,,\"Hepatocellular carcinoma, NOS\",66c6f413-b7a8-4d7c-9e1d-c4fb257b9e5c,released,2019-04-28T13:20:43.661162-05:00,not reported,14613,1963,,,male,not reported,not reported,66c6f413-b7a8-4d7c-9e1d-c4fb257b9e5c,2019-04-28T13:20:43.661162-05:00,released,2019-05-03T14:06:23.922205-05:00,stage iv,44d5eaf0-d376-590c-930b-7ee64a43dfcf,TCGA-DD-A119_diagnosis,asian,not reported,Liver,TCGA-DD-A119_treatment,7af78546-c17e-56cd-980a-72480096fd79,not reported,2003,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A119_treatment_1,,,no,2019-04-28T13:20:43.661162-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:58.071505-05:00,released,139cc8d8-a15c-5dd1-b748-1fcb553a93bc\\r\\n,TCGA-CC-A8HV_demographic,0899a3d5-a830-5bcb-8636-121a48767ddc,8170/3,TCGA-CC-A8HV,,\"Hepatocellular carcinoma, NOS\",5b32d3f4-9b88-42de-aaac-22d1d2f5cde0,released,2019-04-28T13:19:54.986361-05:00,yes,18935,1962,,0,female,not reported,not reported,5b32d3f4-9b88-42de-aaac-22d1d2f5cde0,2019-04-28T13:19:54.986361-05:00,released,2019-05-03T14:06:23.922205-05:00,stage ii,44edd4aa-05c0-5965-bb44-8b2e1a40cb28,TCGA-CC-A8HV_diagnosis,asian,not reported,Liver,TCGA-CC-A8HV_treatment,e3a96b8e-40b3-577d-8311-9eb7aa7005a2,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-CC-A8HV_treatment_1,,,no,2019-04-28T13:19:54.986361-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:58.071505-05:00,released,c8eed5e9-10f6-5135-9a73-e5cd5d1f384b\\r\\n,TCGA-CC-A5UE_demographic,ba02e258-e10c-5fb7-bf98-3cc4a7c52d5b,8170/3,TCGA-CC-A5UE,,\"Hepatocellular carcinoma, NOS\",23d8e6a0-fa79-4323-a0a6-2dea2a319667,released,2019-04-28T13:16:12.905319-05:00,no,17805,1964,,0,male,not reported,not reported,23d8e6a0-fa79-4323-a0a6-2dea2a319667,2019-04-28T13:16:12.905319-05:00,released,2019-05-03T14:06:23.922205-05:00,stage iiib,46293e2f-9cbd-5c4e-8b1c-98db29a2e38f,TCGA-CC-A5UE_diagnosis,asian,not reported,Liver,TCGA-CC-A5UE_treatment,bb7288b2-4df5-5ef7-9faf-447a68eefadd,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-CC-A5UE_treatment_1,,,no,2019-04-28T13:16:12.905319-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:58.071505-05:00,released,045bac88-fa67-59db-994e-ac10c2226921\\r\\n,TCGA-G3-A25T_demographic,3c6e3996-aaa4-52d0-b74e-551d07db5f9a,8170/3,TCGA-G3-A25T,,\"Hepatocellular carcinoma, NOS\",f6e5979d-d6a9-4408-bd1b-1b37d1064e83,released,2019-04-28T13:28:25.829022-05:00,no,16461,1962,,1553,female,not reported,not reported,f6e5979d-d6a9-4408-bd1b-1b37d1064e83,2019-04-28T13:28:25.829022-05:00,released,2019-05-03T14:06:23.922205-05:00,stage iiia,f3cd6dcb-f8d7-52ca-a4de-a5f809edd587,TCGA-G3-A25T_diagnosis,white,not reported,Liver,TCGA-G3-A25T_treatment,5d8a8a50-f1dd-5e0c-8f7d-7afac74d1b31,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-G3-A25T_treatment_1,,,no,2019-04-28T13:28:25.829022-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:27.936420-05:00,released,e078ae58-907f-577a-8569-ffcb090e9403\\r\\n,TCGA-DD-AADB_demographic,ee7b1fd4-99ac-5c0c-aa1e-9f2b98d04fe9,8170/3,TCGA-DD-AADB,,\"Hepatocellular carcinoma, NOS\",5eaaf7ae-36af-4fb4-8940-e0861983ceb0,released,,no,18728,1960,,1242,male,not reported,not reported,5eaaf7ae-36af-4fb4-8940-e0861983ceb0,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:20:12.407668-05:00,stage i,12757fe9-8298-5558-9008-ee5b858aa432,TCGA-DD-AADB_diagnosis,asian,not reported,Liver,TCGA-DD-AADB_treatment_1,0c34f54f-9b82-5217-8cad-6aa615fb50b7,no,,,Liver,released,not reported,2019-04-28T13:20:12.407668-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AADB_treatment,,,no,2019-04-28T13:20:12.407668-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:42.289685-05:00,released,545e15dd-2a3c-58c9-b7ac-0285cf6743ed\\r\\n,TCGA-2Y-A9H1_demographic,b93dee1d-8bf7-5730-9dc9-4a79dc8cb2c8,8170/3,TCGA-2Y-A9H1,,\"Hepatocellular carcinoma, NOS\",9c5e2438-f587-4935-92f0-4bfd57468eaa,released,2019-04-28T13:23:46.349908-05:00,no,21222,1952,,,male,not reported,not reported,9c5e2438-f587-4935-92f0-4bfd57468eaa,2019-04-28T13:23:46.349908-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,3cff2da0-3649-544d-bc98-3541c3a1c3dc,TCGA-2Y-A9H1_diagnosis,white,not reported,Liver,TCGA-2Y-A9H1_treatment,8d425950-7430-5ae8-9e45-c2091d445813,no,2013,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-2Y-A9H1_treatment_1,,,no,2019-04-28T13:23:46.349908-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:35.448559-05:00,released,e9972ac2-3391-5e9f-938c-1ae37baaf4f9\\r\\n,TCGA-G3-A7M6_demographic,8cff3e69-b900-52f8-b61f-f78aafa07792,8170/3,TCGA-G3-A7M6,,\"Hepatocellular carcinoma, NOS\",2681f83d-233f-4ea2-b5e6-3c05af81f123,released,,no,22205,1953,,632,female,not reported,not reported,2681f83d-233f-4ea2-b5e6-3c05af81f123,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:16:24.663653-05:00,stage i,d2815a52-f1a1-57a0-8dcc-4efe8db47aee,TCGA-G3-A7M6_diagnosis,white,not reported,Liver,TCGA-G3-A7M6_treatment_1,2aa7c8f3-a938-573e-8a61-b7d36937d2c8,no,,,Liver,released,not reported,2019-04-28T13:16:24.663653-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-G3-A7M6_treatment,,,no,2019-04-28T13:16:24.663653-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:27.936420-05:00,released,39c9aa4f-c6ca-51a3-bd03-436ae3248906\\r\\n,TCGA-BC-A5W4_demographic,c855d99f-2649-5a39-a975-8aceeb053e34,8170/3,TCGA-BC-A5W4,,\"Hepatocellular carcinoma, NOS\",6bb5d506-8fca-43f3-90a6-03c915d7ede2,released,,no,25503,1943,,289,male,not reported,not reported,6bb5d506-8fca-43f3-90a6-03c915d7ede2,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:21:00.681739-05:00,stage iiia,d29e4448-0546-5e4d-b7ea-f11d1cd3e200,TCGA-BC-A5W4_diagnosis,white,not reported,Liver,TCGA-BC-A5W4_treatment_1,ecbe6edd-0f70-5782-ae51-fb1f7dd64afe,no,,,Liver,released,not reported,2019-04-28T13:21:00.681739-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-BC-A5W4_treatment,,,yes,2019-04-28T13:21:00.681739-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:35.448559-05:00,released,d75cd02c-056a-5065-bcb4-cf0ea6d6eff5\\r\\n,TCGA-DD-AADC_demographic,eb3d29f0-0443-52fc-95ab-9c9b3acfe33d,8170/3,TCGA-DD-AADC,,\"Hepatocellular carcinoma, NOS\",4100fd8b-cf37-4e63-a73d-95c9c392d606,released,,no,19527,1958,,,male,not reported,not reported,4100fd8b-cf37-4e63-a73d-95c9c392d606,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:17:59.870170-05:00,stage i,d338eff5-3e10-552f-952c-a655f976dc82,TCGA-DD-AADC_diagnosis,asian,not reported,Liver,TCGA-DD-AADC_treatment_1,6ec7690d-4a95-5595-8f30-b9f2d9f52977,no,2012,,Liver,released,not reported,2019-04-28T13:17:59.870170-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AADC_treatment,,,no,2019-04-28T13:17:59.870170-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:42.289685-05:00,released,9ba60424-ba84-5a0e-9238-9df4116dbb64\\r\\n,TCGA-EP-A12J_demographic,b07ac05e-d44a-590f-b9df-06141eb194c2,8170/3,TCGA-EP-A12J,,\"Hepatocellular carcinoma, NOS\",959918d7-cb84-4745-a72f-d138176b1ecb,released,,no,22997,1948,,570,male,not reported,not reported,959918d7-cb84-4745-a72f-d138176b1ecb,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:23:26.154208-05:00,stage i,c2990492-cd81-5c52-9a37-6c9a600eade3,TCGA-EP-A12J_diagnosis,black or african american,not reported,Liver,TCGA-EP-A12J_treatment_1,845abc19-3b90-5fdd-8f96-fa8f27e7590e,no,,,Liver,released,not reported,2019-04-28T13:23:26.154208-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-EP-A12J_treatment,,,no,2019-04-28T13:23:26.154208-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:27.936420-05:00,released,2501df72-8136-5508-960f-5f682d7e16e9\\r\\n,TCGA-BC-A112_demographic,ba1c046f-bc74-5540-8d31-0e56a1a65c48,8170/3,TCGA-BC-A112,,\"Hepatocellular carcinoma, NOS\",a2c17e87-d8bc-4160-88ae-e3e894d013e4,released,2019-04-28T13:23:58.551396-05:00,no,29511,1929,,,male,not reported,not reported,a2c17e87-d8bc-4160-88ae-e3e894d013e4,2019-04-28T13:23:58.551396-05:00,released,2019-05-03T14:06:23.922205-05:00,not reported,2965e5e6-ecc5-5bf6-bec3-1da0ce317753,TCGA-BC-A112_diagnosis,white,not reported,Liver,TCGA-BC-A112_treatment,0d829df0-0fac-596b-92be-232fd6f9b675,no,2009,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-BC-A112_treatment_1,,,yes,2019-04-28T13:23:58.551396-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:35.448559-05:00,released,233f016d-5a41-581f-9f1d-111e025860e2\\r\\n,TCGA-DD-A4NR_demographic,691d98be-9aa9-5be9-8437-1eb53e3e3450,8170/3,TCGA-DD-A4NR,,\"Hepatocellular carcinoma, NOS\",52a7f734-da07-49c5-861d-c70da37ff959,released,,no,31386,1920,,,female,not reported,not reported,52a7f734-da07-49c5-861d-c70da37ff959,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:19:22.900615-05:00,stage i,29e47b05-4fd9-57ae-ad1c-065db21ab6c6,TCGA-DD-A4NR_diagnosis,white,not reported,Liver,TCGA-DD-A4NR_treatment_1,711256e5-2ce7-5782-96c0-a0c399d40fc8,no,2005,,Liver,released,not reported,2019-04-28T13:19:22.900615-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A4NR_treatment,,,no,2019-04-28T13:19:22.900615-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:19.490721-05:00,released,138a2a4d-9b7f-5a38-90fa-6d8443abe872\\r\\n,TCGA-DD-A1EI_demographic,765a9c3a-9481-5177-a0f4-a6fd2b625d35,8170/3,TCGA-DD-A1EI,,\"Hepatocellular carcinoma, NOS\",3acf7438-fd65-442c-8a30-68b6714537f3,released,2019-04-28T13:17:32.613226-05:00,not reported,17097,1962,,183,male,not reported,not reported,3acf7438-fd65-442c-8a30-68b6714537f3,2019-04-28T13:17:32.613226-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,dfaafadc-03ba-5380-83ca-4a21f7a03254,TCGA-DD-A1EI_diagnosis,asian,not reported,Liver,TCGA-DD-A1EI_treatment,13c9e344-5617-5303-bb5c-10dc72144dc8,not reported,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A1EI_treatment_1,,,no,2019-04-28T13:17:32.613226-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:19.490721-05:00,released,29c8bab7-c749-525c-bfca-6a78513a2a38\\r\\n,TCGA-ZP-A9D1_demographic,afa7109f-49cc-5552-a1cd-bc7dda963e3a,8170/3,TCGA-ZP-A9D1,,\"Hepatocellular carcinoma, NOS\",447ac9e3-0533-461a-bc92-906a7b2180c3,released,2019-04-28T13:18:21.615831-05:00,no,20584,1956,,21,female,not reported,not reported,447ac9e3-0533-461a-bc92-906a7b2180c3,2019-04-28T13:18:21.615831-05:00,released,2019-05-03T14:06:23.922205-05:00,not reported,e0f65cd1-e0cb-58e9-956d-eead6e5c399c,TCGA-ZP-A9D1_diagnosis,white,not reported,Liver,TCGA-ZP-A9D1_treatment,8ca2e18b-8085-5d99-90b8-259dbb0bacf7,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-ZP-A9D1_treatment_1,,,yes,2019-04-28T13:18:21.615831-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:38:16.668337-05:00,released,5726833d-b730-54ee-a2cd-2dd7e2028805\\r\\n,TCGA-DD-AAD5_demographic,d89db2ae-992c-5517-a073-1a0f7f04d4ee,8170/3,TCGA-DD-AAD5,,\"Hepatocellular carcinoma, NOS\",6312d5b5-68ad-4d4f-a0a9-03d895ae30f9,released,,no,19748,1957,,1345,male,not reported,not reported,6312d5b5-68ad-4d4f-a0a9-03d895ae30f9,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:20:28.993926-05:00,stage i,6d963b88-8833-57b0-ac20-4cc911da8c7c,TCGA-DD-AAD5_diagnosis,asian,not reported,Liver,TCGA-DD-AAD5_treatment_1,954b8257-64a8-51f3-8803-17527023638d,no,,,Liver,released,not reported,2019-04-28T13:20:28.993926-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AAD5_treatment,,,no,2019-04-28T13:20:28.993926-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:42.289685-05:00,released,661f1e62-c1a6-5150-b172-c9669d6d04b8\\r\\n,TCGA-DD-AADK_demographic,dae955fe-b389-5943-bc47-eac4a6d76960,8170/3,TCGA-DD-AADK,,\"Hepatocellular carcinoma, NOS\",40f30ffb-51de-4786-a88f-16c170aac207,released,,no,25046,1943,,1049,female,not reported,not reported,40f30ffb-51de-4786-a88f-16c170aac207,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:17:57.079068-05:00,stage ii,6db3588f-68b4-57b5-bb53-030434f640a3,TCGA-DD-AADK_diagnosis,asian,not reported,Liver,TCGA-DD-AADK_treatment_1,674d3958-eab7-5bf9-a633-910471454813,no,,,Liver,released,not reported,2019-04-28T13:17:57.079068-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AADK_treatment,,,no,2019-04-28T13:17:57.079068-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:42.289685-05:00,released,11ac98e5-c00c-5e62-a46b-c7dc0bbe5a08\\r\\n,TCGA-BC-4072_demographic,b89f5c85-714b-54cd-b049-e7e6bee3d097,8170/3,TCGA-BC-4072,,\"Hepatocellular carcinoma, NOS\",5c9a21a3-d471-401a-9568-59dc84245d28,released,,no,27162,1931,,,female,not reported,not reported,5c9a21a3-d471-401a-9568-59dc84245d28,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:20:02.213210-05:00,stage iiia,dcd6c8ef-dfd9-5b6e-a299-ba0ece4318c0,TCGA-BC-4072_diagnosis,white,not reported,Liver,TCGA-BC-4072_treatment_1,2e0a8211-53b3-5eb5-b391-62a7a639bfc9,no,2009,,Liver,released,not reported,2019-04-28T13:20:02.213210-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-BC-4072_treatment,,,no,2019-04-28T13:20:02.213210-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:35.448559-05:00,released,d0bc2878-2cc7-593e-8463-f910f8457e6b\\r\\n,TCGA-5R-AA1C_demographic,96792a7f-d28a-54dc-9b12-e0fa68c48a6a,8170/3,TCGA-5R-AA1C,,\"Hepatocellular carcinoma, NOS\",290890eb-321c-45dc-9cd1-45676c6e5e96,released,,no,21073,1956,,520,male,not reported,not reported,290890eb-321c-45dc-9cd1-45676c6e5e96,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:16:32.412407-05:00,stage ii,6dbba301-dffd-51a0-9396-c9780c442b3a,TCGA-5R-AA1C_diagnosis,white,not reported,Liver,TCGA-5R-AA1C_treatment_1,1c828ed7-ce0f-5d67-aa9f-a7d0e56fbfe3,no,,,Liver,released,not reported,2019-04-28T13:16:32.412407-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-5R-AA1C_treatment,,,no,2019-04-28T13:16:32.412407-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:35.448559-05:00,released,9045ac44-9bdb-5c69-89b2-6b3da2b7ba71\\r\\n,TCGA-DD-AACQ_demographic,ae4a768c-d123-5822-a2dc-6e2d6a19286c,8170/3,TCGA-DD-AACQ,,\"Hepatocellular carcinoma, NOS\",0f34d654-8984-4b8b-b345-67066d611513,released,2019-04-28T13:14:46.069566-05:00,no,18429,1959,,429,male,not reported,not reported,0f34d654-8984-4b8b-b345-67066d611513,2019-04-28T13:14:46.069566-05:00,released,2019-05-03T14:06:23.922205-05:00,stage ii,2b95cf44-f64e-5467-985c-8d0a477990e7,TCGA-DD-AACQ_diagnosis,asian,not reported,Liver,TCGA-DD-AACQ_treatment,d28861ac-b74e-5b86-bc80-0e4207e7d009,yes,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AACQ_treatment_1,,,no,2019-04-28T13:14:46.069566-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:42.289685-05:00,released,13bc7a95-a31d-5204-9d87-32b84c94012f\\r\\n,TCGA-DD-AACS_demographic,a8e09b62-cb42-59b4-8f91-28030aa6cf46,8170/3,TCGA-DD-AACS,,\"Hepatocellular carcinoma, NOS\",82d6268a-de59-4a14-abd2-7492178fa5bd,released,,no,14473,1970,,1804,male,not reported,not reported,82d6268a-de59-4a14-abd2-7492178fa5bd,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:22:17.954357-05:00,stage i,2c4a8393-5663-5024-88aa-64b6cac61aa9,TCGA-DD-AACS_diagnosis,asian,not reported,Liver,TCGA-DD-AACS_treatment_1,b2b5a2d5-d5c2-5479-85ad-85d8b40694ef,no,,,Liver,released,not reported,2019-04-28T13:22:17.954357-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AACS_treatment,,,no,2019-04-28T13:22:17.954357-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:42.289685-05:00,released,30a8fd73-f7ed-51dd-85a3-1343ef2224b5\\r\\n,TCGA-ED-A4XI_demographic,df2104bc-01b5-56d4-ad5c-52e912677d9c,8170/3,TCGA-ED-A4XI,,\"Hepatocellular carcinoma, NOS\",c52abac9-07da-4b3d-bf8a-2161cacf9682,released,,no,21497,1954,,819,male,not reported,not reported,c52abac9-07da-4b3d-bf8a-2161cacf9682,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:26:14.003554-05:00,stage ii,2f7d4f6f-aee8-536c-8086-bbcd0a3a2510,TCGA-ED-A4XI_diagnosis,asian,not reported,Liver,TCGA-ED-A4XI_treatment_1,f7fe495e-5e89-52a9-a829-3bf6b1b6f2d7,no,,,Liver,released,not reported,2019-04-28T13:26:14.003554-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-ED-A4XI_treatment,,,no,2019-04-28T13:26:14.003554-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:05.743590-05:00,released,1ddd225f-712b-5b6e-87a4-31276cd2cae0\\r\\n,TCGA-DD-A1EK_demographic,d0922097-f988-5994-bcc0-5d42595d001b,8170/3,TCGA-DD-A1EK,,\"Hepatocellular carcinoma, NOS\",a5e4412b-0e49-4d86-9cce-71f440a84048,released,2019-04-28T13:24:07.960273-05:00,yes,23437,1944,,,female,not reported,not reported,a5e4412b-0e49-4d86-9cce-71f440a84048,2019-04-28T13:24:07.960273-05:00,released,2019-05-03T14:06:23.922205-05:00,stage ivb,e3291248-4410-5e59-a6da-98387aaabf1d,TCGA-DD-A1EK_diagnosis,white,not reported,Liver,TCGA-DD-A1EK_treatment,8dc59b50-8cb6-5c99-9b8f-d8d09fa9bff6,no,2009,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A1EK_treatment_1,,,no,2019-04-28T13:24:07.960273-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:19.490721-05:00,released,21a3360f-2df3-53b6-8eda-dadfce3485b4\\r\\n,TCGA-DD-AAEH_demographic,8fa71a7c-15a5-5548-87e8-d12c0a6a5093,8170/3,TCGA-DD-AAEH,,\"Hepatocellular carcinoma, NOS\",fbb0e4bc-5398-4a7e-963c-86ea1108a2de,released,2019-04-28T13:28:34.282989-05:00,no,26894,1939,,784,male,not reported,not reported,fbb0e4bc-5398-4a7e-963c-86ea1108a2de,2019-04-28T13:28:34.282989-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,e53929b4-30ee-5de8-bc06-056cf529212a,TCGA-DD-AAEH_diagnosis,asian,not reported,Liver,TCGA-DD-AAEH_treatment,ec1a6cdd-a2c7-5c95-aad0-063f595e0448,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AAEH_treatment_1,,,no,2019-04-28T13:28:34.282989-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:05.743590-05:00,released,41ac2ffb-6a50-570a-8394-43453254834b\\r\\n,TCGA-ZP-A9CY_demographic,d121fa52-ba66-59eb-a858-0e952cbcff60,8170/3,TCGA-ZP-A9CY,,\"Hepatocellular carcinoma, NOS\",34fd27ce-930a-4f29-8a6e-dae4949d92eb,released,,no,24223,1945,,782,female,not reported,not reported,34fd27ce-930a-4f29-8a6e-dae4949d92eb,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:17:11.133877-05:00,not reported,e5bfe1ad-0fbf-5e94-b1f8-f195ffaaa1b3,TCGA-ZP-A9CY_diagnosis,white,not reported,Liver,TCGA-ZP-A9CY_treatment_1,b1fc6833-dee3-5be2-97e5-376aa2861668,no,,,Liver,released,not reported,2019-04-28T13:17:11.133877-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-ZP-A9CY_treatment,,,no,2019-04-28T13:17:11.133877-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:38:16.668337-05:00,released,132b5d02-ce9b-586c-91e4-31185f2ecf30\\r\\n,TCGA-KR-A7K7_demographic,a0a8f6ce-d47f-5e22-b66d-a4e05fde74d6,8170/3,TCGA-KR-A7K7,,\"Hepatocellular carcinoma, NOS\",7ba3d8f1-0c26-4c49-8d6b-0f2875b58daf,released,,no,22587,1951,,951,female,not reported,not reported,7ba3d8f1-0c26-4c49-8d6b-0f2875b58daf,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:21:44.534476-05:00,stage ii,e6188120-bc91-5104-bb02-38b972b7b678,TCGA-KR-A7K7_diagnosis,white,not reported,Liver,TCGA-KR-A7K7_treatment_1,7f2e150b-e082-5fa0-b971-d6b5d59ca4a3,yes,,,Liver,released,not reported,2019-04-28T13:21:44.534476-05:00,,not reported,released,Adenomas and Adenocarcinomas,TCGA-KR-A7K7_treatment,,,yes,2019-04-28T13:21:44.534476-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:53.093878-05:00,released,c186a898-6f36-5160-bb94-1025065712df\\r\\n,TCGA-DD-AAD2_demographic,a1ea9839-08b7-5bae-a81f-85bb55d0c4ed,8170/3,TCGA-DD-AAD2,,\"Hepatocellular carcinoma, NOS\",03f5de7d-45a9-4a73-8c61-ed816d4a3ac5,released,,no,24221,1944,,658,male,not reported,not reported,03f5de7d-45a9-4a73-8c61-ed816d4a3ac5,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:14:10.419728-05:00,stage i,e68c6cef-837d-5dca-a697-9505d41902ed,TCGA-DD-AAD2_diagnosis,asian,not reported,Liver,TCGA-DD-AAD2_treatment_1,a6752562-ce67-5b4e-968a-68a4cc82478d,no,,,Liver,released,not reported,2019-04-28T13:14:10.419728-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AAD2_treatment,,,no,2019-04-28T13:14:10.419728-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:42.289685-05:00,released,21226f75-25fd-5ff7-ba75-7e5edec32730\\r\\n,TCGA-BC-A10Q_demographic,d9102f8a-3bf6-5a47-8576-86445b93a832,8170/3,TCGA-BC-A10Q,,\"Hepatocellular carcinoma, NOS\",dfa15fbe-bb14-40ce-afc6-70694112e3e2,released,2019-04-28T13:27:32.103048-05:00,yes,26400,1926,,,female,not reported,not reported,dfa15fbe-bb14-40ce-afc6-70694112e3e2,2019-04-28T13:27:32.103048-05:00,released,2019-05-03T14:06:23.922205-05:00,not reported,2f81e314-1ffd-5b24-b4ba-06aaa9680e6b,TCGA-BC-A10Q_diagnosis,white,not reported,Liver,TCGA-BC-A10Q_treatment,c896279a-640a-57f8-91c5-4d1b674cdcca,no,2001,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-BC-A10Q_treatment_1,,,no,2019-04-28T13:27:32.103048-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:35.448559-05:00,released,c6950321-e76b-5549-abc5-e7154dde561e\\r\\n,TCGA-ED-A627_demographic,bf004a07-4655-514c-9971-db3c6719e3d1,8170/3,TCGA-ED-A627,,\"Hepatocellular carcinoma, NOS\",a4af0084-edd4-4dcd-8975-4a59ee5da64c,released,,no,27303,1938,,423,male,not reported,not reported,a4af0084-edd4-4dcd-8975-4a59ee5da64c,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:24:04.488729-05:00,stage i,3060777b-5c5b-5f54-8861-63ffc6c21627,TCGA-ED-A627_diagnosis,white,not reported,Liver,TCGA-ED-A627_treatment_1,a5434643-b965-5398-a3a7-d98d6c6e5c8a,no,,,Liver,released,not reported,2019-04-28T13:24:04.488729-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-ED-A627_treatment,,,no,2019-04-28T13:24:04.488729-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:05.743590-05:00,released,a9820c81-226b-5ae1-8a94-9657a11f0df8\\r\\n,TCGA-UB-A7MB_demographic,ee0af280-0b2c-5afc-8293-87fc41a1b56e,8170/3,TCGA-UB-A7MB,,\"Hepatocellular carcinoma, NOS\",af1e56af-410c-4cad-a4e8-1c6937f1a350,released,2019-04-28T13:24:54.207645-05:00,yes,8951,1989,,601,male,not reported,not reported,af1e56af-410c-4cad-a4e8-1c6937f1a350,2019-04-28T13:24:54.207645-05:00,released,2019-05-03T14:06:23.922205-05:00,stage ii,ac2093be-c88c-5c19-816b-320ba9a291a3,TCGA-UB-A7MB_diagnosis,white,not reported,Liver,TCGA-UB-A7MB_treatment,25368ded-56a4-5c01-8e30-314d420f4c1a,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-UB-A7MB_treatment_1,,,no,2019-04-28T13:24:54.207645-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:53.093878-05:00,released,23640b8c-827c-547b-b5f0-a28882b27cc9\\r\\n,TCGA-CC-A7II_demographic,fb8d3e2a-ac3f-5dce-b9fc-d0a35d046c51,8170/3,TCGA-CC-A7II,,\"Hepatocellular carcinoma, NOS\",aaf7c9b5-6cb7-42bf-a0d1-07975eae3be9,released,2019-04-28T13:24:32.412994-05:00,no,20079,1959,,399,male,not reported,not reported,aaf7c9b5-6cb7-42bf-a0d1-07975eae3be9,2019-04-28T13:24:32.412994-05:00,released,2019-05-03T14:06:23.922205-05:00,stage iiia,30d13f19-6622-5386-a087-b3c6ba664757,TCGA-CC-A7II_diagnosis,asian,not reported,Liver,TCGA-CC-A7II_treatment,35823d42-18c6-5544-8525-e52a5aedf382,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-CC-A7II_treatment_1,,,no,2019-04-28T13:24:32.412994-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:58.071505-05:00,released,f5133737-814c-527c-9fd0-effe1f860b03\\r\\n,TCGA-DD-AACE_demographic,928d50e2-1df7-5d90-bb4b-68bd02e78ad2,8170/3,TCGA-DD-AACE,,\"Hepatocellular carcinoma, NOS\",abbcf6bd-4683-45ac-947a-51ae6ef0a244,released,,no,22727,1946,,2184,male,not reported,not reported,abbcf6bd-4683-45ac-947a-51ae6ef0a244,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:24:37.376029-05:00,stage i,30f3ca56-1778-581f-82a9-40864f5078d1,TCGA-DD-AACE_diagnosis,asian,not reported,Liver,TCGA-DD-AACE_treatment_1,8e197e74-bb2c-5847-8c64-db739ad786c8,no,,,Liver,released,not reported,2019-04-28T13:24:37.376029-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AACE_treatment,,,no,2019-04-28T13:24:37.376029-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:42.289685-05:00,released,794c6aa2-f140-5ab4-afb7-a02703b1a712\\r\\n,TCGA-DD-AACK_demographic,d9f2b14b-2150-56c6-a8f9-e393a8dc75c5,8170/3,TCGA-DD-AACK,,\"Hepatocellular carcinoma, NOS\",d7cd045a-0be2-4b6d-aefd-5d75e57bc6f6,released,,no,25796,1938,,9,male,not reported,not reported,d7cd045a-0be2-4b6d-aefd-5d75e57bc6f6,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:27:19.864378-05:00,stage i,b6d828ea-2412-520e-8b9c-c3a693d575c3,TCGA-DD-AACK_diagnosis,asian,not reported,Liver,TCGA-DD-AACK_treatment_1,e76d1e75-d536-5f2a-b62d-3a542628817b,no,,,Liver,released,not reported,2019-04-28T13:27:19.864378-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AACK_treatment,,,no,2019-04-28T13:27:19.864378-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:42.289685-05:00,released,8d9ebbea-6bdb-54b9-bcbd-4528694b1f5b\\r\\n,TCGA-DD-AACG_demographic,4cfa4385-9fd1-5eef-b183-1a2a99017762,8170/3,TCGA-DD-AACG,,\"Hepatocellular carcinoma, NOS\",b5bef77a-f46c-406c-9aa8-55f7a61aa885,released,,no,19174,1956,,,male,not reported,not reported,b5bef77a-f46c-406c-9aa8-55f7a61aa885,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:25:15.967491-05:00,stage ii,7ebf2159-9c90-52d1-9226-c9a0debc5835,TCGA-DD-AACG_diagnosis,asian,not reported,Liver,TCGA-DD-AACG_treatment_1,be4e43dc-7464-5881-817c-6ed9124f5493,no,2009,,Liver,released,not reported,2019-04-28T13:25:15.967491-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AACG_treatment,,,no,2019-04-28T13:25:15.967491-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:42.289685-05:00,released,46ba92d5-c58a-5037-a9a5-40ed42f6824d\\r\\n,TCGA-DD-A1EF_demographic,24e5dc72-a173-555d-a62e-6468ca46383a,8170/3,TCGA-DD-A1EF,,\"Hepatocellular carcinoma, NOS\",1c1e8987-676f-417b-b3b4-e0321367df55,released,,not reported,21165,1950,,,female,not reported,not reported,1c1e8987-676f-417b-b3b4-e0321367df55,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:15:44.368642-05:00,stage i,e2a374fb-1102-5742-a7cb-db94ab64c851,TCGA-DD-A1EF_diagnosis,white,not reported,Liver,TCGA-DD-A1EF_treatment_1,948e6eab-95dc-535c-8717-5ad2890147c0,not reported,2008,,Liver,released,not reported,2019-04-28T13:15:44.368642-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A1EF_treatment,,,no,2019-04-28T13:15:44.368642-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:19.490721-05:00,released,68ce6c1e-2136-52ae-a4d9-415edee39a05\\r\\n,TCGA-FV-A3I1_demographic,b8a9749c-6840-596d-a74e-bce11d8ef63c,8170/3,TCGA-FV-A3I1,,\"Hepatocellular carcinoma, NOS\",bfd20d71-18a5-4f01-8d56-84378ad92359,released,2019-04-28T13:25:57.109783-05:00,no,,1930,,0,female,not reported,not reported,bfd20d71-18a5-4f01-8d56-84378ad92359,2019-04-28T13:25:57.109783-05:00,released,2019-05-03T14:06:23.922205-05:00,stage ii,7ffd44cb-63d0-5336-b9a5-c39043864110,TCGA-FV-A3I1_diagnosis,white,not reported,Liver,TCGA-FV-A3I1_treatment,54b01d17-db54-5911-a087-ba19fda5469e,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-FV-A3I1_treatment_1,,,yes,2019-04-28T13:25:57.109783-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:27.936420-05:00,released,2208c7b6-c873-5343-b032-3ec71b9c5678\\r\\n,TCGA-DD-AADP_demographic,8e7bf341-3c97-5f33-a9c1-281bfd65de31,8170/3,TCGA-DD-AADP,,\"Hepatocellular carcinoma, NOS\",96d42ecc-1157-453a-9661-9248ddf8f273,released,2019-04-28T13:23:31.311650-05:00,no,16760,1968,,458,male,not reported,not reported,96d42ecc-1157-453a-9661-9248ddf8f273,2019-04-28T13:23:31.311650-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,31ffb6f0-cc23-5675-a718-7c7ada1655bb,TCGA-DD-AADP_diagnosis,asian,not reported,Liver,TCGA-DD-AADP_treatment,1f7a0c06-ea9b-51b1-8ed6-06f8d803ec8b,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AADP_treatment_1,,,no,2019-04-28T13:23:31.311650-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:05.743590-05:00,released,1c57bace-752c-543a-88b5-96c303ea66e3\\r\\n,TCGA-ZP-A9D0_demographic,3c063594-2a80-5184-9124-c1b4efd5bc3f,8170/3,TCGA-ZP-A9D0,,\"Hepatocellular carcinoma, NOS\",396ef7c2-343e-4d5c-9b20-adc0a52c1978,released,2019-04-28T13:17:20.851446-05:00,no,24525,1944,,1091,female,not reported,not reported,396ef7c2-343e-4d5c-9b20-adc0a52c1978,2019-04-28T13:17:20.851446-05:00,released,2019-05-03T14:06:23.922205-05:00,not reported,332f41ba-9841-5571-8ad4-ca3e19efa496,TCGA-ZP-A9D0_diagnosis,black or african american,not reported,Liver,TCGA-ZP-A9D0_treatment,4de29cd4-a569-54b7-ac12-f8e4a6018a29,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-ZP-A9D0_treatment_1,,,no,2019-04-28T13:17:20.851446-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:38:16.668337-05:00,released,66e7c254-7bb8-5350-a603-1381bc0786b6\\r\\n,TCGA-CC-A8HU_demographic,fc7e9440-9c13-5635-911a-fbcb253ccea0,8170/3,TCGA-CC-A8HU,,\"Hepatocellular carcinoma, NOS\",1943ff2c-ca53-4e3c-acc1-5ae84f4ba230,released,,no,14367,1974,,0,female,not reported,not reported,1943ff2c-ca53-4e3c-acc1-5ae84f4ba230,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:15:24.907594-05:00,stage iiia,341477da-e2bb-5fad-9c99-4143c44aaff1,TCGA-CC-A8HU_diagnosis,asian,not reported,Liver,TCGA-CC-A8HU_treatment_1,5a917a83-931e-5b5b-a7f8-737d25d0bc3d,no,,,Liver,released,not reported,2019-04-28T13:15:24.907594-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-CC-A8HU_treatment,,,no,2019-04-28T13:15:24.907594-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:58.071505-05:00,released,8c17d60b-1485-5e83-a96e-70795322baa9\\r\\n,TCGA-DD-AAW1_demographic,be308cbc-ce2b-561a-a372-0f7831d580ce,8170/3,TCGA-DD-AAW1,,\"Hepatocellular carcinoma, NOS\",31c7d56b-4af7-4fdb-ba83-63bf615fcc3d,released,2019-04-28T13:16:56.960049-05:00,no,20288,1954,,1989,male,not reported,not reported,31c7d56b-4af7-4fdb-ba83-63bf615fcc3d,2019-04-28T13:16:56.960049-05:00,released,2019-05-03T14:06:23.922205-05:00,stage iiia,006a089f-5049-5ff3-bae9-48cb33003dae,TCGA-DD-AAW1_diagnosis,asian,not reported,Liver,TCGA-DD-AAW1_treatment,1ae654b5-ea11-5a60-ba28-cb623c59b019,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AAW1_treatment_1,,,no,2019-04-28T13:16:56.960049-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:05.743590-05:00,released,b90fdec3-c9b3-5eda-b661-4bbaf55ccc47\\r\\n,TCGA-DD-AADE_demographic,ba14bbc9-7f6f-5fd6-b8c0-2b0ce9cd5317,8170/3,TCGA-DD-AADE,,\"Hepatocellular carcinoma, NOS\",0904fd43-e25c-4d0f-acee-29faa3fd933b,released,,no,18482,1961,,1202,male,not reported,not reported,0904fd43-e25c-4d0f-acee-29faa3fd933b,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:14:23.289250-05:00,stage i,359f3a5e-83bf-55ba-85b1-a4c59f4407bc,TCGA-DD-AADE_diagnosis,asian,not reported,Liver,TCGA-DD-AADE_treatment_1,69ec5105-b399-5131-822c-d03b2a1e5c7c,no,,,Liver,released,not reported,2019-04-28T13:14:23.289250-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AADE_treatment,,,no,2019-04-28T13:14:23.289250-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:42.289685-05:00,released,20da5aa1-9490-5806-8777-03f95470e52c\\r\\n,TCGA-DD-A4NE_demographic,8faa87df-3c49-56e7-aefd-1609e9eb8623,8170/3,TCGA-DD-A4NE,,\"Hepatocellular carcinoma, NOS\",bce25281-502e-4599-9679-32dc8462ffb1,released,2019-04-28T13:25:41.978536-05:00,no,27549,1936,,,female,not reported,not reported,bce25281-502e-4599-9679-32dc8462ffb1,2019-04-28T13:25:41.978536-05:00,released,2019-05-03T14:06:23.922205-05:00,stage iiia,35bf4d7a-ada8-5ddf-a0d6-4bc610159ee2,TCGA-DD-A4NE_diagnosis,white,not reported,Liver,TCGA-DD-A4NE_treatment,7d06c211-47ef-5988-bb42-c149fd591517,no,2012,,Liver,released,not reported,,,hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A4NE_treatment_1,,,no,2019-04-28T13:25:41.978536-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:19.490721-05:00,released,7bd3324d-385f-5504-b51b-e81bcb704989\\r\\n,TCGA-2Y-A9H4_demographic,5c4fd3b0-bb1b-5bd3-a607-0586402bf814,8170/3,TCGA-2Y-A9H4,,\"Hepatocellular carcinoma, NOS\",801b1d2c-eb6f-4eef-a00b-83da939d755a,released,,no,25096,1942,,1452,male,not reported,not reported,801b1d2c-eb6f-4eef-a00b-83da939d755a,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:22:03.678879-05:00,stage i,b76fbb0a-cea0-5c73-acd8-77f71f3c8cdf,TCGA-2Y-A9H4_diagnosis,black or african american,not reported,Liver,TCGA-2Y-A9H4_treatment_1,0b934735-c994-5ec8-acf5-605884c92425,no,,,Liver,released,not reported,2019-04-28T13:22:03.678879-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-2Y-A9H4_treatment,,,no,2019-04-28T13:22:03.678879-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:35.448559-05:00,released,a8031b16-1b06-5f50-b2f5-39b6ff71f2c9\\r\\n,TCGA-DD-AAE2_demographic,e7f280e6-bda3-5454-966a-0d4d7bd0a9f2,8170/3,TCGA-DD-AAE2,,\"Hepatocellular carcinoma, NOS\",56447eb8-c50c-4e31-a29e-bde6bfd31af4,released,2019-04-28T13:19:37.463900-05:00,no,18695,1962,,638,male,not reported,not reported,56447eb8-c50c-4e31-a29e-bde6bfd31af4,2019-04-28T13:19:37.463900-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,b5eb8246-e610-564e-abeb-c359e1d48f94,TCGA-DD-AAE2_diagnosis,asian,not reported,Liver,TCGA-DD-AAE2_treatment,afaf61b5-1303-5f68-8128-bb076eb82082,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AAE2_treatment_1,,,no,2019-04-28T13:19:37.463900-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:05.743590-05:00,released,a1182797-f11b-5f11-b6ed-bf280738a28c\\r\\n,TCGA-HP-A5MZ_demographic,cb549ddf-e9f1-560d-b364-7a905770e1ab,8170/3,TCGA-HP-A5MZ,,\"Hepatocellular carcinoma, NOS\",2d00f09f-0074-46c8-b357-b5f33567762a,released,,no,22702,,,,male,not reported,not reported,2d00f09f-0074-46c8-b357-b5f33567762a,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:16:45.398852-05:00,stage i,24a3756d-6d26-5354-bbb4-535bb38b95ab,TCGA-HP-A5MZ_diagnosis,not reported,not reported,Liver,TCGA-HP-A5MZ_treatment_1,34a99fb3-f059-51f6-8b76-c11c74c56a25,no,,,Liver,released,not reported,2019-04-28T13:16:45.398852-05:00,,not reported,released,Adenomas and Adenocarcinomas,TCGA-HP-A5MZ_treatment,,,no,2019-04-28T13:16:45.398852-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:53.093878-05:00,released,8aa7d4da-596f-517f-9ba0-90993487214c\\r\\n,TCGA-5R-AAAM_demographic,c013192f-ed49-5205-a687-ac6a69c17afc,8170/3,TCGA-5R-AAAM,,\"Hepatocellular carcinoma, NOS\",477affb9-7c8b-4895-a4f3-6cc6ef8ec5e4,released,,no,24020,1948,,,female,not reported,not reported,477affb9-7c8b-4895-a4f3-6cc6ef8ec5e4,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:18:39.915933-05:00,stage ii,c85b6cc0-77da-54c2-95a0-aa995b0f4d6c,TCGA-5R-AAAM_diagnosis,white,not reported,Liver,TCGA-5R-AAAM_treatment_1,fd4e97be-9521-54ba-8618-d24fb3e4de8c,no,2013,,Liver,released,not reported,2019-04-28T13:18:39.915933-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-5R-AAAM_treatment,,,no,2019-04-28T13:18:39.915933-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:35.448559-05:00,released,7818fa2a-ea58-52de-a182-d187937551ad\\r\\n,TCGA-DD-A3A9_demographic,b198d796-ea76-573c-8c9c-4b2f5b8ea677,8170/3,TCGA-DD-A3A9,,\"Hepatocellular carcinoma, NOS\",457cca7c-a8b4-414e-a3c0-7fccf0ee2034,released,2019-04-28T13:18:24.033300-05:00,not reported,23526,1937,,,female,not reported,not reported,457cca7c-a8b4-414e-a3c0-7fccf0ee2034,2019-04-28T13:18:24.033300-05:00,released,2019-05-03T14:06:23.922205-05:00,stage ivb,b62d0aa3-3e6b-5f76-99cb-e3cfb6629017,TCGA-DD-A3A9_diagnosis,white,not reported,Liver,TCGA-DD-A3A9_treatment,6089c11d-4924-54d4-a8e3-717747994598,not reported,2003,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A3A9_treatment_1,,,no,2019-04-28T13:18:24.033300-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:19.490721-05:00,released,533721df-d5e9-5398-8f77-5c0e4b2bdd2b\\r\\n,TCGA-WX-AA47_demographic,d77d941f-675e-51ed-b764-3d28a5cc30f7,8170/3,TCGA-WX-AA47,,\"Hepatocellular carcinoma, NOS\",39e147c9-2acb-4ba8-a991-e43e1719b2d8,released,2019-04-28T13:17:25.529230-05:00,yes,12056,1979,,,female,not reported,not reported,39e147c9-2acb-4ba8-a991-e43e1719b2d8,2019-04-28T13:17:25.529230-05:00,released,2019-05-03T14:06:23.922205-05:00,stage iiia,4947348d-9bac-5121-b4a8-ae52df695be9,TCGA-WX-AA47_diagnosis,white,not reported,Liver,TCGA-WX-AA47_treatment,1c6d0c3a-4720-5c3c-980b-5474526dd233,yes,2013,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-WX-AA47_treatment_1,,,no,2019-04-28T13:17:25.529230-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:38:16.668337-05:00,released,902caf48-8153-5066-8055-a347dbc45e78\\r\\n,TCGA-BC-A10Y_demographic,dd54ffb7-b816-53ce-a9bd-f767f245ba95,8170/3,TCGA-BC-A10Y,,\"Hepatocellular carcinoma, NOS\",6533648f-1353-4253-b65b-d472aacf5751,released,,no,28049,1926,,,male,not reported,not reported,6533648f-1353-4253-b65b-d472aacf5751,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:20:36.285854-05:00,not reported,49a85814-36a4-5600-bc82-7674afbf7007,TCGA-BC-A10Y_diagnosis,white,not reported,Liver,TCGA-BC-A10Y_treatment_1,5edf7919-8f0f-5e3b-931c-006350ea3f72,no,2003,,Liver,released,not reported,2019-04-28T13:20:36.285854-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-BC-A10Y_treatment,,,no,2019-04-28T13:20:36.285854-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:35.448559-05:00,released,89d4bc1a-701f-5aad-8ccb-bda6d52686bb\\r\\n,TCGA-ZS-A9CG_demographic,32abbbeb-4b83-5c8c-8c85-9c3439d8db2b,8170/3,TCGA-ZS-A9CG,,\"Hepatocellular carcinoma, NOS\",3f6a6891-c6d5-447b-ad32-325fd46ec32b,released,2019-04-28T13:17:52.072018-05:00,no,20100,1958,,341,male,not reported,not reported,3f6a6891-c6d5-447b-ad32-325fd46ec32b,2019-04-28T13:17:52.072018-05:00,released,2019-05-03T14:06:23.922205-05:00,stage ii,e7105e6a-3e03-54cd-baff-5de5334987cf,TCGA-ZS-A9CG_diagnosis,white,not reported,Liver,TCGA-ZS-A9CG_treatment,919e5b67-16c0-52e2-ac43-27d1e0cc386e,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-ZS-A9CG_treatment_1,,,no,2019-04-28T13:17:52.072018-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:38:16.668337-05:00,released,19cb2baa-6823-57f3-a619-d7c0aa9b05fb\\r\\n,TCGA-G3-AAV5_demographic,73ecec3b-43ca-5cf5-896b-0bd7be0b58e5,8170/3,TCGA-G3-AAV5,,\"Hepatocellular carcinoma, NOS\",4dff4242-4a53-4f46-b200-7ed83f6b7808,released,,yes,24655,1946,,354,male,not reported,not reported,4dff4242-4a53-4f46-b200-7ed83f6b7808,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:19:04.503850-05:00,stage ii,323b80c1-1c08-54cc-ac04-c6573bf86f5c,TCGA-G3-AAV5_diagnosis,white,not reported,Liver,TCGA-G3-AAV5_treatment_1,ad068150-55ad-5a92-8d7d-231e1400cdfc,yes,,,Liver,released,not reported,2019-04-28T13:19:04.503850-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-G3-AAV5_treatment,,,no,2019-04-28T13:19:04.503850-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:53.093878-05:00,released,51618b1f-49ea-5dc4-b906-431c25caf79b\\r\\n,TCGA-G3-AAV2_demographic,a00f5416-643a-5b06-a00a-065a4a7f453c,8170/3,TCGA-G3-AAV2,,\"Hepatocellular carcinoma, NOS\",1724c96a-2aa3-43d4-992a-08af948c0f45,released,,no,18363,1963,,372,male,not reported,not reported,1724c96a-2aa3-43d4-992a-08af948c0f45,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:15:12.174985-05:00,stage i,9d3b9929-aca3-5a3d-9258-68f4582c3397,TCGA-G3-AAV2_diagnosis,white,not reported,Liver,TCGA-G3-AAV2_treatment_1,730122ee-d8a0-579e-93b3-b719b6b7eea0,no,,,Liver,released,not reported,2019-04-28T13:15:12.174985-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-G3-AAV2_treatment,,,no,2019-04-28T13:15:12.174985-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:53.093878-05:00,released,3e2c6ad2-f325-5a3a-9a58-7d8052de06f5\\r\\n,TCGA-CC-A3M9_demographic,96dee378-438a-54f2-93f0-de542831335d,8173/3,TCGA-CC-A3M9,,\"Hepatocellular carcinoma, spindle cell variant\",8e938868-d992-47c4-becb-93b0f7fffe07,released,2019-04-28T13:23:01.049162-05:00,no,16460,1966,,3,male,not reported,not reported,8e938868-d992-47c4-becb-93b0f7fffe07,2019-04-28T13:23:01.049162-05:00,released,2019-05-03T14:06:23.922205-05:00,stage iiia,25c0d739-c234-5239-9c1d-135d64e9a191,TCGA-CC-A3M9_diagnosis,asian,not reported,Liver,TCGA-CC-A3M9_treatment,adc91451-1c80-5ee3-b02f-6292a63a19b9,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-CC-A3M9_treatment_1,,,no,2019-04-28T13:23:01.049162-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:58.071505-05:00,released,115fc97c-4a0d-528f-bf70-cc2ef6821a9b\\r\\n,TCGA-MR-A8JO_demographic,c8532952-3674-520b-8d57-2bc5ff77f166,8171/3,TCGA-MR-A8JO,,\"Hepatocellular carcinoma, fibrolamellar\",8574d285-e02a-4d2b-931b-73556a9fda02,released,2019-04-28T13:22:23.012360-05:00,no,12669,1979,,330,male,not reported,not reported,8574d285-e02a-4d2b-931b-73556a9fda02,2019-04-28T13:22:23.012360-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,d6ead212-02a9-5251-8310-02fde92b80a3,TCGA-MR-A8JO_diagnosis,white,not reported,Liver,TCGA-MR-A8JO_treatment,f20df12e-d9f7-5b08-bd89-979ee318b21e,no,,,Liver,released,not reported,,,not reported,released,Adenomas and Adenocarcinomas,TCGA-MR-A8JO_treatment_1,,,no,2019-04-28T13:22:23.012360-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:53.093878-05:00,released,c814a15b-aa4b-5211-9985-48492ffca1df\\r\\n,TCGA-DD-A116_demographic,33576c92-165e-577c-bb0d-2fc2ad6b163d,8170/3,TCGA-DD-A116,,\"Hepatocellular carcinoma, NOS\",994347ba-3045-4ade-926f-06420fbd906c,released,,yes,24934,1934,,,male,not reported,not reported,994347ba-3045-4ade-926f-06420fbd906c,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:23:36.515959-05:00,stage iiia,d7402e34-87fe-536a-9b38-8b1c06018a3f,TCGA-DD-A116_diagnosis,asian,not reported,Liver,TCGA-DD-A116_treatment_1,f3dc64ae-6b29-5d17-b705-d9cb1e6a8b66,no,2006,,Liver,released,not reported,2019-04-28T13:23:36.515959-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A116_treatment,,,no,2019-04-28T13:23:36.515959-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:58.071505-05:00,released,16348e68-4add-5b48-bff1-036b32d33c06\\r\\n,TCGA-DD-AAVU_demographic,53ce2171-53c9-5c98-8441-f0a0c119066b,8170/3,TCGA-DD-AAVU,,\"Hepatocellular carcinoma, NOS\",146c5332-1af5-4c49-b740-9a9edc795f24,released,2019-04-28T13:15:09.869297-05:00,no,16889,1962,,2202,male,not reported,not reported,146c5332-1af5-4c49-b740-9a9edc795f24,2019-04-28T13:15:09.869297-05:00,released,2019-05-03T14:06:23.922205-05:00,stage ii,db02e4e0-ad65-57d3-86d0-ec6adee5fc04,TCGA-DD-AAVU_diagnosis,asian,not reported,Liver,TCGA-DD-AAVU_treatment,f10267ac-12d1-5386-a92e-fdf5d59ca07a,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AAVU_treatment_1,,,no,2019-04-28T13:15:09.869297-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:05.743590-05:00,released,1c2a424f-cfcb-5864-b3b4-2165c21a53d8\\r\\n,TCGA-RC-A6M6_demographic,fbce4137-8c46-58f7-baa2-5550e4ca8393,8170/3,TCGA-RC-A6M6,,\"Hepatocellular carcinoma, NOS\",a62f065e-7491-493a-87b3-d213cd87091d,released,,not reported,27649,1936,,9,male,not reported,not reported,a62f065e-7491-493a-87b3-d213cd87091d,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:24:12.739974-05:00,stage ii,db28ded3-1ea5-5b9c-8972-d7129fb40dc0,TCGA-RC-A6M6_diagnosis,white,not reported,Liver,TCGA-RC-A6M6_treatment_1,662b502c-201b-54dc-b369-307114927cef,not reported,,,Liver,released,not reported,2019-04-28T13:24:12.739974-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-RC-A6M6_treatment,,,no,2019-04-28T13:24:12.739974-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:53.093878-05:00,released,3164f294-e6d4-50c7-b7ae-40975e9de1fb\\r\\n,TCGA-DD-AADO_demographic,7f85ae82-ebd5-5f73-9294-fc39bdf11f00,8170/3,TCGA-DD-AADO,,\"Hepatocellular carcinoma, NOS\",9f056388-7529-4fd1-af11-c82cc350f51c,released,,no,20139,1958,,453,male,not reported,not reported,9f056388-7529-4fd1-af11-c82cc350f51c,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:23:48.718521-05:00,stage i,dbd3d712-b89a-56da-b280-647f98a0f07d,TCGA-DD-AADO_diagnosis,asian,not reported,Liver,TCGA-DD-AADO_treatment_1,ce0ab140-032d-5151-b7b1-71844d6e9fa7,no,,,Liver,released,not reported,2019-04-28T13:23:48.718521-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AADO_treatment,,,no,2019-04-28T13:23:48.718521-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:42.289685-05:00,released,1ee63291-9b5d-5817-b4ba-ba608adab663\\r\\n,TCGA-BC-A69H_demographic,77ce5f92-5d6d-5e2e-8adc-d2e92a587588,8170/3,TCGA-BC-A69H,,\"Hepatocellular carcinoma, NOS\",79df037c-7d37-4e6c-a654-57708a4f87aa,released,2019-04-28T13:21:34.564441-05:00,no,23380,1949,,444,male,not reported,not reported,79df037c-7d37-4e6c-a654-57708a4f87aa,2019-04-28T13:21:34.564441-05:00,released,2019-05-03T14:06:23.922205-05:00,stage ii,dca3211e-6bf9-54b4-adda-c0e643ca08a7,TCGA-BC-A69H_diagnosis,white,not reported,Liver,TCGA-BC-A69H_treatment,4c15ff88-9571-5afe-9001-a04df8768452,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-BC-A69H_treatment_1,,,no,2019-04-28T13:21:34.564441-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:35.448559-05:00,released,f387b93d-3888-5086-861c-fe763466cea5\\r\\n,TCGA-G3-A5SJ_demographic,6b8c68cf-b75b-57d1-a4af-454428933b64,8170/3,TCGA-G3-A5SJ,,\"Hepatocellular carcinoma, NOS\",2c8a1e74-33de-453f-8d1e-e226185e52fc,released,2019-04-28T13:16:42.835356-05:00,no,21848,1953,,698,male,not reported,not reported,2c8a1e74-33de-453f-8d1e-e226185e52fc,2019-04-28T13:16:42.835356-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,25de6eeb-ee54-52f4-8d69-f988f2dcad25,TCGA-G3-A5SJ_diagnosis,white,not reported,Liver,TCGA-G3-A5SJ_treatment,bb5b0cb1-a308-509e-ab8b-ea3cc0e6a564,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-G3-A5SJ_treatment_1,,,no,2019-04-28T13:16:42.835356-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:27.936420-05:00,released,9c8f8d3d-8761-58d5-a98e-8d860910c2d1\\r\\n,TCGA-DD-A4NK_demographic,ebc03980-6c6f-5377-97cd-803506f202c9,8170/3,TCGA-DD-A4NK,,\"Hepatocellular carcinoma, NOS\",5b8d04b2-ef40-4216-a3bb-42520efbe863,released,2019-04-28T13:19:57.292785-05:00,no,29244,1924,,,female,not reported,not reported,5b8d04b2-ef40-4216-a3bb-42520efbe863,2019-04-28T13:19:57.292785-05:00,released,2019-05-03T14:06:23.922205-05:00,stage iiia,d1b8456b-76b9-5cf9-871f-bd152662c7bd,TCGA-DD-A4NK_diagnosis,white,not reported,Liver,TCGA-DD-A4NK_treatment,f4c98c94-e662-5bf0-99ca-5354c6e5e2cf,no,2007,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A4NK_treatment_1,,,no,2019-04-28T13:19:57.292785-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:19.490721-05:00,released,7075eac5-bd31-5619-9ff6-4b9a3d4bc13c\\r\\n,TCGA-NI-A4U2_demographic,dc2353bf-0a54-597d-aadb-0b4a62c49b84,8170/3,TCGA-NI-A4U2,,\"Hepatocellular carcinoma, NOS\",9aea3437-572a-48c6-beb9-9bdbcb243875,released,2019-04-28T13:23:41.353049-05:00,yes,26011,1934,,,male,not reported,not reported,9aea3437-572a-48c6-beb9-9bdbcb243875,2019-04-28T13:23:41.353049-05:00,released,2019-05-03T14:06:23.922205-05:00,stage iiia,916255be-c631-59c4-b3b5-8defa5e86e60,TCGA-NI-A4U2_diagnosis,white,not reported,Liver,TCGA-NI-A4U2_treatment,80488079-f557-5e79-8fae-6fa07eb61ba8,yes,2009,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-NI-A4U2_treatment_1,,,no,2019-04-28T13:23:41.353049-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:53.093878-05:00,released,2c3f0efd-5aec-5ebd-9ce2-66d25cef1a10\\r\\n,TCGA-ZP-A9D2_demographic,c56e12b3-a265-5734-b51e-ba3b4bb89cba,8170/3,TCGA-ZP-A9D2,,\"Hepatocellular carcinoma, NOS\",cbb89556-d783-4e70-8db4-ef53e9a45922,released,2019-04-28T13:26:36.164107-05:00,no,18717,1961,,743,male,not reported,not reported,cbb89556-d783-4e70-8db4-ef53e9a45922,2019-04-28T13:26:36.164107-05:00,released,2019-05-03T14:06:23.922205-05:00,not reported,a97bbe8b-c6b5-5b97-9c6e-074c06bebcce,TCGA-ZP-A9D2_diagnosis,white,not reported,Liver,TCGA-ZP-A9D2_treatment,679afc06-c097-55fa-9595-f0caf186d7c3,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-ZP-A9D2_treatment_1,,,no,2019-04-28T13:26:36.164107-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:38:16.668337-05:00,released,b9035034-9b24-52d0-af52-796d364da9cd\\r\\n,TCGA-DD-A4NJ_demographic,789d2746-dff2-5737-9ece-9e85c270fc5d,8170/3,TCGA-DD-A4NJ,,\"Hepatocellular carcinoma, NOS\",815dffb0-0c22-4e05-868c-26e6c553980a,released,2019-04-28T13:22:13.188955-05:00,no,19964,1957,,928,female,not reported,not reported,815dffb0-0c22-4e05-868c-26e6c553980a,2019-04-28T13:22:13.188955-05:00,released,2019-05-03T14:06:23.922205-05:00,stage ii,182fc894-02c6-59d3-887b-3cc27fae47c4,TCGA-DD-A4NJ_diagnosis,white,not reported,Liver,TCGA-DD-A4NJ_treatment,748a7863-a3b3-5d64-b08a-ebda6f1feedb,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A4NJ_treatment_1,,,no,2019-04-28T13:22:13.188955-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:19.490721-05:00,released,c0830ea5-192e-5c5b-91d7-7f5fdde768b1\\r\\n,TCGA-G3-AAV6_demographic,6f50de72-1cc6-587e-9a2d-cfdbff8e9c11,8170/3,TCGA-G3-AAV6,,\"Hepatocellular carcinoma, NOS\",a6733fa1-030a-45ed-9c24-0e64164d4998,released,,no,19556,1960,,,female,not reported,not reported,a6733fa1-030a-45ed-9c24-0e64164d4998,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:24:15.177046-05:00,stage iiia,7e57cab6-6cf5-5369-b49d-61e6baecd0fb,TCGA-G3-AAV6_diagnosis,white,not reported,Liver,TCGA-G3-AAV6_treatment_1,eddd7444-9373-5cbe-b00f-db1501bc949d,no,2013,,Liver,released,not reported,2019-04-28T13:24:15.177046-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-G3-AAV6_treatment,,,no,2019-04-28T13:24:15.177046-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:53.093878-05:00,released,382c5e0d-87e6-5ef6-9fc5-792ddc317c26\\r\\n,TCGA-DD-AAVY_demographic,2e5e9eab-d14b-54af-86ec-fbaa532a9605,8170/3,TCGA-DD-AAVY,,\"Hepatocellular carcinoma, NOS\",c36f9ffe-515b-4895-b82a-aadc49fe3016,released,,no,20709,1953,,1970,male,not reported,not reported,c36f9ffe-515b-4895-b82a-aadc49fe3016,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:26:04.172473-05:00,stage iiia,184a84c8-1183-56e3-bd67-1d58227a6bfd,TCGA-DD-AAVY_diagnosis,asian,not reported,Liver,TCGA-DD-AAVY_treatment_1,c0a72b35-100f-50d1-b79c-f63f4c5c5a10,no,,,Liver,released,not reported,2019-04-28T13:26:04.172473-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AAVY_treatment,,,no,2019-04-28T13:26:04.172473-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:05.743590-05:00,released,395eba24-b8c0-5393-80a8-e447ccff93ff\\r\\n,TCGA-G3-A5SI_demographic,dd3f4e6b-8725-5fde-875b-2f943742d78b,8170/3,TCGA-G3-A5SI,,\"Hepatocellular carcinoma, NOS\",14201da5-4446-47be-af72-120b7780c6bf,released,,no,16126,1967,,447,male,not reported,not reported,14201da5-4446-47be-af72-120b7780c6bf,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:15:07.609473-05:00,stage ii,91f46c41-312f-5c8b-b45b-de7c588078cd,TCGA-G3-A5SI_diagnosis,asian,not reported,Liver,TCGA-G3-A5SI_treatment_1,9929bde9-ac3a-53dd-ac6f-5a2668667141,no,,,Liver,released,not reported,2019-04-28T13:15:07.609473-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-G3-A5SI_treatment,,,no,2019-04-28T13:15:07.609473-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:27.936420-05:00,released,bfc561a4-5693-5348-b6bd-ab6754029450\\r\\n,TCGA-EP-A3JL_demographic,64b7e03d-b69a-58c5-9355-de436007053d,8170/3,TCGA-EP-A3JL,,\"Hepatocellular carcinoma, NOS\",a196a937-b17d-4d4a-965b-8af0f4f41367,released,,no,27886,1935,,303,male,not reported,not reported,a196a937-b17d-4d4a-965b-8af0f4f41367,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:23:53.530990-05:00,stage i,9359de28-3313-5e30-a319-cf54d9501f19,TCGA-EP-A3JL_diagnosis,white,not reported,Liver,TCGA-EP-A3JL_treatment_1,ab2ff2c2-b4b8-5fe9-b67e-ca2ee99d8bbf,no,,,Liver,released,not reported,2019-04-28T13:23:53.530990-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-EP-A3JL_treatment,,,yes,2019-04-28T13:23:53.530990-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:27.936420-05:00,released,e600f138-7e34-546b-99e1-5cc0c31f28f2\\r\\n,TCGA-ED-A66X_demographic,e5c646c9-fdf7-5762-8169-572d9d668330,8170/3,TCGA-ED-A66X,,\"Hepatocellular carcinoma, NOS\",b75ca9e4-a474-4960-9343-c8e9524cd096,released,,no,12947,1978,,406,male,not reported,not reported,b75ca9e4-a474-4960-9343-c8e9524cd096,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:25:20.956019-05:00,stage iiia,93716951-1ffb-5a09-84c7-382353a619e7,TCGA-ED-A66X_diagnosis,asian,not reported,Liver,TCGA-ED-A66X_treatment_1,6c368a7d-ad92-59c4-a20b-5edb545b3b46,no,,,Liver,released,not reported,2019-04-28T13:25:20.956019-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-ED-A66X_treatment,,,no,2019-04-28T13:25:20.956019-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:05.743590-05:00,released,73a40823-65b8-5e75-aa94-2092eeb978af\\r\\n,TCGA-DD-AAE9_demographic,7a2a8f75-6073-5be4-b7a6-b2454b007778,8170/3,TCGA-DD-AAE9,,\"Hepatocellular carcinoma, NOS\",4c960eee-e4b5-499d-a596-238aa78745a4,released,,no,25451,1943,,722,male,not reported,not reported,4c960eee-e4b5-499d-a596-238aa78745a4,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:18:59.724805-05:00,stage i,aa0b7d86-4b86-55a4-859d-219c7ce16300,TCGA-DD-AAE9_diagnosis,asian,not reported,Liver,TCGA-DD-AAE9_treatment_1,3eb6cdc9-31e6-5761-b161-cc7bb8fe58e2,no,,,Liver,released,not reported,2019-04-28T13:18:59.724805-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AAE9_treatment,,,no,2019-04-28T13:18:59.724805-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:05.743590-05:00,released,2e3df80a-8e7d-52fe-a12c-4bd277b843ba\\r\\n,TCGA-KR-A7K0_demographic,79cf58d9-c6a1-529a-b7b6-b096383919e9,8170/3,TCGA-KR-A7K0,,\"Hepatocellular carcinoma, NOS\",5a7706ba-3cea-41eb-b78a-fd69206daa93,released,,no,23974,1948,,,male,not reported,not reported,5a7706ba-3cea-41eb-b78a-fd69206daa93,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:19:52.512958-05:00,stage i,12d8ba07-7705-5cb6-905b-a08b475ce67f,TCGA-KR-A7K0_diagnosis,white,not reported,Liver,TCGA-KR-A7K0_treatment_1,f083fdcc-8917-56b7-a2c0-15264f148091,no,2013,,Liver,released,not reported,2019-04-28T13:19:52.512958-05:00,,not reported,released,Adenomas and Adenocarcinomas,TCGA-KR-A7K0_treatment,,,yes,2019-04-28T13:19:52.512958-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:53.093878-05:00,released,7a449f64-d7eb-542f-b6e2-73ce8d874de0\\r\\n,TCGA-DD-A4NS_demographic,2e4b65de-7bc8-50b7-9790-c4201ea23652,8170/3,TCGA-DD-A4NS,,\"Hepatocellular carcinoma, NOS\",a6a3f07c-ced4-451b-b2e5-c93e4ed622c1,released,2019-04-28T13:24:17.617711-05:00,yes,22638,1944,,,female,not reported,not reported,a6a3f07c-ced4-451b-b2e5-c93e4ed622c1,2019-04-28T13:24:17.617711-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,1b348322-cc4c-5c5f-959d-748510f321a2,TCGA-DD-A4NS_diagnosis,white,not reported,Liver,TCGA-DD-A4NS_treatment,077fb677-9f61-5271-b4de-f9e2e73dd464,yes,2011,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A4NS_treatment_1,,,no,2019-04-28T13:24:17.617711-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:19.490721-05:00,released,21255b2e-46d3-5293-9317-a7dc144f4fd4\\r\\n,TCGA-EP-A2KA_demographic,096e7caf-e17a-55e6-94e6-3bcb9693fab2,8170/3,TCGA-EP-A2KA,,\"Hepatocellular carcinoma, NOS\",440375d7-cdcd-418a-8992-0a8ca42d290d,released,2019-04-28T13:18:19.229240-05:00,yes,19214,1959,,357,female,not reported,not reported,440375d7-cdcd-418a-8992-0a8ca42d290d,2019-04-28T13:18:19.229240-05:00,released,2019-05-03T14:06:23.922205-05:00,stage iiia,74dbb0d8-0b37-5650-8183-250643056c17,TCGA-EP-A2KA_diagnosis,white,not reported,Liver,TCGA-EP-A2KA_treatment,5302581d-379b-56a2-8e1e-25551e2bdf0a,yes,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-EP-A2KA_treatment_1,,,no,2019-04-28T13:18:19.229240-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:27.936420-05:00,released,851e1ec8-1170-5137-890f-13c36ec806b6\\r\\n,TCGA-DD-A118_demographic,0b306b4e-2d9f-5afb-bf41-c0c766add590,8170/3,TCGA-DD-A118,,\"Hepatocellular carcinoma, NOS\",7d914d07-f250-4c7a-8fa2-df14e708936e,released,,no,28406,1926,,3437,female,not reported,not reported,7d914d07-f250-4c7a-8fa2-df14e708936e,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:21:49.279844-05:00,stage ii,6356c0e9-032b-56fb-bc48-a4084d590520,TCGA-DD-A118_diagnosis,white,not reported,Liver,TCGA-DD-A118_treatment_1,187f81dc-ca2a-53f3-be82-7336fcbf5f03,no,,,Liver,released,not reported,2019-04-28T13:21:49.279844-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A118_treatment,,,no,2019-04-28T13:21:49.279844-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:58.071505-05:00,released,710010be-4a63-50b9-8129-2aca8f7ffbb3\\r\\n,TCGA-MI-A75I_demographic,00498a18-72e7-55e5-8926-0829e3ac9cf4,8170/3,TCGA-MI-A75I,,\"Hepatocellular carcinoma, NOS\",55e53229-c58f-4922-8869-0f5e2f6c2d7d,released,2019-04-28T13:19:32.944077-05:00,no,22341,1950,,630,male,not reported,not reported,55e53229-c58f-4922-8869-0f5e2f6c2d7d,2019-04-28T13:19:32.944077-05:00,released,2019-05-03T14:06:23.922205-05:00,not reported,9686c98c-994f-56a1-a2e5-a659ea6f9d9a,TCGA-MI-A75I_diagnosis,black or african american,not reported,Liver,TCGA-MI-A75I_treatment,b4652c31-8760-5d84-966f-c36de439f982,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-MI-A75I_treatment_1,,,no,2019-04-28T13:19:32.944077-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:53.093878-05:00,released,f927f0a8-2656-5e01-bafd-d5ff431ec98b\\r\\n,TCGA-DD-AADA_demographic,03292b91-31e8-520d-a8a2-e5f932de0398,8170/3,TCGA-DD-AADA,,\"Hepatocellular carcinoma, NOS\",e50edba1-8ec4-47e7-a01e-9f1b2cd75fd7,released,,no,24288,1945,,1233,female,not reported,not reported,e50edba1-8ec4-47e7-a01e-9f1b2cd75fd7,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:27:46.698935-05:00,stage i,638e9962-ec28-5bbd-bb7d-b10b27853fda,TCGA-DD-AADA_diagnosis,asian,not reported,Liver,TCGA-DD-AADA_treatment_1,8b96f2cc-4d09-5682-ac81-06e74071ee9a,no,,,Liver,released,not reported,2019-04-28T13:27:46.698935-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AADA_treatment,,,no,2019-04-28T13:27:46.698935-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:42.289685-05:00,released,ec534a5e-34e9-5f33-a288-fb26edbd0b26\\r\\n,TCGA-RC-A6M5_demographic,5c6fa26c-fbad-5b74-ba2a-ced42361b7a9,8171/3,TCGA-RC-A6M5,,\"Hepatocellular carcinoma, fibrolamellar\",d504ee30-6955-4a7b-9311-55ad3decadd5,released,2019-04-28T13:27:05.247836-05:00,not reported,7634,1992,,15,female,not reported,not reported,d504ee30-6955-4a7b-9311-55ad3decadd5,2019-04-28T13:27:05.247836-05:00,released,2019-05-03T14:06:23.922205-05:00,stage iva,989e5864-d033-5007-b5f9-30d63f5a256b,TCGA-RC-A6M5_diagnosis,white,not reported,Liver,TCGA-RC-A6M5_treatment,6e994e12-0189-59aa-880c-e447c46c52a5,not reported,,,Liver,released,not reported,,,not reported,released,Adenomas and Adenocarcinomas,TCGA-RC-A6M5_treatment_1,,,no,2019-04-28T13:27:05.247836-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:53.093878-05:00,released,35b7cc94-52cb-592d-a8f0-0e55d41497e6\\r\\n,TCGA-DD-AAE8_demographic,b140399e-d1ab-5b12-9e87-1f5ca1f84058,8170/3,TCGA-DD-AAE8,,\"Hepatocellular carcinoma, NOS\",b929ece7-6caf-4081-83d3-9923306b4a8a,released,,no,16549,1967,,664,male,not reported,not reported,b929ece7-6caf-4081-83d3-9923306b4a8a,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:25:28.698005-05:00,stage i,991e188a-5397-596e-aaa9-bae9708174f6,TCGA-DD-AAE8_diagnosis,asian,not reported,Liver,TCGA-DD-AAE8_treatment_1,19893064-411f-5c13-82d1-65ee454c2732,no,,,Liver,released,not reported,2019-04-28T13:25:28.698005-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AAE8_treatment,,,yes,2019-04-28T13:25:28.698005-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:05.743590-05:00,released,13278c1b-edc0-5e87-996e-5ce2263c6d1a\\r\\n,TCGA-DD-AAVP_demographic,28d698d5-b9d7-5897-b2ff-c1e36cd4bcf7,8170/3,TCGA-DD-AAVP,,\"Hepatocellular carcinoma, NOS\",0004d251-3f70-4395-b175-c94c2f5b1b81,released,,no,17833,1959,,2752,male,not reported,not reported,0004d251-3f70-4395-b175-c94c2f5b1b81,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:13:44.149411-05:00,stage i,aac73088-e280-54f6-bc81-f6a9fa29ab0f,TCGA-DD-AAVP_diagnosis,asian,not reported,Liver,TCGA-DD-AAVP_treatment_1,042507ff-0397-5464-891f-aa527c20f2eb,no,,,Liver,released,not reported,2019-04-28T13:13:44.149411-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AAVP_treatment,,,no,2019-04-28T13:13:44.149411-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:05.743590-05:00,released,13241640-0112-5ec0-bcbe-15fafe7c6634\\r\\n,TCGA-CC-5263_demographic,4aa27359-8ced-561f-94ca-7dfd1d08594d,8170/3,TCGA-CC-5263,,\"Hepatocellular carcinoma, NOS\",a6af3061-1484-4f6c-bb4b-c8f4626b4161,released,,no,12863,1975,,,male,not reported,not reported,a6af3061-1484-4f6c-bb4b-c8f4626b4161,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:24:19.869068-05:00,stage iiia,9a506434-9ffe-583d-8346-e7099c519682,TCGA-CC-5263_diagnosis,asian,not reported,Liver,TCGA-CC-5263_treatment_1,f79a9a25-7c4c-52f8-9bdb-7ba49ab47378,no,2010,,Liver,released,not reported,2019-04-28T13:24:19.869068-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-CC-5263_treatment,,,no,2019-04-28T13:24:19.869068-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:58.071505-05:00,released,1ba0ee0e-74ce-5078-acf9-ab101d3e9b88\\r\\n,TCGA-DD-A73C_demographic,9332be3b-e934-535a-bf92-ea19d78e0782,8170/3,TCGA-DD-A73C,,\"Hepatocellular carcinoma, NOS\",79f9331c-9e00-4277-a9d1-7c848e132134,released,,no,23782,1947,,701,female,not reported,not reported,79f9331c-9e00-4277-a9d1-7c848e132134,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:21:37.101106-05:00,stage iiia,649c1255-bdfe-5868-9849-9de62923b992,TCGA-DD-A73C_diagnosis,white,not reported,Liver,TCGA-DD-A73C_treatment_1,e6edb4c6-0879-536f-a35c-ae00ebb37058,no,,,Liver,released,not reported,2019-04-28T13:21:37.101106-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A73C_treatment,,,no,2019-04-28T13:21:37.101106-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:19.490721-05:00,released,41c6f756-0233-59de-95f1-f6dd7ece852c\\r\\n,TCGA-DD-AAW0_demographic,d5b57cbb-f13e-5b53-96e0-3467ef3fc6cf,8170/3,TCGA-DD-AAW0,,\"Hepatocellular carcinoma, NOS\",109436aa-a655-429b-8d3b-1a43385c9016,released,2019-04-28T13:14:55.634127-05:00,no,19981,1955,,2015,male,not reported,not reported,109436aa-a655-429b-8d3b-1a43385c9016,2019-04-28T13:14:55.634127-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,9f2f2377-62a0-5f32-bd80-177e1a0a760d,TCGA-DD-AAW0_diagnosis,asian,not reported,Liver,TCGA-DD-AAW0_treatment,3cd21457-69d0-5e94-b9b7-592e532574e6,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AAW0_treatment_1,,,no,2019-04-28T13:14:55.634127-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:05.743590-05:00,released,34a5a14d-59c9-5469-9be9-8e137e3986c1\\r\\n,TCGA-DD-A39W_demographic,4cd9b99e-b04a-52b0-b9fa-3db02eb300e2,8170/3,TCGA-DD-A39W,,\"Hepatocellular carcinoma, NOS\",48d33449-b969-423a-b4e7-541809109617,released,2019-04-28T13:18:44.837909-05:00,not reported,10699,1966,,,female,not reported,not reported,48d33449-b969-423a-b4e7-541809109617,2019-04-28T13:18:44.837909-05:00,released,2019-05-03T14:06:23.922205-05:00,stage iii,107e3c21-1a10-5ed0-9f2e-a85bb371ef6e,TCGA-DD-A39W_diagnosis,white,not reported,Liver,TCGA-DD-A39W_treatment,2d47515a-f371-58fc-8001-d398dd8cbe4d,not reported,1997,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A39W_treatment_1,,,no,2019-04-28T13:18:44.837909-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:19.490721-05:00,released,fc2fd4d1-6729-53fa-b628-a5f0526a77b6\\r\\n,TCGA-2Y-A9HA_demographic,1af75d93-12ab-5b1e-8116-1f14300cb5f0,8170/3,TCGA-2Y-A9HA,,\"Hepatocellular carcinoma, NOS\",a25a714e-c142-482b-91c8-4fea763e0254,released,2019-04-28T13:23:56.091685-05:00,no,25892,1942,,,male,not reported,not reported,a25a714e-c142-482b-91c8-4fea763e0254,2019-04-28T13:23:56.091685-05:00,released,2019-05-03T14:06:23.922205-05:00,stage ii,d535f5ef-a463-506d-9440-a869487359b7,TCGA-2Y-A9HA_diagnosis,white,not reported,Liver,TCGA-2Y-A9HA_treatment,58d5083c-2239-5c13-b21b-a6c9fb2bd64a,no,2012,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-2Y-A9HA_treatment_1,,,no,2019-04-28T13:23:56.091685-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:35.448559-05:00,released,ad55f0d9-30a5-5c2f-a398-9557e12bbbb1\\r\\n,TCGA-DD-A3A7_demographic,e14aa50f-cf7e-59ee-8d9a-1891bc506184,8170/3,TCGA-DD-A3A7,,\"Hepatocellular carcinoma, NOS\",614c0ecf-6a84-4c86-8706-79be5bb00991,released,2019-04-28T13:20:22.001576-05:00,yes,24599,1931,,,male,not reported,not reported,614c0ecf-6a84-4c86-8706-79be5bb00991,2019-04-28T13:20:22.001576-05:00,released,2019-05-03T14:06:23.922205-05:00,stage iiib,5ae53073-0b92-553a-a768-b7d287731aac,TCGA-DD-A3A7_diagnosis,not reported,not reported,Liver,TCGA-DD-A3A7_treatment,31ce6fd1-8644-52d6-917f-f5275e33388c,no,1999,,Liver,released,not reported,,,not reported,released,Adenomas and Adenocarcinomas,TCGA-DD-A3A7_treatment_1,,,no,2019-04-28T13:20:22.001576-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:19.490721-05:00,released,dfe42dec-89d9-5ca9-adba-b4ecf333432b\\r\\n,TCGA-ED-A97K_demographic,f46f6d7b-45bd-5b2f-99f5-46ec6242a59b,8180/3,TCGA-ED-A97K,,Combined hepatocellular carcinoma and cholangiocarcinoma,8778dc9e-a7db-4464-a8af-11addb5e441a,released,,no,20073,1959,,6,male,not reported,not reported,8778dc9e-a7db-4464-a8af-11addb5e441a,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:22:32.540383-05:00,stage iiia,5be1625f-8bb2-55cd-a064-072814eabcc6,TCGA-ED-A97K_diagnosis,asian,not reported,Liver,TCGA-ED-A97K_treatment_1,82fb6d3a-3b1d-50e1-8fca-37202a0f703e,not reported,,,Liver,released,not reported,2019-04-28T13:22:32.540383-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-ED-A97K_treatment,,,no,2019-04-28T13:22:32.540383-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:27.936420-05:00,released,342d61a9-506c-502d-867e-08b0125e7695\\r\\n,TCGA-G3-A7M9_demographic,a8b6a378-7376-5256-99c5-68d82b033d4b,8170/3,TCGA-G3-A7M9,,\"Hepatocellular carcinoma, NOS\",115b754d-8559-4f1d-af44-fcd8c2cef86a,released,,no,25588,1943,,,male,not reported,not reported,115b754d-8559-4f1d-af44-fcd8c2cef86a,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:14:57.982674-05:00,stage iiib,5c26a06c-4140-5108-83ad-73f12f7491c0,TCGA-G3-A7M9_diagnosis,white,not reported,Liver,TCGA-G3-A7M9_treatment_1,32c71a55-274a-5255-87ed-61ec3559dd1b,no,2013,,Liver,released,not reported,2019-04-28T13:14:57.982674-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-G3-A7M9_treatment,,,yes,2019-04-28T13:14:57.982674-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:27.936420-05:00,released,8f6c1705-f8a0-5da4-aa2a-43298f233cd7\\r\\n,TCGA-BC-A10X_demographic,25163168-47a2-58f6-8d2b-0eab41970f89,8170/3,TCGA-BC-A10X,,\"Hepatocellular carcinoma, NOS\",3dc48ea9-a3c6-437f-af5a-88feb300cc5f,released,2019-04-28T09:25:06.149821-05:00,no,19140,1950,,,female,not reported,not reported,3dc48ea9-a3c6-437f-af5a-88feb300cc5f,2019-04-28T09:25:06.149821-05:00,released,2019-05-03T14:06:23.922205-05:00,stage iiia,5cc4f1c4-81ba-5d05-a6a1-0040464dbdad,TCGA-BC-A10X_diagnosis,white,not reported,Liver,TCGA-BC-A10X_treatment,31bf39df-c90d-5081-9358-9f8a31a168b1,no,2004,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-BC-A10X_treatment_1,,,no,2019-04-28T09:25:06.149821-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:35.448559-05:00,released,f80a1377-df50-5e86-ab3c-a9ee271a388b\\r\\n,TCGA-3K-AAZ8_demographic,f1a89da8-55ec-5c61-bc52-3aa77be5e07d,8170/3,TCGA-3K-AAZ8,,\"Hepatocellular carcinoma, NOS\",94e387ae-b641-4e9f-bb53-22c7b2a9cccb,released,,no,24046,1948,,396,male,not reported,not reported,94e387ae-b641-4e9f-bb53-22c7b2a9cccb,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:23:21.219676-05:00,stage iiib,5f3e7317-49fd-5c72-9772-97078861672e,TCGA-3K-AAZ8_diagnosis,black or african american,not reported,Liver,TCGA-3K-AAZ8_treatment_1,cf7bc27c-a62b-5b3b-a9ed-312f1801e81b,yes,,,Liver,released,not reported,2019-04-28T13:23:21.219676-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-3K-AAZ8_treatment,,,no,2019-04-28T13:23:21.219676-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:35.448559-05:00,released,0ab80814-8341-572a-8c39-3dc87adb2cc6\\r\\n,TCGA-G3-AAV1_demographic,4458f978-6407-5e27-84de-b9aa7519e9b5,8170/3,TCGA-G3-AAV1,,\"Hepatocellular carcinoma, NOS\",ee6d81bf-0470-4652-aff0-d85f6ab67626,released,2019-04-28T13:28:03.958454-05:00,no,18973,1962,,,male,not reported,not reported,ee6d81bf-0470-4652-aff0-d85f6ab67626,2019-04-28T13:28:03.958454-05:00,released,2019-05-03T14:06:23.922205-05:00,stage iiic,a4606ce8-84c5-5473-a7bc-6bf01a893cfa,TCGA-G3-AAV1_diagnosis,asian,not reported,Liver,TCGA-G3-AAV1_treatment,a6abc2fc-b447-5cbb-98a6-70c4f70fa60f,no,2013,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-G3-AAV1_treatment_1,,,no,2019-04-28T13:28:03.958454-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:53.093878-05:00,released,17b79e7f-c95d-537d-93ce-a2a9dd0d72a8\\r\\n,TCGA-ES-A2HT_demographic,08db6312-9201-5583-a74b-4d2de4bd4a12,8170/3,TCGA-ES-A2HT,,\"Hepatocellular carcinoma, NOS\",7dd3bda9-3a0a-46fa-b052-a6d24b847804,released,,not reported,20023,1953,,,male,not reported,not reported,7dd3bda9-3a0a-46fa-b052-a6d24b847804,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:21:51.524564-05:00,stage i,5f516eb8-c408-54f1-b582-80c275f8a8f7,TCGA-ES-A2HT_diagnosis,black or african american,not reported,Liver,TCGA-ES-A2HT_treatment_1,61369d5f-2073-5967-9e95-2abbbe878aa2,not reported,2008,,Liver,released,not reported,2019-04-28T13:21:51.524564-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-ES-A2HT_treatment,,,no,2019-04-28T13:21:51.524564-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:27.936420-05:00,released,db905dbf-466d-588c-b59a-20d6893aba0c\\r\\n,TCGA-CC-5264_demographic,d60e1bbf-b6f5-5df7-9066-8816fdf8c6ec,8170/3,TCGA-CC-5264,,\"Hepatocellular carcinoma, NOS\",61902cb6-b041-48ac-aacc-483a28949865,released,,no,25979,1939,,0,male,not reported,not reported,61902cb6-b041-48ac-aacc-483a28949865,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:20:24.403892-05:00,stage iiia,6048a0e0-20f0-54ad-9573-51f91e583e2d,TCGA-CC-5264_diagnosis,asian,not reported,Liver,TCGA-CC-5264_treatment_1,989a25de-2231-5ce5-aa85-4f19a4f381c6,no,,,Liver,released,not reported,2019-04-28T13:20:24.403892-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-CC-5264_treatment,,,no,2019-04-28T13:20:24.403892-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:58.071505-05:00,released,4e69a169-a045-55e6-94bb-31dc3bcd77b8\\r\\n,TCGA-DD-A1EL_demographic,fbf872de-b76c-5875-a098-d3941bf17268,8170/3,TCGA-DD-A1EL,,\"Hepatocellular carcinoma, NOS\",2854ffe8-1f77-497a-bf49-11e0189fee35,released,2019-04-28T13:16:30.005712-05:00,no,8573,1986,,,male,not reported,not reported,2854ffe8-1f77-497a-bf49-11e0189fee35,2019-04-28T13:16:30.005712-05:00,released,2019-05-03T14:06:23.922205-05:00,stage ii,618089d3-91c9-5efa-b785-80cfbeecedae,TCGA-DD-A1EL_diagnosis,black or african american,not reported,Liver,TCGA-DD-A1EL_treatment,9e5fdaec-867f-5e80-9abb-f0993ef1ceb7,no,2010,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A1EL_treatment_1,,,no,2019-04-28T13:16:30.005712-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:19.490721-05:00,released,37b16fdb-a34c-5118-a19a-2e7aaee0a907\\r\\n,TCGA-2Y-A9H2_demographic,617037ba-4b94-534e-9e4c-13cc7f17649a,8170/3,TCGA-2Y-A9H2,,\"Hepatocellular carcinoma, NOS\",cf7f0473-eaf3-4259-a68e-475a782fc84c,released,,no,23653,1946,,1731,female,not reported,not reported,cf7f0473-eaf3-4259-a68e-475a782fc84c,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:26:50.778116-05:00,stage i,ee39c0ca-b1f2-50b4-adb6-f46e31f6865e,TCGA-2Y-A9H2_diagnosis,white,not reported,Liver,TCGA-2Y-A9H2_treatment_1,38a9808a-dc0f-5d46-98d3-3b21d19aeff0,no,,,Liver,released,not reported,2019-04-28T13:26:50.778116-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-2Y-A9H2_treatment,,,no,2019-04-28T13:26:50.778116-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:35.448559-05:00,released,b927f96d-5176-5df5-a2e2-ab02124739a4\\r\\n,TCGA-2Y-A9H6_demographic,deb8ee2d-67ac-50e9-9f0c-199030face37,8170/3,TCGA-2Y-A9H6,,\"Hepatocellular carcinoma, NOS\",bc3502bc-bbf6-44f2-a1f4-d1567819aefb,released,,no,24982,1943,,357,female,not reported,not reported,bc3502bc-bbf6-44f2-a1f4-d1567819aefb,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:25:39.771610-05:00,stage i,6f1177a7-46f1-5fc0-8f6d-ef370f7a7339,TCGA-2Y-A9H6_diagnosis,white,not reported,Liver,TCGA-2Y-A9H6_treatment_1,f47783d4-790e-5d80-9eb2-d719d6b8ba6f,no,,,Liver,released,not reported,2019-04-28T13:25:39.771610-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-2Y-A9H6_treatment,,,yes,2019-04-28T13:25:39.771610-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:35.448559-05:00,released,b6df23f0-21ee-5b7f-a4ce-db883f3c60a1\\r\\n,TCGA-G3-A5SM_demographic,dfc7d4f6-9ecb-5ac2-8f61-b495afa7f928,8170/3,TCGA-G3-A5SM,,\"Hepatocellular carcinoma, NOS\",d397e70f-c174-4656-9b7e-5e4c00754410,released,,no,21236,1954,,520,male,not reported,not reported,d397e70f-c174-4656-9b7e-5e4c00754410,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:26:58.107166-05:00,stage ii,62ac3ca9-6e62-5613-831e-a3defeb86674,TCGA-G3-A5SM_diagnosis,white,not reported,Liver,TCGA-G3-A5SM_treatment_1,b8bec37b-65b4-52f7-990c-211d08251022,no,,,Liver,released,not reported,2019-04-28T13:26:58.107166-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-G3-A5SM_treatment,,,no,2019-04-28T13:26:58.107166-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:27.936420-05:00,released,68be2dde-1693-5ea6-8265-31f936e33e39\\r\\n,TCGA-CC-A5UD_demographic,35aff3b8-7457-5c65-8c12-418ebadaebc4,8170/3,TCGA-CC-A5UD,,\"Hepatocellular carcinoma, NOS\",3837c8ac-6c9e-499b-a4e7-d42c870bcb49,released,,no,16702,1967,,0,male,not reported,not reported,3837c8ac-6c9e-499b-a4e7-d42c870bcb49,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:17:18.404526-05:00,stage iiia,705a3311-1ab5-5f22-b826-18bae97e2ef9,TCGA-CC-A5UD_diagnosis,asian,not reported,Liver,TCGA-CC-A5UD_treatment_1,c6f49c91-c636-52a3-941e-08ad39d023d1,no,,,Liver,released,not reported,2019-04-28T13:17:18.404526-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-CC-A5UD_treatment,,,no,2019-04-28T13:17:18.404526-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:58.071505-05:00,released,f4aafad1-6a32-5efb-8f9d-0688f074d57a\\r\\n,TCGA-GJ-A9DB_demographic,c5b98fc3-f70d-5456-a49f-e90e859344fd,8170/3,TCGA-GJ-A9DB,,\"Hepatocellular carcinoma, NOS\",45f00f00-d793-4dca-aeb9-7626d4575c90,released,2019-04-28T13:18:29.880805-05:00,no,25020,1945,,,male,not reported,not reported,45f00f00-d793-4dca-aeb9-7626d4575c90,2019-04-28T13:18:29.880805-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,6517c8be-e22d-56ad-b5e8-839ba32ddd96,TCGA-GJ-A9DB_diagnosis,white,not reported,Liver,TCGA-GJ-A9DB_treatment,729938f0-5600-5c24-a818-f9c02bb3c707,no,2013,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-GJ-A9DB_treatment_1,,,no,2019-04-28T13:18:29.880805-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:53.093878-05:00,released,06cdfc78-398d-50a7-93e2-6a921d63e308\\r\\n,TCGA-ED-A8O6_demographic,7f8ef37b-e29c-53a0-9f19-378b555ce2ca,8170/3,TCGA-ED-A8O6,,\"Hepatocellular carcinoma, NOS\",7fb03840-5153-4dc6-a302-5a89aa4e1fb6,released,,no,18572,1963,,6,female,not reported,not reported,7fb03840-5153-4dc6-a302-5a89aa4e1fb6,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:21:58.682851-05:00,stage iiia,a48bbdba-9146-5f1d-b630-017269f73004,TCGA-ED-A8O6_diagnosis,asian,not reported,Liver,TCGA-ED-A8O6_treatment_1,f6775622-1801-5ebd-bb25-49eea29ba904,no,,,Liver,released,not reported,2019-04-28T13:21:58.682851-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-ED-A8O6_treatment,,,no,2019-04-28T13:21:58.682851-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:27.936420-05:00,released,53927004-1a4e-53ec-a641-8fd8d9bd8555\\r\\n,TCGA-4R-AA8I_demographic,7c93346b-5383-582f-9d80-a701838a8530,8170/3,TCGA-4R-AA8I,,\"Hepatocellular carcinoma, NOS\",91a0c8cd-4f23-4569-8e5c-e5442f7af530,released,2019-04-28T13:23:13.604101-05:00,no,24279,1947,,216,male,not reported,not reported,91a0c8cd-4f23-4569-8e5c-e5442f7af530,2019-04-28T13:23:13.604101-05:00,released,2019-05-03T14:06:23.922205-05:00,stage ii,ed16a1a5-759c-5234-8c1d-b61f4a989608,TCGA-4R-AA8I_diagnosis,white,not reported,Liver,TCGA-4R-AA8I_treatment,6c239a8f-ec69-57b3-861e-19b11e11a66e,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-4R-AA8I_treatment_1,,,yes,2019-04-28T13:23:13.604101-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:35.448559-05:00,released,43a8b049-317c-5ff6-850a-cda56eab5c5c\\r\\n,TCGA-DD-AAVR_demographic,9730cb66-15fa-50d8-b669-257c5f6982fb,8170/3,TCGA-DD-AAVR,,\"Hepatocellular carcinoma, NOS\",834cff01-3c12-42fa-abbe-ae0ae168c568,released,2019-04-28T13:22:20.509118-05:00,no,16157,1963,,2513,male,not reported,not reported,834cff01-3c12-42fa-abbe-ae0ae168c568,2019-04-28T13:22:20.509118-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,ed27408d-ba2d-5eea-ac08-bbe45b7d431f,TCGA-DD-AAVR_diagnosis,asian,not reported,Liver,TCGA-DD-AAVR_treatment,f7f59c2b-ed4e-570d-8bfd-11d5208c35c4,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AAVR_treatment_1,,,no,2019-04-28T13:22:20.509118-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:05.743590-05:00,released,3cf561fa-15d8-5bad-beaa-fc1b09b267c6\\r\\n,TCGA-5R-AA1D_demographic,fe3d5b60-a4d4-522b-8e44-7bf02f00ad72,8170/3,TCGA-5R-AA1D,,\"Hepatocellular carcinoma, NOS\",d3d3dba9-139e-4f57-ac70-b741553d1687,released,2019-04-28T13:27:02.839426-05:00,no,6545,1996,,449,female,not reported,not reported,d3d3dba9-139e-4f57-ac70-b741553d1687,2019-04-28T13:27:02.839426-05:00,released,2019-05-03T14:06:23.922205-05:00,stage iiia,ee3b4264-16c7-5352-bdac-2cd1d55eb9e3,TCGA-5R-AA1D_diagnosis,white,not reported,Liver,TCGA-5R-AA1D_treatment,34d58179-f543-53b7-9e60-4a8c4a973f87,yes,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-5R-AA1D_treatment_1,,,no,2019-04-28T13:27:02.839426-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:35.448559-05:00,released,e2a68988-8477-5844-9536-cc65920b4ea6\\r\\n,TCGA-DD-AACF_demographic,cbc910f9-3bf3-5d23-8ea7-b53d4145b768,8170/3,TCGA-DD-AACF,,\"Hepatocellular carcinoma, NOS\",635aad0b-9c47-4564-821f-c00ddb280d53,released,2019-04-28T13:20:31.443934-05:00,no,25172,1940,,,male,not reported,not reported,635aad0b-9c47-4564-821f-c00ddb280d53,2019-04-28T13:20:31.443934-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,ee71561f-fa60-59d8-8d23-4ec0ff4c4308,TCGA-DD-AACF_diagnosis,asian,not reported,Liver,TCGA-DD-AACF_treatment,fa8ea70d-ecd5-53be-876a-209ff53e3a1a,no,2009,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AACF_treatment_1,,,no,2019-04-28T13:20:31.443934-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:42.289685-05:00,released,a0de0050-b8d6-5164-b294-2a698953a268\\r\\n,TCGA-DD-A3A5_demographic,a96d6ef0-33f6-535b-ab02-966bab6a4fa3,8170/3,TCGA-DD-A3A5,,\"Hepatocellular carcinoma, NOS\",d8549d23-37d4-42bd-b472-f49bbebd09b0,released,2019-04-28T13:27:22.293186-05:00,no,24288,1930,,,female,not reported,not reported,d8549d23-37d4-42bd-b472-f49bbebd09b0,2019-04-28T13:27:22.293186-05:00,released,2019-05-03T14:06:23.922205-05:00,stage iii,effdef70-549b-5bca-8f66-ef1848127b8e,TCGA-DD-A3A5_diagnosis,white,not reported,Liver,TCGA-DD-A3A5_treatment,feae1f48-47c4-5e60-9ec9-8cc4d951b7db,no,2004,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A3A5_treatment_1,,,no,2019-04-28T13:27:22.293186-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:19.490721-05:00,released,07969d69-fdd5-57e2-8fa1-88bcbf5329ef\\r\\n,TCGA-G3-A3CJ_demographic,1e4318ab-281e-5d03-956a-dae3562b6649,8170/3,TCGA-G3-A3CJ,,\"Hepatocellular carcinoma, NOS\",cb8f3c76-da86-4a1d-977c-44ab399b342a,released,,yes,19305,1959,,594,male,not reported,not reported,cb8f3c76-da86-4a1d-977c-44ab399b342a,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:26:33.821415-05:00,stage ii,547a4a84-4f6b-5a32-899f-5d866e736284,TCGA-G3-A3CJ_diagnosis,american indian or alaska native,not reported,Liver,TCGA-G3-A3CJ_treatment_1,91a50186-51bc-56b3-909d-c6358ca63be1,yes,,,Liver,released,not reported,2019-04-28T13:26:33.821415-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-G3-A3CJ_treatment,,,no,2019-04-28T13:26:33.821415-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:27.936420-05:00,released,20aca155-207b-55bc-b0f7-117d8cf8d4bf\\r\\n,TCGA-PD-A5DF_demographic,b31f5b33-983d-5d1d-981e-034557651e74,8170/3,TCGA-PD-A5DF,,\"Hepatocellular carcinoma, NOS\",1987b453-f97d-45c7-9c89-b9a33313d645,released,,no,21414,1949,,,female,not reported,not reported,1987b453-f97d-45c7-9c89-b9a33313d645,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:15:29.685663-05:00,stage iiib,cd197697-522d-5315-8b7d-cc539c7c3fca,TCGA-PD-A5DF_diagnosis,white,not reported,Liver,TCGA-PD-A5DF_treatment_1,fae2738a-c190-5f09-a17e-8127c6ba73fd,yes,2008,,Liver,released,not reported,2019-04-28T13:15:29.685663-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-PD-A5DF_treatment,,,no,2019-04-28T13:15:29.685663-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:53.093878-05:00,released,df1a49c5-df21-5522-a5ee-0f6406c7165c\\r\\n,TCGA-FV-A2QR_demographic,8f1fda03-a220-5915-93db-f1c91371963e,8170/3,TCGA-FV-A2QR,,\"Hepatocellular carcinoma, NOS\",d3a03f7a-3482-4548-957e-05c692b20101,released,2019-04-28T13:27:00.504498-05:00,no,,1931,,,male,not reported,not reported,d3a03f7a-3482-4548-957e-05c692b20101,2019-04-28T13:27:00.504498-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,a49576c7-6187-5e9a-9ce1-0ee2a603e886,TCGA-FV-A2QR_diagnosis,white,not reported,Liver,TCGA-FV-A2QR_treatment,aa10e7eb-a1e4-55c0-98ba-9f8568e2fb36,no,2007,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-FV-A2QR_treatment_1,,,no,2019-04-28T13:27:00.504498-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:27.936420-05:00,released,4e6e64ff-7899-594e-b4bd-a8530a3eb001\\r\\n,TCGA-DD-A1EB_demographic,fd246f91-7036-598e-9fdc-0a29308fffab,8170/3,TCGA-DD-A1EB,,\"Hepatocellular carcinoma, NOS\",68015cc7-d3a1-4c90-b8fb-5d14143d9960,released,2019-04-28T13:20:51.093481-05:00,no,26471,1929,,2017,female,not reported,not reported,68015cc7-d3a1-4c90-b8fb-5d14143d9960,2019-04-28T13:20:51.093481-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,6562249e-de78-5013-9410-2e96a0249796,TCGA-DD-A1EB_diagnosis,not reported,not reported,Liver,TCGA-DD-A1EB_treatment,b632c3e5-9066-50c6-939d-6b9825e68bca,no,,,Liver,released,not reported,,,not reported,released,Adenomas and Adenocarcinomas,TCGA-DD-A1EB_treatment_1,,,no,2019-04-28T13:20:51.093481-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:19.490721-05:00,released,f542dc46-8865-5c98-b14b-a0023c3d6b22\\r\\n,TCGA-ZP-A9CZ_demographic,c410eb3b-f090-5278-9cbb-790513fb0fe8,8170/3,TCGA-ZP-A9CZ,,\"Hepatocellular carcinoma, NOS\",22077056-067d-4db5-98e5-106778ceca56,released,,no,26403,1939,,706,male,not reported,not reported,22077056-067d-4db5-98e5-106778ceca56,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:16:03.611151-05:00,not reported,116222c6-c2dc-5aab-b4cd-7ec083a176bd,TCGA-ZP-A9CZ_diagnosis,asian,not reported,Liver,TCGA-ZP-A9CZ_treatment_1,f297fc5b-e8e7-5990-8f02-978afc206c04,no,,,Liver,released,not reported,2019-04-28T13:16:03.611151-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-ZP-A9CZ_treatment,,,no,2019-04-28T13:16:03.611151-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:38:16.668337-05:00,released,05d504e0-b8c2-53c6-9a1e-42314bb7a620\\r\\n,TCGA-G3-A3CG_demographic,c37753b0-3705-5c80-aadd-92e3a64ea2a3,8170/3,TCGA-G3-A3CG,,\"Hepatocellular carcinoma, NOS\",8a14d153-bbf7-4512-a067-976edfb65f91,released,,no,29432,1931,,673,male,not reported,not reported,8a14d153-bbf7-4512-a067-976edfb65f91,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:22:49.037898-05:00,stage i,65e2e281-1edc-52b1-8402-2f498e658f8e,TCGA-G3-A3CG_diagnosis,white,not reported,Liver,TCGA-G3-A3CG_treatment_1,8f272612-e7fa-5840-b55f-42ca8b82231f,yes,,,Liver,released,not reported,2019-04-28T13:22:49.037898-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-G3-A3CG_treatment,,,yes,2019-04-28T13:22:49.037898-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:27.936420-05:00,released,52954d33-7a49-5a10-a855-9fe1d01e332e\\r\\n,TCGA-HP-A5N0_demographic,fc85888f-381c-55fd-954b-bbbad6f9b85e,8174/3,TCGA-HP-A5N0,,\"Hepatocellular carcinoma, clear cell type\",7f8e25d4-6021-4327-96ab-79b6fcc97a24,released,,no,32120,,,,female,not reported,not reported,7f8e25d4-6021-4327-96ab-79b6fcc97a24,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:21:56.387360-05:00,not reported,66bfa9c1-e989-598f-b521-19ed3bba92ac,TCGA-HP-A5N0_diagnosis,not reported,not reported,Liver,TCGA-HP-A5N0_treatment_1,a7736b14-a845-59ab-9213-c36310a3486d,no,,,Liver,released,not reported,2019-04-28T13:21:56.387360-05:00,,not reported,released,Adenomas and Adenocarcinomas,TCGA-HP-A5N0_treatment,,,no,2019-04-28T13:21:56.387360-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:53.093878-05:00,released,4a881f1c-0d78-53f3-a948-82fa287965dc\\r\\n,TCGA-DD-A4NG_demographic,9a0525fb-9e06-5e24-8c84-885b3edccc6d,8170/3,TCGA-DD-A4NG,,\"Hepatocellular carcinoma, NOS\",89791f8f-dc06-4a04-b166-afbfd6cf53de,released,2019-04-28T13:22:42.036417-05:00,no,28234,1934,,445,male,not reported,not reported,89791f8f-dc06-4a04-b166-afbfd6cf53de,2019-04-28T13:22:42.036417-05:00,released,2019-05-03T14:06:23.922205-05:00,stage iiia,5753e6a7-7d1e-5d4e-8816-7b374e62849e,TCGA-DD-A4NG_diagnosis,white,not reported,Liver,TCGA-DD-A4NG_treatment,8cbf4c7e-af04-5f72-8c4f-cec968e50a97,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A4NG_treatment_1,,,no,2019-04-28T13:22:42.036417-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:19.490721-05:00,released,c0e96cf2-5bee-5eb4-a685-3da7c7ce70c1\\r\\n,TCGA-DD-AADI_demographic,11e52765-8b08-515f-9d79-4421a47b0fb4,8170/3,TCGA-DD-AADI,,\"Hepatocellular carcinoma, NOS\",97472e71-66eb-434b-81b0-d727765f44cb,released,2019-04-28T13:23:33.978421-05:00,no,15928,1968,,1085,female,not reported,not reported,97472e71-66eb-434b-81b0-d727765f44cb,2019-04-28T13:23:33.978421-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,66cfb842-40f9-5230-8b6f-afb2d0319610,TCGA-DD-AADI_diagnosis,asian,not reported,Liver,TCGA-DD-AADI_treatment,758094bc-7e0d-5910-a97d-3d4b8599b23d,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AADI_treatment_1,,,no,2019-04-28T13:23:33.978421-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:42.289685-05:00,released,0c4bbe53-88b5-59e6-8407-8189c8e5bfde\\r\\n,TCGA-BC-A110_demographic,f1205624-ce42-5777-a069-7861c3da43c2,8170/3,TCGA-BC-A110,,\"Hepatocellular carcinoma, NOS\",cf028bce-d20d-42b8-8507-1ec94a391e85,released,2019-04-28T13:26:45.887914-05:00,yes,18951,1952,,,female,not reported,not reported,cf028bce-d20d-42b8-8507-1ec94a391e85,2019-04-28T13:26:45.887914-05:00,released,2019-05-03T14:06:23.922205-05:00,not reported,11acc0ec-455a-5ef3-b1da-8cf71a8f6b45,TCGA-BC-A110_diagnosis,black or african american,not reported,Liver,TCGA-BC-A110_treatment,217f7f7f-eafb-52e8-aa2a-89a4501d2ffe,no,2008,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-BC-A110_treatment_1,,,yes,2019-04-28T13:26:45.887914-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:35.448559-05:00,released,ba00b738-75a1-582d-a257-92af67d21cc6\\r\\n,TCGA-DD-AAEG_demographic,41f36242-527f-5e61-b66d-7d5327ea37cc,8170/3,TCGA-DD-AAEG,,\"Hepatocellular carcinoma, NOS\",bd627786-31a8-46d9-b3e2-7f489d50f608,released,2019-04-28T13:25:47.500702-05:00,no,21853,1953,,719,female,not reported,not reported,bd627786-31a8-46d9-b3e2-7f489d50f608,2019-04-28T13:25:47.500702-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,a55fbe11-4113-52ae-b17f-206a4df5c78c,TCGA-DD-AAEG_diagnosis,asian,not reported,Liver,TCGA-DD-AAEG_treatment,94d2474f-93de-50cd-8021-f29c706a5cf6,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AAEG_treatment_1,,,yes,2019-04-28T13:25:47.500702-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:05.743590-05:00,released,339b26a8-2969-5d11-adf0-79a0cc497852\\r\\n,TCGA-DD-AAEI_demographic,a1287a49-26d1-5f77-bae5-93d9f29b6079,8170/3,TCGA-DD-AAEI,,\"Hepatocellular carcinoma, NOS\",34416be6-b6d6-4029-b899-9ba685e39590,released,,yes,26465,1938,,1531,male,not reported,not reported,34416be6-b6d6-4029-b899-9ba685e39590,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:17:08.921645-05:00,stage i,68e52e0c-e760-5880-887e-8485ca76926e,TCGA-DD-AAEI_diagnosis,asian,not reported,Liver,TCGA-DD-AAEI_treatment_1,a3856d70-4ba1-5bcb-a7fd-0cb17714d8c5,no,,,Liver,released,not reported,2019-04-28T13:17:08.921645-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AAEI_treatment,,,no,2019-04-28T13:17:08.921645-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:05.743590-05:00,released,92bb6d24-3c13-54b8-a36b-ab6476b40c9d\\r\\n,TCGA-FV-A3I0_demographic,9b33ca58-cb03-5830-befe-59d6294d30e2,8180/3,TCGA-FV-A3I0,,Combined hepatocellular carcinoma and cholangiocarcinoma,a8c2aa08-9156-4845-ad77-5e060858c757,released,,no,28101,1935,,848,female,not reported,not reported,a8c2aa08-9156-4845-ad77-5e060858c757,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:24:27.527700-05:00,stage ii,690e2dd1-aa31-54af-b56f-39feacaa7ecf,TCGA-FV-A3I0_diagnosis,white,not reported,Liver,TCGA-FV-A3I0_treatment_1,8b63bf23-2c22-5ee5-89b4-0be69c1ea61a,yes,,,Liver,released,not reported,2019-04-28T13:24:27.527700-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-FV-A3I0_treatment,,,no,2019-04-28T13:24:27.527700-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:27.936420-05:00,released,fd77d012-571f-52b7-99e5-08c735992e89\\r\\n,TCGA-DD-A3A0_demographic,853c03e9-56a2-5fd8-a3de-2713d3ec4ea1,8170/3,TCGA-DD-A3A0,,\"Hepatocellular carcinoma, NOS\",ae99d9fd-1735-4217-b4ef-33b377fbd594,released,,no,25889,1931,,,male,not reported,not reported,ae99d9fd-1735-4217-b4ef-33b377fbd594,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:24:49.516429-05:00,stage i,11eafdd5-affe-5cd8-93dd-b14e37771e8a,TCGA-DD-A3A0_diagnosis,white,not reported,Liver,TCGA-DD-A3A0_treatment_1,562df5e8-716b-5e3f-97fc-ca94e114e2b5,no,2003,,Liver,released,not reported,2019-04-28T13:24:49.516429-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A3A0_treatment,,,no,2019-04-28T13:24:49.516429-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:19.490721-05:00,released,ce753f2d-7ed5-50f1-b690-8c273df6ffce\\r\\n,TCGA-DD-A39Y_demographic,88ea69f5-8fe0-5bd8-9fd3-7fc9005447d3,8170/3,TCGA-DD-A39Y,,\"Hepatocellular carcinoma, NOS\",bed1d731-e382-4b80-9604-e6dd68d9c0ab,released,2019-04-28T13:25:52.367765-05:00,no,24769,1935,,,male,not reported,not reported,bed1d731-e382-4b80-9604-e6dd68d9c0ab,2019-04-28T13:25:52.367765-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,6b2dee40-d785-5ff1-896c-75b38c1b25eb,TCGA-DD-A39Y_diagnosis,asian,not reported,Liver,TCGA-DD-A39Y_treatment,2df3fc28-56e1-5ff9-a2b8-9fb662f0f5d8,no,2002,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A39Y_treatment_1,,,no,2019-04-28T13:25:52.367765-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:19.490721-05:00,released,fe4bd31b-c3ce-512c-b85a-a5e47c086a71\\r\\n,TCGA-CC-A1HT_demographic,2e997d7d-8957-507d-9dcc-d098acfab4c2,8170/3,TCGA-CC-A1HT,,\"Hepatocellular carcinoma, NOS\",670c1cbc-4494-45f1-bb8b-18db82d4f7e0,released,,no,18553,1960,,0,male,not reported,not reported,670c1cbc-4494-45f1-bb8b-18db82d4f7e0,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:20:46.325336-05:00,stage iiia,6cc79a8b-40ea-525d-937c-4eef2f1030ae,TCGA-CC-A1HT_diagnosis,asian,not reported,Liver,TCGA-CC-A1HT_treatment_1,1a8fae6a-3f49-5ec4-a224-d75161fd2170,no,,,Liver,released,not reported,2019-04-28T13:20:46.325336-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-CC-A1HT_treatment,,,no,2019-04-28T13:20:46.325336-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:58.071505-05:00,released,5eb9cd9f-2996-5aa3-a0f2-630bfb3e7e0e\\r\\n,TCGA-DD-AACZ_demographic,e8650e5b-f1bf-5bb0-80d6-c1550c3453f4,8170/3,TCGA-DD-AACZ,,\"Hepatocellular carcinoma, NOS\",cce2bb32-84cb-4991-9628-1ea408a9b11a,released,,no,23230,1947,,,female,not reported,not reported,cce2bb32-84cb-4991-9628-1ea408a9b11a,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:26:41.052005-05:00,stage i,bac8cf91-e922-5754-9ee1-8c0ac6fe6c52,TCGA-DD-AACZ_diagnosis,asian,not reported,Liver,TCGA-DD-AACZ_treatment_1,1994571a-62a6-5ef2-8e2e-5de2370ad01c,no,2010,,Liver,released,not reported,2019-04-28T13:26:41.052005-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AACZ_treatment,,,no,2019-04-28T13:26:41.052005-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:42.289685-05:00,released,e3038a09-6d53-57c0-b427-0ea872d65316\\r\\n,TCGA-CC-A9FS_demographic,d6500501-e95e-5b53-a358-b43624cf3f13,8170/3,TCGA-CC-A9FS,,\"Hepatocellular carcinoma, NOS\",f661a921-2e59-424b-a145-e22664b73728,released,2019-04-28T13:28:23.150354-05:00,no,20157,1958,,211,male,not reported,not reported,f661a921-2e59-424b-a145-e22664b73728,2019-04-28T13:28:23.150354-05:00,released,2019-05-03T14:06:23.922205-05:00,stage ii,b17cca21-2ee9-5aa1-8e4a-01d8d688db04,TCGA-CC-A9FS_diagnosis,asian,not reported,Liver,TCGA-CC-A9FS_treatment,c6d72ebb-c463-5cb5-93d9-19da2a28dc98,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-CC-A9FS_treatment_1,,,no,2019-04-28T13:28:23.150354-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:58.071505-05:00,released,aa01512f-972c-5282-b30c-a59eff6695a6\\r\\n,TCGA-BD-A3ER_demographic,ffa89772-1c7a-5723-a7bc-0b97a2e8797c,8170/3,TCGA-BD-A3ER,,\"Hepatocellular carcinoma, NOS\",9457a9a1-3dd1-4d88-b1e1-d20aae4491dd,released,2019-04-28T13:23:18.729192-05:00,no,22657,1949,,1115,male,not reported,not reported,9457a9a1-3dd1-4d88-b1e1-d20aae4491dd,2019-04-28T13:23:18.729192-05:00,released,2019-05-03T14:06:23.922205-05:00,stage ii,6cd87abb-29de-517b-92c7-605010ff700a,TCGA-BD-A3ER_diagnosis,white,not reported,Liver,TCGA-BD-A3ER_treatment,dbf9313e-2638-53a5-9b5a-eeb1ea124a20,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-BD-A3ER_treatment_1,,,yes,2019-04-28T13:23:18.729192-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:58.071505-05:00,released,8e78ac06-e15e-5cd8-a290-36bb26d13cc3\\r\\n,TCGA-LG-A9QC_demographic,e827466e-bc70-5683-84a6-7eff003d0501,8170/3,TCGA-LG-A9QC,,\"Hepatocellular carcinoma, NOS\",8c2783ef-aa41-44c9-be87-fa4c84108f1e,released,,no,17842,1965,,425,male,not reported,not reported,8c2783ef-aa41-44c9-be87-fa4c84108f1e,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T09:25:21.167222-05:00,stage i,6d0fbb73-21aa-53f2-8f35-3b7f4cd44977,TCGA-LG-A9QC_diagnosis,white,not reported,Liver,TCGA-LG-A9QC_treatment_1,66317052-4539-5177-a46d-b3b921eb993f,no,,,Liver,released,not reported,2019-04-28T09:25:21.167222-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-LG-A9QC_treatment,,,no,2019-04-28T09:25:21.167222-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:53.093878-05:00,released,aa76128f-dc82-5101-9bd9-f19b6621f5e4\\r\\n,TCGA-DD-AADY_demographic,cb308217-0501-5fe5-8dfc-a05519a5d280,8170/3,TCGA-DD-AADY,,\"Hepatocellular carcinoma, NOS\",e42e4244-dce8-453a-b5e0-7593a9b5af61,released,2019-04-28T13:27:41.976421-05:00,no,20233,1958,,555,female,not reported,not reported,e42e4244-dce8-453a-b5e0-7593a9b5af61,2019-04-28T13:27:41.976421-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,a640c638-f8b4-50eb-ab3e-8b4bb105bdb9,TCGA-DD-AADY_diagnosis,asian,not reported,Liver,TCGA-DD-AADY_treatment,026679ae-0acc-549b-9f6a-f92f03475a83,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AADY_treatment_1,,,no,2019-04-28T13:27:41.976421-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:05.743590-05:00,released,24514ac5-bd1b-5f99-a3b8-4ae29ffef9d3\\r\\n,TCGA-DD-A4NL_demographic,ce9f0ab5-2f25-51b8-8db6-ba44d5d76ba5,8170/3,TCGA-DD-A4NL,,\"Hepatocellular carcinoma, NOS\",e0067280-2722-46f2-a5a8-352c77b47e38,released,2019-04-28T13:27:34.547272-05:00,no,16874,1961,,1711,male,not reported,not reported,e0067280-2722-46f2-a5a8-352c77b47e38,2019-04-28T13:27:34.547272-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,0a333dc8-fcb8-59a0-a98b-0f455116f627,TCGA-DD-A4NL_diagnosis,white,not reported,Liver,TCGA-DD-A4NL_treatment,8ace609e-7502-5695-8e0a-298923f01c18,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A4NL_treatment_1,,,no,2019-04-28T13:27:34.547272-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:19.490721-05:00,released,04079283-0bf6-5e10-8c27-6c08f838f8a2\\r\\n,TCGA-MI-A75G_demographic,d851b88e-9d58-57dd-a5ca-a255d0690744,8170/3,TCGA-MI-A75G,,\"Hepatocellular carcinoma, NOS\",22dd3876-1f2c-4ddd-8fae-f5fb820993ba,released,,no,23284,1949,,698,male,not reported,not reported,22dd3876-1f2c-4ddd-8fae-f5fb820993ba,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:16:08.275617-05:00,stage ii,b7b1e785-bf8f-506a-b7fa-f512d90c296f,TCGA-MI-A75G_diagnosis,white,not reported,Liver,TCGA-MI-A75G_treatment_1,2172ef4d-2dc1-537d-a1ea-f2602358086a,no,,,Liver,released,not reported,2019-04-28T13:16:08.275617-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-MI-A75G_treatment,,,no,2019-04-28T13:16:08.275617-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:53.093878-05:00,released,30db3b01-eb72-5b0d-beae-55d32d7e0e72\\r\\n,TCGA-FV-A23B_demographic,3ad4075c-3a40-523b-9165-942db42b66c6,8170/3,TCGA-FV-A23B,,\"Hepatocellular carcinoma, NOS\",c95ed407-bcc2-44aa-bc59-bf7549f2d665,released,2019-04-28T13:26:26.406557-05:00,no,25788,1935,,987,female,not reported,not reported,c95ed407-bcc2-44aa-bc59-bf7549f2d665,2019-04-28T13:26:26.406557-05:00,released,2019-05-03T14:06:23.922205-05:00,stage ii,476cb668-6754-5233-a801-8a658a9d24f5,TCGA-FV-A23B_diagnosis,white,not reported,Liver,TCGA-FV-A23B_treatment,1ea4c227-7bbc-5f1b-9377-e5b12aba1286,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-FV-A23B_treatment_1,,,no,2019-04-28T13:26:26.406557-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:27.936420-05:00,released,0e47ee6f-8c69-533d-b353-950707df1beb\\r\\n,TCGA-2Y-A9H7_demographic,d0114d8a-4971-5d0c-ab40-88978b912d20,8170/3,TCGA-2Y-A9H7,,\"Hepatocellular carcinoma, NOS\",18602ec8-aed1-4515-b0d1-0db6d1cbb2c4,released,,no,29752,1930,,1168,female,not reported,not reported,18602ec8-aed1-4515-b0d1-0db6d1cbb2c4,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:15:19.724487-05:00,stage i,d143d2d0-3597-5534-bcfc-ad7749efd76a,TCGA-2Y-A9H7_diagnosis,white,not reported,Liver,TCGA-2Y-A9H7_treatment_1,85bf2c64-4177-5f79-ae5a-7cb4847ab7e3,no,,,Liver,released,not reported,2019-04-28T13:15:19.724487-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-2Y-A9H7_treatment,,,yes,2019-04-28T13:15:19.724487-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:35.448559-05:00,released,40212afb-a9da-52ac-816d-70bbcde9b7e8\\r\\n,TCGA-DD-AACX_demographic,4653729e-a8ae-5f9c-ab10-8f31daef6043,8170/3,TCGA-DD-AACX,,\"Hepatocellular carcinoma, NOS\",431a72e1-ea03-4e40-89c4-2f02d454c897,released,2019-04-28T13:18:16.870649-05:00,yes,24329,1944,,170,male,not reported,not reported,431a72e1-ea03-4e40-89c4-2f02d454c897,2019-04-28T13:18:16.870649-05:00,released,2019-05-03T14:06:23.922205-05:00,stage ii,8508351b-9e62-51f3-b29b-e0ca1217a17b,TCGA-DD-AACX_diagnosis,asian,not reported,Liver,TCGA-DD-AACX_treatment,188c87de-66bc-5b61-bf42-7dc945ab137a,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AACX_treatment_1,,,no,2019-04-28T13:18:16.870649-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:42.289685-05:00,released,3873ea08-b9b9-54c0-872e-c6e7f42513b5\\r\\n,TCGA-DD-AADU_demographic,832f1dcc-cdf8-5436-b2ff-dcbbbe4a9371,8170/3,TCGA-DD-AADU,,\"Hepatocellular carcinoma, NOS\",cf358fb8-866c-4780-a550-d6c1c30b8c63,released,,no,21940,1953,,554,male,not reported,not reported,cf358fb8-866c-4780-a550-d6c1c30b8c63,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:26:48.301106-05:00,stage ii,ff54dab0-0bb5-5731-b7a4-bd58491e1918,TCGA-DD-AADU_diagnosis,asian,not reported,Liver,TCGA-DD-AADU_treatment_1,cfe89546-3a2b-5186-8215-7406e0f862db,no,,,Liver,released,not reported,2019-04-28T13:26:48.301106-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AADU_treatment,,,no,2019-04-28T13:26:48.301106-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:05.743590-05:00,released,4ab1375b-d4b4-539e-be0b-3f3218fc29df\\r\\n,TCGA-DD-A4NP_demographic,cd87c95c-ec58-564d-b7a9-46b54f014a69,8170/3,TCGA-DD-A4NP,,\"Hepatocellular carcinoma, NOS\",001887aa-36d0-463f-8bca-dec7043b4f2e,released,2019-04-28T13:13:46.816725-05:00,no,11838,1973,,3308,male,not reported,not reported,001887aa-36d0-463f-8bca-dec7043b4f2e,2019-04-28T13:13:46.816725-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,ffc31d98-a943-5d4a-9f79-3d0fa8612e3b,TCGA-DD-A4NP_diagnosis,white,not reported,Liver,TCGA-DD-A4NP_treatment,4e399cb2-5fd8-5e6a-8236-e26c7e4e9440,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A4NP_treatment_1,,,no,2019-04-28T13:13:46.816725-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:19.490721-05:00,released,875b2306-10d8-5eaa-937a-f92607f454a5\\r\\n,TCGA-RC-A6M3_demographic,2be29f8b-f81e-5514-9116-92abd4285ed6,8170/3,TCGA-RC-A6M3,,\"Hepatocellular carcinoma, NOS\",c6a74db2-cf97-4c7b-be8c-557ee27e1d43,released,,not reported,8899,1985,,0,male,not reported,not reported,c6a74db2-cf97-4c7b-be8c-557ee27e1d43,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:26:18.930725-05:00,stage ii,ffe40d22-00cf-5283-af6d-2fbb01986722,TCGA-RC-A6M3_diagnosis,american indian or alaska native,not reported,Liver,TCGA-RC-A6M3_treatment_1,d948e9fa-5b83-515e-ad95-e9564d4a1a99,not reported,,,Liver,released,not reported,2019-04-28T13:26:18.930725-05:00,,not reported,released,Adenomas and Adenocarcinomas,TCGA-RC-A6M3_treatment,,,no,2019-04-28T13:26:18.930725-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:53.093878-05:00,released,62310fe4-e1f1-5311-82ab-12d4edad5681\\r\\n,TCGA-LG-A9QD_demographic,a2f33670-dde0-5bba-8bdc-b769565b65d6,8170/3,TCGA-LG-A9QD,,\"Hepatocellular carcinoma, NOS\",948a9bbc-60b0-4fb7-a707-76bc41294217,released,2019-04-28T09:25:23.670440-05:00,yes,24969,1945,,366,male,not reported,not reported,948a9bbc-60b0-4fb7-a707-76bc41294217,2019-04-28T09:25:23.670440-05:00,released,2019-05-03T14:06:23.922205-05:00,stage iiia,0aac631c-1931-5ee8-ac95-e3d4cfcf1b89,TCGA-LG-A9QD_diagnosis,white,not reported,Liver,TCGA-LG-A9QD_treatment,d28e833a-d213-5a32-abaf-ab7a91dcbecc,no,,,Liver,released,not reported,,,hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-LG-A9QD_treatment_1,,,no,2019-04-28T09:25:23.670440-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:53.093878-05:00,released,627ce4f3-300f-5e40-8148-1416bca09c74\\r\\n,TCGA-G3-A3CH_demographic,56bd90cc-9bfb-57fc-8950-e858523aabb7,8170/3,TCGA-G3-A3CH,,\"Hepatocellular carcinoma, NOS\",3a2d7482-c246-411e-841f-71d96e353328,released,,no,19473,1957,,780,male,not reported,not reported,3a2d7482-c246-411e-841f-71d96e353328,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:17:30.208597-05:00,stage iiia,49ab2865-f2f4-5d68-9240-f2e12b628c26,TCGA-G3-A3CH_diagnosis,asian,not reported,Liver,TCGA-G3-A3CH_treatment_1,0048391f-a4d5-5c21-8c16-a43e85567785,yes,,,Liver,released,not reported,2019-04-28T13:17:30.208597-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-G3-A3CH_treatment,,,no,2019-04-28T13:17:30.208597-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:27.936420-05:00,released,20625b24-dc47-5bfc-bd01-a2541f771ddb\\r\\n,TCGA-DD-A1EH_demographic,6b5e772d-23b0-5638-bfad-4584009e25be,8170/3,TCGA-DD-A1EH,,\"Hepatocellular carcinoma, NOS\",cab5b264-abab-4bdb-816e-9d2c0ac30629,released,2019-04-28T13:26:31.317589-05:00,yes,8499,1985,,1495,male,not reported,not reported,cab5b264-abab-4bdb-816e-9d2c0ac30629,2019-04-28T13:26:31.317589-05:00,released,2019-05-03T14:06:23.922205-05:00,stage iii,4afbc555-5b5f-52ef-8a2f-2e72d0458722,TCGA-DD-A1EH_diagnosis,white,not reported,Liver,TCGA-DD-A1EH_treatment,b59e5416-fbab-5072-a1d5-78d15f9178c2,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A1EH_treatment_1,,,no,2019-04-28T13:26:31.317589-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:19.490721-05:00,released,111ffd20-041c-55e6-aa1c-f91c980a3dde\\r\\n,TCGA-EP-A2KC_demographic,56b5c69a-0b7a-5c70-bd89-9d5a4a13e08e,8170/3,TCGA-EP-A2KC,,\"Hepatocellular carcinoma, NOS\",71681db9-fa90-4fe1-a497-67d501eb75f0,released,2019-04-28T13:21:17.035350-05:00,no,22677,1949,,,male,not reported,not reported,71681db9-fa90-4fe1-a497-67d501eb75f0,2019-04-28T13:21:17.035350-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,4d3c3d63-e471-5365-9ac5-94c60c5b3de6,TCGA-EP-A2KC_diagnosis,black or african american,not reported,Liver,TCGA-EP-A2KC_treatment,3356d08e-a5b7-5067-badf-b55577bc5de9,no,2011,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-EP-A2KC_treatment_1,,,no,2019-04-28T13:21:17.035350-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:27.936420-05:00,released,3039de9d-6bfc-5b3b-a2d8-5ab493e1f2e2\\r\\n,TCGA-CC-A123_demographic,ec5e7357-2062-55e0-a233-ffc894ed0dea,8170/3,TCGA-CC-A123,,\"Hepatocellular carcinoma, NOS\",e2f6d3aa-b817-4193-a550-8e53265aa336,released,,no,9107,1986,,219,female,not reported,not reported,e2f6d3aa-b817-4193-a550-8e53265aa336,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T09:25:08.473500-05:00,stage iiia,cf43dabd-7e9e-52c4-8f26-a59622042222,TCGA-CC-A123_diagnosis,asian,not reported,Liver,TCGA-CC-A123_treatment_1,b98d20da-1cb3-5751-bcd5-284b20891882,no,,,Liver,released,not reported,2019-04-28T09:25:08.473500-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-CC-A123_treatment,,,no,2019-04-28T09:25:08.473500-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:58.071505-05:00,released,8b35eae4-98bd-5c73-a8b1-a12689ed3090\\r\\n,TCGA-CC-5260_demographic,5913487a-ec7b-53a2-8f8b-1d1c6736cd0e,8170/3,TCGA-CC-5260,,\"Hepatocellular carcinoma, NOS\",ca8afb2c-be3d-41e8-8dbc-19fe7ab6154b,released,2019-04-28T13:26:28.814426-05:00,no,22345,1949,,0,female,not reported,not reported,ca8afb2c-be3d-41e8-8dbc-19fe7ab6154b,2019-04-28T13:26:28.814426-05:00,released,2019-05-03T14:06:23.922205-05:00,stage iiic,cf498496-b1a7-577a-9baf-02268cb90e1e,TCGA-CC-5260_diagnosis,asian,not reported,Liver,TCGA-CC-5260_treatment,739343cc-f279-56a4-841e-8050e7a1d5f5,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-CC-5260_treatment_1,,,no,2019-04-28T13:26:28.814426-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:58.071505-05:00,released,040e0320-c2de-55e7-b2be-2893207fe7c9\\r\\n,TCGA-DD-AA3A_demographic,e34f8022-1500-5485-ad29-9ff9667bc910,8180/3,TCGA-DD-AA3A,,Combined hepatocellular carcinoma and cholangiocarcinoma,56abd1c1-8f22-4856-8b0a-73d7e092bdb3,released,,no,29712,1928,,,female,not reported,not reported,56abd1c1-8f22-4856-8b0a-73d7e092bdb3,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:19:45.056119-05:00,stage i,9daa0404-a37e-5a8e-97c1-63bbb37d229e,TCGA-DD-AA3A_diagnosis,white,not reported,Liver,TCGA-DD-AA3A_treatment_1,4b7a94fb-0563-59b3-a696-7acd83006ddf,no,2010,,Liver,released,not reported,2019-04-28T13:19:45.056119-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AA3A_treatment,,,no,2019-04-28T13:19:45.056119-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:42.289685-05:00,released,9c2aca84-03c0-5fd3-8436-c21c6ca0cf2a\\r\\n,TCGA-DD-A4NV_demographic,bf571134-e2ad-54dc-b1c9-f785244c1da1,8170/3,TCGA-DD-A4NV,,\"Hepatocellular carcinoma, NOS\",8e5ce60b-2eda-482d-b109-210df1321aff,released,,no,22438,1946,,2398,male,not reported,not reported,8e5ce60b-2eda-482d-b109-210df1321aff,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:22:55.919944-05:00,stage iiia,e9c103bd-7f04-5cc1-b7a8-5e6dafbec6a6,TCGA-DD-A4NV_diagnosis,white,not reported,Liver,TCGA-DD-A4NV_treatment_1,ab396d42-f668-5261-900c-448f9df23d02,no,,,Liver,released,not reported,2019-04-28T13:22:55.919944-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A4NV_treatment,,,no,2019-04-28T13:22:55.919944-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:19.490721-05:00,released,1d857536-d1b9-5757-aba8-e11a5a752a04\\r\\n,TCGA-DD-AAD0_demographic,94689096-704a-5224-92e0-e6c64e7ec071,8170/3,TCGA-DD-AAD0,,\"Hepatocellular carcinoma, NOS\",09790a9b-cc2f-4d7e-a971-8fb4ecd9f791,released,,no,26781,1937,,137,female,not reported,not reported,09790a9b-cc2f-4d7e-a971-8fb4ecd9f791,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:14:28.234274-05:00,stage i,eac7b9b4-dfc3-501a-9ec9-92faf2de53f1,TCGA-DD-AAD0_diagnosis,asian,not reported,Liver,TCGA-DD-AAD0_treatment_1,707a78f3-6024-5ec2-ba36-89322650849c,no,,,Liver,released,not reported,2019-04-28T13:14:28.234274-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AAD0_treatment,,,no,2019-04-28T13:14:28.234274-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:42.289685-05:00,released,007c76f6-bda0-55ce-8d6d-86f4c2c47912\\r\\n,TCGA-RC-A7SK_demographic,9ff497c4-f5ee-5cde-855d-372576a640fb,8170/3,TCGA-RC-A7SK,,\"Hepatocellular carcinoma, NOS\",acfd58eb-c546-49c3-a846-684f22428219,released,2019-04-28T13:24:42.127230-05:00,no,21814,1954,,472,male,not reported,not reported,acfd58eb-c546-49c3-a846-684f22428219,2019-04-28T13:24:42.127230-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,4dc73a79-ac13-54de-bbed-59c23f2ba43e,TCGA-RC-A7SK_diagnosis,asian,not reported,Liver,TCGA-RC-A7SK_treatment,b7dbb0f6-3549-5183-99ce-98de8caef000,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-RC-A7SK_treatment_1,,,no,2019-04-28T13:24:42.127230-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:53.093878-05:00,released,c18a6cb4-ae37-5a85-914e-bb1982047ded\\r\\n,TCGA-G3-A3CK_demographic,d0c824c1-f5fa-5bde-8233-985e059e261d,8170/3,TCGA-G3-A3CK,,\"Hepatocellular carcinoma, NOS\",39eb1db0-2722-4af4-8254-d0e10256c64d,released,,no,22462,1950,,585,male,not reported,not reported,39eb1db0-2722-4af4-8254-d0e10256c64d,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:17:27.895137-05:00,stage i,eb84ad09-7468-511e-9bcf-977843d8f0d1,TCGA-G3-A3CK_diagnosis,asian,not reported,Liver,TCGA-G3-A3CK_treatment_1,fda0dbe7-5ac0-5acf-ae36-3fd35ec7a0fa,no,,,Liver,released,not reported,2019-04-28T13:17:27.895137-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-G3-A3CK_treatment,,,no,2019-04-28T13:17:27.895137-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:27.936420-05:00,released,bb110c0e-df9d-537c-887f-dd5742c1234e\\r\\n,TCGA-RG-A7D4_demographic,a27f5587-6615-5bba-95b7-6110473f7c3f,8170/3,TCGA-RG-A7D4,,\"Hepatocellular carcinoma, NOS\",08cbbb39-d05a-48b0-a966-5212c5923c8b,released,2019-04-28T13:14:20.954683-05:00,no,25302,1943,,1098,male,not reported,not reported,08cbbb39-d05a-48b0-a966-5212c5923c8b,2019-04-28T13:14:20.954683-05:00,released,2019-05-03T14:06:23.922205-05:00,stage ii,ebf70d7c-a94a-56c0-beec-d0522f50c165,TCGA-RG-A7D4_diagnosis,black or african american,not reported,Liver,TCGA-RG-A7D4_treatment,b0cb03ba-9b4c-5326-99a4-c37ebc2f7581,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-RG-A7D4_treatment_1,,,no,2019-04-28T13:14:20.954683-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:53.093878-05:00,released,290f3c72-d366-5928-9d3d-8eaa9558fcbb\\r\\n,TCGA-BC-4073_demographic,2ce8d7ed-dcd3-584f-acd3-b26c519e7238,8170/3,TCGA-BC-4073,,\"Hepatocellular carcinoma, NOS\",00f209c3-041a-4c6e-8b0f-6383eb3c85fc,released,,no,26795,1936,,849,male,not reported,not reported,00f209c3-041a-4c6e-8b0f-6383eb3c85fc,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:13:49.359789-05:00,stage iiia,ec073edd-50f5-5e34-a41b-6fe8a7aa06fe,TCGA-BC-4073_diagnosis,white,not reported,Liver,TCGA-BC-4073_treatment_1,ab52cd53-015f-52a3-a8cc-2d164f0b2be5,no,,,Liver,released,not reported,2019-04-28T13:13:49.359789-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-BC-4073_treatment,,,no,2019-04-28T13:13:49.359789-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:35.448559-05:00,released,d00cf74f-7c87-5b2d-8c0a-1d2e6cffb59a\\r\\n,TCGA-CC-A7IK_demographic,7314da94-d917-5069-afa4-9115ee2930ad,8170/3,TCGA-CC-A7IK,,\"Hepatocellular carcinoma, NOS\",eba5208b-404a-45df-9133-31ff122e7fc0,released,2019-04-28T13:27:54.539919-05:00,no,21552,1954,,0,male,not reported,not reported,eba5208b-404a-45df-9133-31ff122e7fc0,2019-04-28T13:27:54.539919-05:00,released,2019-05-03T14:06:23.922205-05:00,stage iiia,ec41b82b-1bbd-5a42-9ae4-69fffaafa61b,TCGA-CC-A7IK_diagnosis,asian,not reported,Liver,TCGA-CC-A7IK_treatment,e555578c-99ef-54e4-82cd-0102de8bc23f,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-CC-A7IK_treatment_1,,,no,2019-04-28T13:27:54.539919-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:58.071505-05:00,released,4b202c15-5027-5fa9-9fca-43b75bacb584\\r\\n,TCGA-G3-AAV4_demographic,8802ff0d-ec6b-5b91-83de-5669f961a69c,8170/3,TCGA-G3-AAV4,,\"Hepatocellular carcinoma, NOS\",0955d871-5413-4ab2-8fdf-b4feb3aeef5d,released,2019-04-28T13:14:25.558763-05:00,no,30466,1929,,,female,not reported,not reported,0955d871-5413-4ab2-8fdf-b4feb3aeef5d,2019-04-28T13:14:25.558763-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,c9d32e5a-d846-50fe-a8b6-3ae4b6e0f663,TCGA-G3-AAV4_diagnosis,white,not reported,Liver,TCGA-G3-AAV4_treatment,608356a9-0ac8-576d-998c-715ba29e4e3c,no,2012,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-G3-AAV4_treatment_1,,,no,2019-04-28T13:14:25.558763-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:53.093878-05:00,released,b1d40e4e-d4d5-5896-8fce-2305e62b0323\\r\\n,TCGA-DD-A4NI_demographic,5817df91-7d5e-5162-854c-dacc8e1b4bbd,8170/3,TCGA-DD-A4NI,,\"Hepatocellular carcinoma, NOS\",518aa9cc-71cf-4734-9d55-b435da99d300,released,,no,24516,1944,,816,male,not reported,not reported,518aa9cc-71cf-4734-9d55-b435da99d300,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:19:13.546556-05:00,stage ii,cab47aea-0419-5fdb-b522-1e18d521c17b,TCGA-DD-A4NI_diagnosis,white,not reported,Liver,TCGA-DD-A4NI_treatment_1,598cf464-1e6e-54a7-ab08-97f3f4fc4f72,no,,,Liver,released,not reported,2019-04-28T13:19:13.546556-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A4NI_treatment,,,yes,2019-04-28T13:19:13.546556-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:19.490721-05:00,released,3fc89ab8-5262-534b-9461-2257166a7aa4\\r\\n,TCGA-BC-A10T_demographic,ec94462e-96ad-5074-aac3-43b5e8e835aa,8170/3,TCGA-BC-A10T,,\"Hepatocellular carcinoma, NOS\",8a9cde9a-c38c-423e-bc14-354ee26468c9,released,2019-04-28T13:22:53.474309-05:00,no,27944,1924,,,male,not reported,not reported,8a9cde9a-c38c-423e-bc14-354ee26468c9,2019-04-28T13:22:53.474309-05:00,released,2019-05-03T14:06:23.922205-05:00,not reported,0b978cda-7e4f-54df-89d4-77b304ea1d0f,TCGA-BC-A10T_diagnosis,white,not reported,Liver,TCGA-BC-A10T_treatment,b5925a40-cb9f-5954-9cfb-c7ab86404e60,no,2002,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-BC-A10T_treatment_1,,,no,2019-04-28T13:22:53.474309-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:35.448559-05:00,released,5c94c953-a5e4-5236-8451-963da8869e50\\r\\n,TCGA-DD-AAVZ_demographic,d5018c8d-4fa5-57a9-a87f-66c58bcb2e6c,8170/3,TCGA-DD-AAVZ,,\"Hepatocellular carcinoma, NOS\",11f69d9f-a67d-41fa-95a9-baa194b3fcfb,released,2019-04-28T13:15:02.838394-05:00,no,14005,1971,,1900,male,not reported,not reported,11f69d9f-a67d-41fa-95a9-baa194b3fcfb,2019-04-28T13:15:02.838394-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,47ea77c6-b343-544e-ad1e-b23792e4d707,TCGA-DD-AAVZ_diagnosis,asian,not reported,Liver,TCGA-DD-AAVZ_treatment,95842733-92c4-5e49-b51e-395b6d0aeddb,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AAVZ_treatment_1,,,no,2019-04-28T13:15:02.838394-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:05.743590-05:00,released,bdef9f0e-6978-51d5-a807-555a37630009\\r\\n,TCGA-UB-A7ME_demographic,094636cb-e5b4-53cc-92e2-48550f94816f,8170/3,TCGA-UB-A7ME,,\"Hepatocellular carcinoma, NOS\",be1240f0-34dc-4205-b152-c26f11d28462,released,2019-04-28T13:25:49.898495-05:00,no,18846,1962,,486,male,not reported,not reported,be1240f0-34dc-4205-b152-c26f11d28462,2019-04-28T13:25:49.898495-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,50e363f0-3de0-5563-8bf7-0c5a769a9c83,TCGA-UB-A7ME_diagnosis,asian,not reported,Liver,TCGA-UB-A7ME_treatment,a907aa77-de13-5ef5-bcd0-00b35d24108e,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-UB-A7ME_treatment_1,,,no,2019-04-28T13:25:49.898495-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:38:16.668337-05:00,released,d4124cb5-b14a-525b-bda5-34e4e3b91b1b\\r\\n,TCGA-DD-A3A8_demographic,718868a8-94b5-50fd-bf82-d09c766354e8,8170/3,TCGA-DD-A3A8,,\"Hepatocellular carcinoma, NOS\",69d6881b-9e9a-407b-8b02-bad5fc2455bf,released,2019-04-28T13:20:53.496426-05:00,no,27524,1926,,,male,not reported,not reported,69d6881b-9e9a-407b-8b02-bad5fc2455bf,2019-04-28T13:20:53.496426-05:00,released,2019-05-03T14:06:23.922205-05:00,stage ii,51c453f9-b377-5077-af3c-640cf955f317,TCGA-DD-A3A8_diagnosis,white,not reported,Liver,TCGA-DD-A3A8_treatment,c14bc45b-84f3-58ec-a7e3-e93d8c769b7d,no,2001,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A3A8_treatment_1,,,yes,2019-04-28T13:20:53.496426-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:19.490721-05:00,released,a958aa64-dd4d-5a52-86f7-8737054ee861\\r\\n,TCGA-DD-A114_demographic,5800c4cd-2cf0-57f0-9478-4f746568bcec,8170/3,TCGA-DD-A114,,\"Hepatocellular carcinoma, NOS\",02931491-f56b-4233-a079-812e08bc0c59,released,2019-04-28T13:14:03.350002-05:00,no,15410,1963,,,male,not reported,not reported,02931491-f56b-4233-a079-812e08bc0c59,2019-04-28T13:14:03.350002-05:00,released,2019-05-03T14:06:23.922205-05:00,stage ii,52006106-e643-5fe6-956c-6882c3a90603,TCGA-DD-A114_diagnosis,black or african american,not reported,Liver,TCGA-DD-A114_treatment,7471d1f5-900b-597b-b005-7bc783a12dd1,no,2008,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A114_treatment_1,,,no,2019-04-28T13:14:03.350002-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:58.071505-05:00,released,0e12e16a-26cb-5e60-9c10-a1d6cb790835\\r\\n,TCGA-CC-5262_demographic,577f2bd3-8f75-5537-8647-8f8c6b28f798,8170/3,TCGA-CC-5262,,\"Hepatocellular carcinoma, NOS\",1b428ada-eb3f-40c2-b4bf-1bbf6b61729d,released,2019-04-28T13:15:39.442749-05:00,no,24787,1943,,0,male,not reported,not reported,1b428ada-eb3f-40c2-b4bf-1bbf6b61729d,2019-04-28T13:15:39.442749-05:00,released,2019-05-03T14:06:23.922205-05:00,stage iiic,5216d5fb-ff7c-5675-8c3e-1c16fe8bda63,TCGA-CC-5262_diagnosis,asian,not reported,Liver,TCGA-CC-5262_treatment,7ecca1e2-25e7-57f3-8fcb-5856558c3573,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-CC-5262_treatment_1,,,no,2019-04-28T13:15:39.442749-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:58.071505-05:00,released,b5290952-3cba-5ff9-a9b3-135f8e4ffc16\\r\\n,TCGA-K7-A6G5_demographic,f5edbb6f-1b63-5fa1-a866-55ae945deb71,8170/3,TCGA-K7-A6G5,,\"Hepatocellular carcinoma, NOS\",81eddcda-0069-4652-9dc6-8aac89cba1ff,released,,no,24233,1947,,512,male,not reported,not reported,81eddcda-0069-4652-9dc6-8aac89cba1ff,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:22:15.522360-05:00,stage i,d2350310-6d4e-599e-88c7-0b852b58ef96,TCGA-K7-A6G5_diagnosis,white,not reported,Liver,TCGA-K7-A6G5_treatment_1,96a2c3c7-8a31-5642-bebc-dcc43c855070,no,,,Liver,released,not reported,2019-04-28T13:22:15.522360-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-K7-A6G5_treatment,,,no,2019-04-28T13:22:15.522360-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:53.093878-05:00,released,3acc798f-a10a-515b-918f-f34263e34ea3\\r\\n,TCGA-CC-A7IH_demographic,8a533a39-1c61-57b2-9fe3-30132b00883b,8170/3,TCGA-CC-A7IH,,\"Hepatocellular carcinoma, NOS\",e4e0bc11-ad61-4419-857c-44fb5c7877a3,released,2019-04-28T13:27:44.321300-05:00,no,21381,1955,,365,male,not reported,not reported,e4e0bc11-ad61-4419-857c-44fb5c7877a3,2019-04-28T13:27:44.321300-05:00,released,2019-05-03T14:06:23.922205-05:00,stage iiia,d2731ac0-97f0-5527-8128-1e99b1bd4e95,TCGA-CC-A7IH_diagnosis,asian,not reported,Liver,TCGA-CC-A7IH_treatment,389dc3d6-b8b5-53bd-b8b3-f18fdef091b6,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-CC-A7IH_treatment_1,,,no,2019-04-28T13:27:44.321300-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:58.071505-05:00,released,2f20bcb1-5503-5bb2-8dc6-5808fb931b3b\\r\\n,TCGA-T1-A6J8_demographic,e01e0b87-2f50-56e0-896f-b710711ef15a,8170/3,TCGA-T1-A6J8,,\"Hepatocellular carcinoma, NOS\",59f163d2-6a7c-41b8-b4d6-f07174dafc6e,released,,not reported,24853,1945,,23,male,not reported,not reported,59f163d2-6a7c-41b8-b4d6-f07174dafc6e,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:19:49.725324-05:00,not reported,0b990cce-038a-5ae4-93a7-b61893b02a99,TCGA-T1-A6J8_diagnosis,white,not reported,Liver,TCGA-T1-A6J8_treatment_1,c95a0798-7337-5d2c-ad3b-3fca2bf6f27f,not reported,,,Liver,released,not reported,2019-04-28T13:19:49.725324-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-T1-A6J8_treatment,,,yes,2019-04-28T13:19:49.725324-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:53.093878-05:00,released,45685885-5eb7-5603-8fe0-1e04f03bcede\\r\\n,TCGA-FV-A2QQ_demographic,bd23d434-8b58-545f-9f24-c7d6a6ee2747,8170/3,TCGA-FV-A2QQ,,\"Hepatocellular carcinoma, NOS\",d680df09-368e-42b5-b540-45c41ed31042,released,2019-04-28T13:27:12.678303-05:00,no,29354,1931,,729,male,not reported,not reported,d680df09-368e-42b5-b540-45c41ed31042,2019-04-28T13:27:12.678303-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,0bb3449d-c027-5dee-884c-fa21131ed3c8,TCGA-FV-A2QQ_diagnosis,white,not reported,Liver,TCGA-FV-A2QQ_treatment,3f81f9ef-ad69-5917-983a-a7417342ccad,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-FV-A2QQ_treatment_1,,,no,2019-04-28T13:27:12.678303-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:27.936420-05:00,released,986cf184-7567-579a-8cde-0a913bb22b4c\\r\\n,TCGA-DD-A1EA_demographic,88e4f571-e177-57cc-94ca-45876b4c50b4,8170/3,TCGA-DD-A1EA,,\"Hepatocellular carcinoma, NOS\",8052c374-9435-4588-b970-68565c56dbb7,released,,no,24925,1934,,2415,male,not reported,not reported,8052c374-9435-4588-b970-68565c56dbb7,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:22:06.016970-05:00,stage ii,005503bc-a377-5afa-89c1-1b0fa283239e,TCGA-DD-A1EA_diagnosis,asian,not reported,Liver,TCGA-DD-A1EA_treatment_1,de8a74e5-7b60-56ad-8043-afe8e07bbb30,no,,,Liver,released,not reported,2019-04-28T13:22:06.016970-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A1EA_treatment,,,no,2019-04-28T13:22:06.016970-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:58.071505-05:00,released,a3b49d60-3ad8-51bd-b08f-03af99c9a423\\r\\n,TCGA-K7-A5RF_demographic,7cde9c2f-caa8-5b3f-a113-7767d771bee8,8170/3,TCGA-K7-A5RF,,\"Hepatocellular carcinoma, NOS\",3134f7d1-3359-497a-b8be-1f317d8ddaaa,released,2019-04-28T13:16:52.326291-05:00,no,23557,1948,,631,male,not reported,not reported,3134f7d1-3359-497a-b8be-1f317d8ddaaa,2019-04-28T13:16:52.326291-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,cdd1d8a1-a5fa-51cb-acee-8148388eb19b,TCGA-K7-A5RF_diagnosis,white,not reported,Liver,TCGA-K7-A5RF_treatment,55a2b445-e09f-5206-97d4-e1229cb7ad4e,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-K7-A5RF_treatment_1,,,no,2019-04-28T13:16:52.326291-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:53.093878-05:00,released,6c193c4b-ba22-5a32-8819-0050976d4b26\\r\\n,TCGA-DD-AACB_demographic,252e00db-54b4-5121-843c-38aaadd48b48,8170/3,TCGA-DD-AACB,,\"Hepatocellular carcinoma, NOS\",6d2e8bc2-ca86-41c1-ae49-289e20fce758,released,,no,27103,1934,,2324,female,not reported,not reported,6d2e8bc2-ca86-41c1-ae49-289e20fce758,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T09:25:13.615201-05:00,stage i,9e63c3ef-0cff-5b32-af55-8fdc9ee03439,TCGA-DD-AACB_diagnosis,asian,not reported,Liver,TCGA-DD-AACB_treatment_1,19ea620d-b5b1-55cc-aff5-891a520733e7,no,,,Liver,released,not reported,2019-04-28T09:25:13.615201-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AACB_treatment,,,no,2019-04-28T09:25:13.615201-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:42.289685-05:00,released,b017d09d-58bb-5365-9d62-8a7bb93fb585\\r\\n,TCGA-DD-A73A_demographic,7f585b6b-408b-567a-a389-051b2bd6e267,8170/3,TCGA-DD-A73A,,\"Hepatocellular carcinoma, NOS\",b6c0266a-cf34-464a-808d-1d3c28dc90f2,released,2019-04-28T13:25:18.495626-05:00,no,26136,1941,,728,male,not reported,not reported,b6c0266a-cf34-464a-808d-1d3c28dc90f2,2019-04-28T13:25:18.495626-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,5257621b-cae3-5725-8a52-3f37db4bb47a,TCGA-DD-A73A_diagnosis,white,not reported,Liver,TCGA-DD-A73A_treatment,4b1d1e96-df63-5627-800e-83bdd744cd88,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A73A_treatment_1,,,no,2019-04-28T13:25:18.495626-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:19.490721-05:00,released,6e50612e-6e2b-5505-bc65-70bd996185a4\\r\\n,TCGA-G3-A5SL_demographic,d6b3bab4-5aae-517f-9560-9399cc5d8e45,8170/3,TCGA-G3-A5SL,,\"Hepatocellular carcinoma, NOS\",9a56d8a8-dadd-442e-bc09-732cd619aef7,released,2019-04-28T13:23:38.985285-05:00,no,25671,1942,,621,male,not reported,not reported,9a56d8a8-dadd-442e-bc09-732cd619aef7,2019-04-28T13:23:38.985285-05:00,released,2019-05-03T14:06:23.922205-05:00,stage ii,5275def5-d081-5a78-a30b-c1c53d0cf8e7,TCGA-G3-A5SL_diagnosis,white,not reported,Liver,TCGA-G3-A5SL_treatment,7513b6c6-1f95-5a0e-8283-d2a1011c57df,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-G3-A5SL_treatment_1,,,no,2019-04-28T13:23:38.985285-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:27.936420-05:00,released,148c8e4c-ee3d-5526-bd95-d92cafdcedb8\\r\\n,TCGA-DD-A1ED_demographic,fe15090d-3fc6-5b3d-9c23-b59ba63d8990,8170/3,TCGA-DD-A1ED,,\"Hepatocellular carcinoma, NOS\",0ff6364a-e6f4-47ca-a7e7-14705bf0a8df,released,2019-04-28T13:14:48.484261-05:00,no,25039,1938,,2301,male,not reported,not reported,0ff6364a-e6f4-47ca-a7e7-14705bf0a8df,2019-04-28T13:14:48.484261-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,5396bf88-f4b3-5e28-94cf-31773208a51a,TCGA-DD-A1ED_diagnosis,white,not reported,Liver,TCGA-DD-A1ED_treatment,b444205b-81c2-580e-80f6-1ee5605944e9,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A1ED_treatment_1,,,no,2019-04-28T13:14:48.484261-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:19.490721-05:00,released,4786c2df-532c-5aaa-9115-dc35b73a75ba\\r\\n,TCGA-2Y-A9HB_demographic,be6c54dc-0af3-5f33-a911-231fe1ad94e0,8170/3,TCGA-2Y-A9HB,,\"Hepatocellular carcinoma, NOS\",b181b591-269c-4e48-b681-243d28772025,released,2019-04-28T13:25:03.669157-05:00,no,24359,1946,,260,male,not reported,not reported,b181b591-269c-4e48-b681-243d28772025,2019-04-28T13:25:03.669157-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,671a0f55-dece-51be-8eb1-329b43ec1372,TCGA-2Y-A9HB_diagnosis,not reported,not reported,Liver,TCGA-2Y-A9HB_treatment,a817aecf-dd3d-5e03-8d58-e3faf7930d91,no,,,Liver,released,not reported,,,hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-2Y-A9HB_treatment_1,,,no,2019-04-28T13:25:03.669157-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:35.448559-05:00,released,b270b0dc-6845-56bf-bab3-61d85ef2a194\\r\\n,TCGA-ED-A7XP_demographic,b71423de-7ea6-5c77-8831-824645f34a8d,8170/3,TCGA-ED-A7XP,,\"Hepatocellular carcinoma, NOS\",cca827ca-0066-497d-83dc-477f3b08ea6d,released,,no,19504,1960,,400,female,not reported,not reported,cca827ca-0066-497d-83dc-477f3b08ea6d,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:26:38.532654-05:00,stage ii,68319de6-9ad3-5bda-87c6-fee3650492f0,TCGA-ED-A7XP_diagnosis,asian,not reported,Liver,TCGA-ED-A7XP_treatment_1,f6053e70-ced2-59fb-baac-daceb155181b,no,,,Liver,released,not reported,2019-04-28T13:26:38.532654-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-ED-A7XP_treatment,,,no,2019-04-28T13:26:38.532654-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:05.743590-05:00,released,dcfd483b-b984-5d2f-908e-5a032c70db71\\r\\n,TCGA-5C-AAPD_demographic,bce4cef7-e2a3-58bc-88db-8eb85d49ded9,8180/3,TCGA-5C-AAPD,,Combined hepatocellular carcinoma and cholangiocarcinoma,7a6162a4-1166-4310-84cd-ffc2b06f124c,released,,no,22552,1952,,20,male,not reported,not reported,7a6162a4-1166-4310-84cd-ffc2b06f124c,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:21:39.558011-05:00,stage ii,68716d44-6d98-50e2-a221-1fef1a07565e,TCGA-5C-AAPD_diagnosis,asian,not reported,Liver,TCGA-5C-AAPD_treatment_1,f7575f91-0267-5dde-961e-ef1a96995fa4,no,,,Liver,released,not reported,2019-04-28T13:21:39.558011-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-5C-AAPD_treatment,,,no,2019-04-28T13:21:39.558011-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:35.448559-05:00,released,b879fc6b-ec0a-565a-a0c3-73672f6349ef\\r\\n,TCGA-G3-AAV7_demographic,e9293923-7b50-510a-a28d-959a94cf7723,8170/3,TCGA-G3-AAV7,,\"Hepatocellular carcinoma, NOS\",5d259f26-3bef-4fe4-948b-495183f5f8be,released,2019-04-28T13:20:04.605942-05:00,no,14229,1975,,361,male,not reported,not reported,5d259f26-3bef-4fe4-948b-495183f5f8be,2019-04-28T13:20:04.605942-05:00,released,2019-05-03T14:06:23.922205-05:00,stage ii,0ca82729-685f-516c-b65a-54f543d51dbd,TCGA-G3-AAV7_diagnosis,asian,not reported,Liver,TCGA-G3-AAV7_treatment,e475b397-1382-57c4-b3ec-cd703141319f,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-G3-AAV7_treatment_1,,,no,2019-04-28T13:20:04.605942-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:53.093878-05:00,released,ab033923-b297-5c02-8522-5d79b7708ddb\\r\\n,TCGA-DD-A4ND_demographic,d71168cd-8d9b-5132-b0df-28752fd410d9,8170/3,TCGA-DD-A4ND,,\"Hepatocellular carcinoma, NOS\",c0bf9278-9cbb-4361-b4d8-ab172b67e276,released,2019-04-28T13:26:01.998968-05:00,no,20782,1951,,2746,female,not reported,not reported,c0bf9278-9cbb-4361-b4d8-ab172b67e276,2019-04-28T13:26:01.998968-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,558fa8f5-53b3-5466-b48f-1b65cc077fdf,TCGA-DD-A4ND_diagnosis,white,not reported,Liver,TCGA-DD-A4ND_treatment,b5f79a87-9e12-5bcc-9bcb-77807a7df2dd,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A4ND_treatment_1,,,yes,2019-04-28T13:26:01.998968-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:19.490721-05:00,released,3e1ab4b2-f8cf-55d7-bd33-9f7b67de1d18\\r\\n,TCGA-DD-AADN_demographic,32d009e1-841f-5adf-afcb-95ebc48007dc,8170/3,TCGA-DD-AADN,,\"Hepatocellular carcinoma, NOS\",32e39c1d-b8e8-4efe-b451-8efb112d3518,released,,no,21632,1953,,898,male,not reported,not reported,32e39c1d-b8e8-4efe-b451-8efb112d3518,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:17:01.883357-05:00,stage i,cdb1a0a9-2b5b-5b4b-806e-12c816d34296,TCGA-DD-AADN_diagnosis,asian,not reported,Liver,TCGA-DD-AADN_treatment_1,621a1855-660f-5283-be84-26f970adc8f7,no,,,Liver,released,not reported,2019-04-28T13:17:01.883357-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AADN_treatment,,,no,2019-04-28T13:17:01.883357-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:42.289685-05:00,released,e0175f2e-1c20-5408-a0ed-27a7e5d304ee\\r\\n,TCGA-2Y-A9GW_demographic,3b993486-e97c-5dc4-8a73-e2d2f788a8ea,8170/3,TCGA-2Y-A9GW,,\"Hepatocellular carcinoma, NOS\",3e1920b3-3bd4-4506-a0cf-567257154bcf,released,,no,23587,1943,,,male,not reported,not reported,3e1920b3-3bd4-4506-a0cf-567257154bcf,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:17:47.412830-05:00,stage i,563fcdc3-c1e9-5e97-9910-a3a447746859,TCGA-2Y-A9GW_diagnosis,white,not reported,Liver,TCGA-2Y-A9GW_treatment_1,666b8bc5-82f1-509e-947f-ae1a0af6a7c1,no,2010,,Liver,released,not reported,2019-04-28T13:17:47.412830-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-2Y-A9GW_treatment,,,no,2019-04-28T13:17:47.412830-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:35.448559-05:00,released,4b8db2c5-888e-5209-8afe-cdd47eef4842\\r\\n,TCGA-G3-AAUZ_demographic,a51872a0-b5b4-5c3b-8a72-00f7f3c05d1f,8170/3,TCGA-G3-AAUZ,,\"Hepatocellular carcinoma, NOS\",d74ddbe2-5860-40b1-9bd8-99cc50f3392d,released,,no,17760,1965,,480,male,not reported,not reported,d74ddbe2-5860-40b1-9bd8-99cc50f3392d,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:27:17.506938-05:00,stage i,373929fc-fb4a-56ea-8619-a8f87c61fd59,TCGA-G3-AAUZ_diagnosis,not reported,not reported,Liver,TCGA-G3-AAUZ_treatment_1,e9bde52f-fbdf-560b-951f-b8602bdfbed1,no,,,Liver,released,not reported,2019-04-28T13:27:17.506938-05:00,,hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-G3-AAUZ_treatment,,,no,2019-04-28T13:27:17.506938-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:27.936420-05:00,released,20404099-49eb-541e-8d51-abbb7a38e2ed\\r\\n,TCGA-G3-A25X_demographic,2ee4d32f-3aeb-5d21-af8a-47d260ad2501,8170/3,TCGA-G3-A25X,,\"Hepatocellular carcinoma, NOS\",08428220-abd4-484e-85ca-3673454c837e,released,,no,26988,1934,,1779,male,not reported,not reported,08428220-abd4-484e-85ca-3673454c837e,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:14:18.127694-05:00,stage ii,77ce6b8f-5eaa-5a38-8c07-766b759ffddd,TCGA-G3-A25X_diagnosis,asian,not reported,Liver,TCGA-G3-A25X_treatment_1,27c48002-8a70-56d3-b6ca-5104f9a453ea,no,,,Liver,released,not reported,2019-04-28T13:14:18.127694-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-G3-A25X_treatment,,,no,2019-04-28T13:14:18.127694-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:27.936420-05:00,released,c47632cb-ffab-59bc-921b-c65d91fd72f5\\r\\n,TCGA-CC-A7IF_demographic,6539de10-6bb6-5231-832f-540c48544310,8170/3,TCGA-CC-A7IF,,\"Hepatocellular carcinoma, NOS\",e0674b82-2fba-421e-be62-58efd0348d44,released,2019-04-28T13:27:39.581484-05:00,no,21845,1954,,0,male,not reported,not reported,e0674b82-2fba-421e-be62-58efd0348d44,2019-04-28T13:27:39.581484-05:00,released,2019-05-03T14:06:23.922205-05:00,stage iiia,b29f5ffa-ee78-5963-931d-4d29cebb2f80,TCGA-CC-A7IF_diagnosis,asian,not reported,Liver,TCGA-CC-A7IF_treatment,7584e5e8-978f-5085-9cb0-8a6f787c9cb1,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-CC-A7IF_treatment_1,,,no,2019-04-28T13:27:39.581484-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:58.071505-05:00,released,36fcee46-6cfb-5834-8684-0aa3d00ca2d2\\r\\n,TCGA-CC-A9FU_demographic,85cf2106-ab87-53ba-b463-c02949c49037,8170/3,TCGA-CC-A9FU,,\"Hepatocellular carcinoma, NOS\",5e2a99a1-41c1-49ca-97d6-69f9b9938d24,released,2019-04-28T13:20:06.923901-05:00,not reported,19326,1961,,0,female,not reported,not reported,5e2a99a1-41c1-49ca-97d6-69f9b9938d24,2019-04-28T13:20:06.923901-05:00,released,2019-05-03T14:06:23.922205-05:00,stage iiia,239aedb6-3595-5a05-a005-7fb31231ec52,TCGA-CC-A9FU_diagnosis,asian,not reported,Liver,TCGA-CC-A9FU_treatment,2e6e365c-cf3b-50a6-aeeb-953400be4939,not reported,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-CC-A9FU_treatment_1,,,no,2019-04-28T13:20:06.923901-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:58.071505-05:00,released,13af4dcd-0644-5f24-a6e0-aa12830a0133\\r\\n,TCGA-DD-AAEB_demographic,69bba14e-55e1-58dc-81bf-2f10966a78c0,8170/3,TCGA-DD-AAEB,,\"Hepatocellular carcinoma, NOS\",f0ece8e2-a6b0-4ed9-a613-d2fbb20e51b1,released,,no,22121,1952,,478,male,not reported,not reported,f0ece8e2-a6b0-4ed9-a613-d2fbb20e51b1,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:28:11.300723-05:00,stage i,1ec1b71d-416e-5ac7-b442-48e8bdb4ba5a,TCGA-DD-AAEB_diagnosis,asian,not reported,Liver,TCGA-DD-AAEB_treatment_1,6175e7f8-b521-5b04-9820-611f40a36f90,no,,,Liver,released,not reported,2019-04-28T13:28:11.300723-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AAEB_treatment,,,no,2019-04-28T13:28:11.300723-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:05.743590-05:00,released,471bdcfc-9125-51fa-94a2-586a0a7c7d35\\r\\n,TCGA-DD-AAE7_demographic,1434cf1b-6b05-574e-b037-1ffaad2294c5,8170/3,TCGA-DD-AAE7,,\"Hepatocellular carcinoma, NOS\",427fdbf8-1603-466f-a5c6-963bb2ec3dac,released,,no,26568,1940,,644,male,not reported,not reported,427fdbf8-1603-466f-a5c6-963bb2ec3dac,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:18:11.860316-05:00,stage i,b3576557-2bb2-5917-a3d6-5804efaf14a7,TCGA-DD-AAE7_diagnosis,asian,not reported,Liver,TCGA-DD-AAE7_treatment_1,a28fc219-f1b1-54b5-88e4-68abfa0ee402,no,,,Liver,released,not reported,2019-04-28T13:18:11.860316-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AAE7_treatment,,,yes,2019-04-28T13:18:11.860316-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:05.743590-05:00,released,0db20ea4-c802-57b9-9786-0078ef3ebce1\\r\\n,TCGA-DD-AADS_demographic,b56fbd5f-3705-5064-a358-69ed7472d1d8,8170/3,TCGA-DD-AADS,,\"Hepatocellular carcinoma, NOS\",460a3cbd-c63c-4e6f-b670-2619687ac5a0,released,2019-04-28T13:18:32.583014-05:00,no,23227,1950,,474,male,not reported,not reported,460a3cbd-c63c-4e6f-b670-2619687ac5a0,2019-04-28T13:18:32.583014-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,b365d22e-d351-5f35-9235-c8981f454542,TCGA-DD-AADS_diagnosis,asian,not reported,Liver,TCGA-DD-AADS_treatment,268a1140-434b-5465-9e50-dc5cd6be176a,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AADS_treatment_1,,,no,2019-04-28T13:18:32.583014-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:05.743590-05:00,released,9737bd8c-b1ed-5644-9139-ad50f30f92d2\\r\\n,TCGA-DD-AAEE_demographic,252fbca6-d8f3-519e-afe2-10f4b6cfbc24,8170/3,TCGA-DD-AAEE,,\"Hepatocellular carcinoma, NOS\",3c51fee0-da54-40e9-a954-dfe30f6f075c,released,,yes,20396,1957,,810,male,not reported,not reported,3c51fee0-da54-40e9-a954-dfe30f6f075c,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:17:37.908785-05:00,stage i,0b63d5fa-7cd3-52d9-9b91-c4233217b640,TCGA-DD-AAEE_diagnosis,asian,not reported,Liver,TCGA-DD-AAEE_treatment_1,57265c3b-99b8-5c32-afd5-e9ef437df17f,no,,,Liver,released,not reported,2019-04-28T13:17:37.908785-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AAEE_treatment,,,no,2019-04-28T13:17:37.908785-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:05.743590-05:00,released,754a8efd-261f-51fb-a55f-c80503771367\\r\\n,TCGA-CC-A7IG_demographic,b1fcce1c-b695-5780-a83f-b6fa37cb96a7,8170/3,TCGA-CC-A7IG,,\"Hepatocellular carcinoma, NOS\",534a7b11-3abd-4581-a9c9-d984d6aa33a0,released,,no,17453,1966,,0,male,not reported,not reported,534a7b11-3abd-4581-a9c9-d984d6aa33a0,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:19:25.402795-05:00,stage ii,24390922-f2bb-552f-a3c7-c5a6ea3f1588,TCGA-CC-A7IG_diagnosis,asian,not reported,Liver,TCGA-CC-A7IG_treatment_1,13a6a9d3-e843-53eb-a7cb-2df2ee334e8e,no,,,Liver,released,not reported,2019-04-28T13:19:25.402795-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-CC-A7IG_treatment,,,no,2019-04-28T13:19:25.402795-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:58.071505-05:00,released,754bc5cf-b7b7-572a-8ff0-e16eb29f09a1\\r\\n,TCGA-DD-A73E_demographic,a1334f3f-67aa-5de9-bfb6-d0709467ca58,8170/3,TCGA-DD-A73E,,\"Hepatocellular carcinoma, NOS\",e0863874-f7b8-49b6-a88b-5ae5f1ec2b15,released,,no,24377,1946,,44,male,not reported,not reported,e0863874-f7b8-49b6-a88b-5ae5f1ec2b15,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:27:36.992050-05:00,stage i,97bfae54-b307-5c73-ab0b-7b10dc4e6a8a,TCGA-DD-A73E_diagnosis,white,not reported,Liver,TCGA-DD-A73E_treatment_1,ea0dc2b5-bf88-5d98-bd12-082caf49a1f7,no,,,Liver,released,not reported,2019-04-28T13:27:36.992050-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A73E_treatment,,,no,2019-04-28T13:27:36.992050-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:19.490721-05:00,released,1faf259f-be3a-512e-93a1-b3042c504838\\r\\n,TCGA-BC-A69I_demographic,84e73d0f-22ef-52b3-8f2c-e8c74b7fba37,8170/3,TCGA-BC-A69I,,\"Hepatocellular carcinoma, NOS\",70aecc90-17f0-4064-8ebb-be81f9b1d7fd,released,2019-04-28T13:21:09.701720-05:00,no,25370,1944,,387,male,not reported,not reported,70aecc90-17f0-4064-8ebb-be81f9b1d7fd,2019-04-28T13:21:09.701720-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,2b47fbe3-afee-54e0-a10c-bb9a4751072d,TCGA-BC-A69I_diagnosis,white,not reported,Liver,TCGA-BC-A69I_treatment,e7f0a05a-da62-58d9-ba7c-17f913bd872f,no,,,Liver,released,not reported,,,not reported,released,Adenomas and Adenocarcinomas,TCGA-BC-A69I_treatment_1,,,no,2019-04-28T13:21:09.701720-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:35.448559-05:00,released,4734b508-fc0a-5c51-842b-1a275371b841\\r\\n,TCGA-DD-AAD8_demographic,57cbba23-ac57-540a-991d-392295efd446,8170/3,TCGA-DD-AAD8,,\"Hepatocellular carcinoma, NOS\",24b66729-242b-4771-819d-77c9a1fcbb10,released,2019-04-28T13:16:20.136847-05:00,no,26781,1938,,1219,female,not reported,not reported,24b66729-242b-4771-819d-77c9a1fcbb10,2019-04-28T13:16:20.136847-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,b37c23c6-a0e2-5a63-a7e9-f6dafba11481,TCGA-DD-AAD8_diagnosis,asian,not reported,Liver,TCGA-DD-AAD8_treatment,0134f3c2-c7c0-597d-8a97-5efe1a0e7c7a,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AAD8_treatment_1,,,no,2019-04-28T13:16:20.136847-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:42.289685-05:00,released,7f505856-33f2-5b76-b13c-1d5f3e731839\\r\\n,TCGA-BC-A10R_demographic,f9d9cd5a-71ca-5f74-9510-d6b65aa9dde0,8170/3,TCGA-BC-A10R,,\"Hepatocellular carcinoma, NOS\",0bf5bbd4-d9e8-42a6-9ab5-f2c174dec12c,released,,no,24274,1933,,,female,not reported,not reported,0bf5bbd4-d9e8-42a6-9ab5-f2c174dec12c,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:14:33.412794-05:00,not reported,c39ea615-5fce-5cfe-943d-11d25aee73bd,TCGA-BC-A10R_diagnosis,white,not reported,Liver,TCGA-BC-A10R_treatment_1,ef53ae43-7ab9-546f-b40c-71018f4bf37a,yes,1999,,Liver,released,not reported,2019-04-28T13:14:33.412794-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-BC-A10R_treatment,,,no,2019-04-28T13:14:33.412794-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:35.448559-05:00,released,24a8cc47-7c40-5dab-9d5f-49bedfba3f87\\r\\n,TCGA-WQ-AB4B_demographic,4f633d2f-aa39-5b55-88ef-af16a2f9013b,8170/3,TCGA-WQ-AB4B,,\"Hepatocellular carcinoma, NOS\",d5471a2b-f14c-44de-9142-5a5fb07b6fc2,released,,no,22769,1951,,395,male,not reported,not reported,d5471a2b-f14c-44de-9142-5a5fb07b6fc2,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:27:07.602708-05:00,stage ii,245fd052-daa2-57a6-a1a2-d40a66918e7d,TCGA-WQ-AB4B_diagnosis,white,not reported,Liver,TCGA-WQ-AB4B_treatment_1,587bc676-39f4-5194-8288-bf122189ac75,no,,,Liver,released,not reported,2019-04-28T13:27:07.602708-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-WQ-AB4B_treatment,,,no,2019-04-28T13:27:07.602708-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:38:16.668337-05:00,released,13640a67-f633-52ba-a529-ae9de1e57e26\\r\\n,TCGA-DD-A4NH_demographic,61928a7f-1608-5b09-8d4e-80863ad7dcce,8170/3,TCGA-DD-A4NH,,\"Hepatocellular carcinoma, NOS\",4012ea90-5768-4acc-af3a-ba954f493db4,released,2019-04-28T13:17:54.726119-05:00,yes,23865,1946,,917,female,not reported,not reported,4012ea90-5768-4acc-af3a-ba954f493db4,2019-04-28T13:17:54.726119-05:00,released,2019-05-03T14:06:23.922205-05:00,stage iiib,41d54d27-9bcf-55c6-b453-495d4d202fb4,TCGA-DD-A4NH_diagnosis,white,not reported,Liver,TCGA-DD-A4NH_treatment,ef1b80e9-e8ae-5505-9cbb-48c8a31d757e,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A4NH_treatment_1,,,no,2019-04-28T13:17:54.726119-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:19.490721-05:00,released,67841aa9-4cfb-5efd-8190-f56b218af7c0\\r\\n,TCGA-BC-A10W_demographic,fb32dc68-3776-5c36-bdef-71c5952f281e,8170/3,TCGA-BC-A10W,,\"Hepatocellular carcinoma, NOS\",39baf24a-4032-4c23-b3fe-2c50df1881f6,released,2019-04-28T09:25:03.751958-05:00,yes,18562,1952,,,male,not reported,not reported,39baf24a-4032-4c23-b3fe-2c50df1881f6,2019-04-28T09:25:03.751958-05:00,released,2019-05-03T14:06:23.922205-05:00,not reported,b44ee0db-1f7f-5fcb-b27a-5fcc680c7cba,TCGA-BC-A10W_diagnosis,asian,not reported,Liver,TCGA-BC-A10W_treatment,794dc197-6a95-53d8-9e51-df4934a63641,no,2002,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-BC-A10W_treatment_1,,,no,2019-04-28T09:25:03.751958-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:35.448559-05:00,released,ac6b67a0-6c22-5cc6-abcf-45286d3c78d3\\r\\n,TCGA-DD-A4NQ_demographic,526e6e48-680a-525e-a053-cdb711230c7e,8170/3,TCGA-DD-A4NQ,,\"Hepatocellular carcinoma, NOS\",c05720fe-19c1-4cff-819b-6806b26fc312,released,,no,22111,1947,,,male,not reported,not reported,c05720fe-19c1-4cff-819b-6806b26fc312,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:25:59.615795-05:00,stage ii,f77358eb-e564-5beb-888b-7799e6026ae8,TCGA-DD-A4NQ_diagnosis,white,not reported,Liver,TCGA-DD-A4NQ_treatment_1,61e04137-c475-598d-8df4-878cee88a0da,yes,2008,,Liver,released,not reported,2019-04-28T13:25:59.615795-05:00,,hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A4NQ_treatment,,,no,2019-04-28T13:25:59.615795-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:19.490721-05:00,released,2538d6a7-3b72-5732-997d-559c32528dc6\\r\\n,TCGA-G3-A5SK_demographic,2c1481fa-312c-590a-9c28-43b88b677a55,8170/3,TCGA-G3-A5SK,,\"Hepatocellular carcinoma, NOS\",24259d55-20ac-4359-861f-dcad7ad88cee,released,,no,21320,1954,,744,male,not reported,not reported,24259d55-20ac-4359-861f-dcad7ad88cee,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:16:17.758457-05:00,stage i,f7db4285-14be-55c2-b056-d67ef46d990c,TCGA-G3-A5SK_diagnosis,white,not reported,Liver,TCGA-G3-A5SK_treatment_1,71cfb092-241e-599e-8344-ca81dd3da31c,no,,,Liver,released,not reported,2019-04-28T13:16:17.758457-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-G3-A5SK_treatment,,,no,2019-04-28T13:16:17.758457-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:27.936420-05:00,released,6cd8db22-5113-5541-9b37-ce2ead44858c\\r\\n,TCGA-BW-A5NO_demographic,fd753998-490d-53dd-97b6-dce916e2d299,8170/3,TCGA-BW-A5NO,,\"Hepatocellular carcinoma, NOS\",ee63c44b-91f4-4004-8dea-192eab527036,released,,no,18510,1960,,20,male,not reported,not reported,ee63c44b-91f4-4004-8dea-192eab527036,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:28:01.851536-05:00,stage iiia,f84a5b56-999f-5805-b25c-257282b045b5,TCGA-BW-A5NO_diagnosis,black or african american,not reported,Liver,TCGA-BW-A5NO_treatment_1,5aefc089-25b9-5133-83af-3f4e06eccf7c,no,,,Liver,released,not reported,2019-04-28T13:28:01.851536-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-BW-A5NO_treatment,,,no,2019-04-28T13:28:01.851536-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:58.071505-05:00,released,d1088ee3-d38c-5145-8d7c-c50a98900ed2\\r\\n,TCGA-K7-A5RG_demographic,ed7a4afe-2562-5204-aaf7-371310605d78,8170/3,TCGA-K7-A5RG,,\"Hepatocellular carcinoma, NOS\",4fd3ed02-7b66-47bf-8b92-31fee1093a87,released,,no,24218,1946,,519,male,not reported,not reported,4fd3ed02-7b66-47bf-8b92-31fee1093a87,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:19:06.688853-05:00,stage i,f925a76e-02b8-5c46-814f-d300af31f5cd,TCGA-K7-A5RG_diagnosis,black or african american,not reported,Liver,TCGA-K7-A5RG_treatment_1,ccceb580-aa36-5ba1-9505-0e7958313b01,no,,,Liver,released,not reported,2019-04-28T13:19:06.688853-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-K7-A5RG_treatment,,,no,2019-04-28T13:19:06.688853-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:53.093878-05:00,released,e1cd84f2-9763-5f2c-8d73-94c7c05cb10b\\r\\n,TCGA-2Y-A9H8_demographic,8ca8c863-cb24-5179-9999-caaa21f31fb1,8170/3,TCGA-2Y-A9H8,,\"Hepatocellular carcinoma, NOS\",3528dd91-1a6d-4d41-a3ee-829c857cc904,released,,no,31322,1926,,,female,not reported,not reported,3528dd91-1a6d-4d41-a3ee-829c857cc904,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:17:13.609317-05:00,not reported,f9889e9b-ddbf-5a7c-a171-359707340f6f,TCGA-2Y-A9H8_diagnosis,white,not reported,Liver,TCGA-2Y-A9H8_treatment_1,ac62ff26-7d59-5dc0-9861-ff92547e2670,yes,2012,,Liver,released,not reported,2019-04-28T13:17:13.609317-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-2Y-A9H8_treatment,,,no,2019-04-28T13:17:13.609317-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:35.448559-05:00,released,44a71d05-a5b3-54eb-8ec6-ce237c9d31d3\\r\\n,TCGA-DD-AAE3_demographic,cfabb0cc-e976-568b-82d1-2e500f738b6b,8170/3,TCGA-DD-AAE3,,\"Hepatocellular carcinoma, NOS\",3c969bdf-cae8-44f5-839f-5abd4cba0ec8,released,2019-04-28T13:17:40.380177-05:00,no,18271,1963,,566,male,not reported,not reported,3c969bdf-cae8-44f5-839f-5abd4cba0ec8,2019-04-28T13:17:40.380177-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,f9af3d7c-fd82-58ad-9526-0436e6ac57a2,TCGA-DD-AAE3_diagnosis,asian,not reported,Liver,TCGA-DD-AAE3_treatment,b5c23e85-5057-558a-bf91-901c86220dd5,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AAE3_treatment_1,,,no,2019-04-28T13:17:40.380177-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:05.743590-05:00,released,a9dcf727-f048-5392-a33e-727dd5511b9d\\r\\n,TCGA-ZP-A9CV_demographic,c491f678-c6b6-5906-9982-822e9767a83b,8170/3,TCGA-ZP-A9CV,,\"Hepatocellular carcinoma, NOS\",91909c63-debc-42ad-b4be-56870195bdcb,released,2019-04-28T13:23:08.585567-05:00,no,21633,1952,,142,male,not reported,not reported,91909c63-debc-42ad-b4be-56870195bdcb,2019-04-28T13:23:08.585567-05:00,released,2019-05-03T14:06:23.922205-05:00,not reported,fa517fbd-4b9b-51ce-bab7-735a4ef5bc4f,TCGA-ZP-A9CV_diagnosis,white,not reported,Liver,TCGA-ZP-A9CV_treatment,040e04d4-ff2b-50e4-a82c-c9ecc80c0f52,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-ZP-A9CV_treatment_1,,,no,2019-04-28T13:23:08.585567-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:38:16.668337-05:00,released,8dfd1467-49e5-5604-9622-d776631c7d2d\\r\\n,TCGA-DD-A4NB_demographic,7332d8dd-b85b-5878-938f-3b218a22ad8e,8171/3,TCGA-DD-A4NB,,\"Hepatocellular carcinoma, fibrolamellar\",1983fade-44f1-41e0-8983-f2ce8d649655,released,,no,9426,1986,,989,male,not reported,not reported,1983fade-44f1-41e0-8983-f2ce8d649655,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:15:27.276138-05:00,stage i,246cb8a1-2c9e-5963-ad13-cda35a3f51bb,TCGA-DD-A4NB_diagnosis,white,not reported,Liver,TCGA-DD-A4NB_treatment_1,20d2fd5d-9295-512f-9720-0dd8323ede76,no,,,Liver,released,not reported,2019-04-28T13:15:27.276138-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A4NB_treatment,,,no,2019-04-28T13:15:27.276138-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:19.490721-05:00,released,ff4e2c05-8eb6-505d-8f80-8ed847522887\\r\\n,TCGA-DD-A11B_demographic,5535be87-9766-5be3-b0d9-3e0d48af6973,8170/3,TCGA-DD-A11B,,\"Hepatocellular carcinoma, NOS\",1b1b1af0-b19b-4086-b1b7-669fa0b88235,released,2019-04-28T13:15:34.492944-05:00,no,26857,1932,,,male,not reported,not reported,1b1b1af0-b19b-4086-b1b7-669fa0b88235,2019-04-28T13:15:34.492944-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,4d670fdc-dd3a-5042-b450-b0ef565ab00c,TCGA-DD-A11B_diagnosis,white,not reported,Liver,TCGA-DD-A11B_treatment,262d2169-69bc-541d-a413-2aabdbbf98a8,no,2005,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A11B_treatment_1,,,no,2019-04-28T13:15:34.492944-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:58.071505-05:00,released,43f9345b-7292-5ae8-b845-058559c8b552\\r\\n,TCGA-CC-A8HT_demographic,36d1a7e9-0d89-501b-b72f-4bd6bb6e6c7a,8170/3,TCGA-CC-A8HT,,\"Hepatocellular carcinoma, NOS\",95408571-9d4e-412b-8ee8-7992e0270b0f,released,2019-04-28T13:23:23.616245-05:00,no,27334,1939,,0,male,not reported,not reported,95408571-9d4e-412b-8ee8-7992e0270b0f,2019-04-28T13:23:23.616245-05:00,released,2019-05-03T14:06:23.922205-05:00,stage iiia,ead11d33-3b95-5370-8d54-633d0674c335,TCGA-CC-A8HT_diagnosis,asian,not reported,Liver,TCGA-CC-A8HT_treatment,b4f504b6-a3fa-5223-84be-5bcd050d7bbf,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-CC-A8HT_treatment_1,,,no,2019-04-28T13:23:23.616245-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:58.071505-05:00,released,d36719a1-342d-524d-ac6e-44e193948ba6\\r\\n,TCGA-FV-A4ZQ_demographic,7c188d40-3e7d-56a8-bb0d-ef10f3746770,8170/3,TCGA-FV-A4ZQ,,\"Hepatocellular carcinoma, NOS\",65e430e1-0c9a-4045-83a9-653b7cff811d,released,,not reported,19090,1960,,12,male,not reported,not reported,65e430e1-0c9a-4045-83a9-653b7cff811d,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:20:41.074772-05:00,stage i,247999d1-55f2-5450-893b-e8fa9ea05eb7,TCGA-FV-A4ZQ_diagnosis,white,not reported,Liver,TCGA-FV-A4ZQ_treatment_1,d6148ca6-32e0-52e9-8bac-eaa81747004d,not reported,,,Liver,released,not reported,2019-04-28T13:20:41.074772-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-FV-A4ZQ_treatment,,,no,2019-04-28T13:20:41.074772-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:27.936420-05:00,released,38363b80-1958-5b5a-bf40-33348e09c32f\\r\\n,TCGA-DD-AACA_demographic,5461b32f-dcf8-5a05-a379-cfc643b417d4,8170/3,TCGA-DD-AACA,,\"Hepatocellular carcinoma, NOS\",d6486001-240a-455a-980c-e06c25c61fa5,released,2019-04-28T13:27:10.147446-05:00,no,23973,1943,,2301,male,not reported,not reported,d6486001-240a-455a-980c-e06c25c61fa5,2019-04-28T13:27:10.147446-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,b4b6c67a-a361-5d18-b8db-c869d87e2c67,TCGA-DD-AACA_diagnosis,asian,not reported,Liver,TCGA-DD-AACA_treatment,4eb035f5-7244-5c76-8f18-bf29360de1f7,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AACA_treatment_1,,,no,2019-04-28T13:27:10.147446-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:42.289685-05:00,released,0e3a9cdd-81fd-5550-9b68-21bb92403187\\r\\n,TCGA-2Y-A9GV_demographic,feb37c5f-1ccd-59c2-8464-2337aac3dc92,8170/3,TCGA-2Y-A9GV,,\"Hepatocellular carcinoma, NOS\",d1aa9c1a-d732-48c0-b669-8a14e0397344,released,2019-04-28T13:26:55.734028-05:00,yes,20011,1953,,,female,not reported,not reported,d1aa9c1a-d732-48c0-b669-8a14e0397344,2019-04-28T13:26:55.734028-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,b56f5f34-9a5a-51e5-b546-eff1794931da,TCGA-2Y-A9GV_diagnosis,white,not reported,Liver,TCGA-2Y-A9GV_treatment,b2d7952d-da97-591e-88d8-3fcf74070e28,no,2013,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-2Y-A9GV_treatment_1,,,yes,2019-04-28T13:26:55.734028-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:35.448559-05:00,released,1c1d8a99-8591-5ab8-94e1-a2476114508e\\r\\n,TCGA-WX-AA44_demographic,ade694fa-f7ab-5582-8bd0-28d792d7adf4,8170/3,TCGA-WX-AA44,,\"Hepatocellular carcinoma, NOS\",5436fafb-bc16-4450-ac8b-568e1e5ee5fe,released,2019-04-28T13:19:28.009519-05:00,yes,23654,1947,,615,female,not reported,not reported,5436fafb-bc16-4450-ac8b-568e1e5ee5fe,2019-04-28T13:19:28.009519-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,73f2b5ba-e762-5551-b43d-0d47e8a16ef7,TCGA-WX-AA44_diagnosis,white,not reported,Liver,TCGA-WX-AA44_treatment,f7e5c78f-4e01-5acc-876d-14a91cf5fd89,yes,,,Liver,released,not reported,,,hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-WX-AA44_treatment_1,,,no,2019-04-28T13:19:28.009519-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:38:16.668337-05:00,released,4f8dbc80-f7cd-53b1-b3bf-3e2193019723\\r\\n,TCGA-DD-A4NA_demographic,9d0a5984-75a0-5ae3-a763-f3f4e768804c,8170/3,TCGA-DD-A4NA,,\"Hepatocellular carcinoma, NOS\",bee9d6c8-948f-4b76-97ca-b985064249ef,released,,no,24603,1942,,1008,female,not reported,not reported,bee9d6c8-948f-4b76-97ca-b985064249ef,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:25:54.787171-05:00,stage iiic,05cba5ed-2c7e-58ae-9c00-9254139ff731,TCGA-DD-A4NA_diagnosis,white,not reported,Liver,TCGA-DD-A4NA_treatment_1,15269a3e-174f-561c-9783-cdb5568a5481,no,,,Liver,released,not reported,2019-04-28T13:25:54.787171-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A4NA_treatment,,,no,2019-04-28T13:25:54.787171-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:19.490721-05:00,released,90064261-b8e2-570d-ae3f-0a300ecab86f\\r\\n,TCGA-ED-A66Y_demographic,cf217fcf-041d-5f7a-9be7-c225a68600c6,8170/3,TCGA-ED-A66Y,,\"Hepatocellular carcinoma, NOS\",34303cdd-c31c-4b95-9965-2a5513dc322d,released,,no,18797,1962,,7,female,not reported,not reported,34303cdd-c31c-4b95-9965-2a5513dc322d,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:17:04.143320-05:00,stage iiia,74ebcf4e-da1c-50f6-8f72-66f220ca6594,TCGA-ED-A66Y_diagnosis,asian,not reported,Liver,TCGA-ED-A66Y_treatment_1,d68fe933-fec0-568b-88c9-ce15d9279754,no,,,Liver,released,not reported,2019-04-28T13:17:04.143320-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-ED-A66Y_treatment,,,no,2019-04-28T13:17:04.143320-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:05.743590-05:00,released,542f49ce-745f-56c3-9462-fa7afb90094b\\r\\n,TCGA-XR-A8TF_demographic,9c8c22f5-2e92-531a-b6b6-b0d3f9d44a47,8170/3,TCGA-XR-A8TF,,\"Hepatocellular carcinoma, NOS\",1e9f910c-82c0-4222-a62f-b656839307fc,released,2019-04-28T13:15:51.603581-05:00,no,27145,1938,,,male,not reported,not reported,1e9f910c-82c0-4222-a62f-b656839307fc,2019-04-28T13:15:51.603581-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,9b500fab-b7c1-564a-90df-a2b802a38394,TCGA-XR-A8TF_diagnosis,white,not reported,Liver,TCGA-XR-A8TF_treatment,436b9dc6-ac97-5bbe-a939-795cd93a9fc7,no,2013,,Liver,released,not reported,,,hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-XR-A8TF_treatment_1,,,no,2019-04-28T13:15:51.603581-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:38:16.668337-05:00,released,5f59483f-8578-5bbd-84a3-09b1a1bf2e93\\r\\n,TCGA-CC-A7IL_demographic,6252ba36-c1e2-5cf8-acc3-387735196c1d,8170/3,TCGA-CC-A7IL,,\"Hepatocellular carcinoma, NOS\",b54df65f-8a6b-4405-9918-90d53418804c,released,,no,22319,1952,,0,male,not reported,not reported,b54df65f-8a6b-4405-9918-90d53418804c,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:25:13.523846-05:00,stage iiia,9bd0f051-e435-5ceb-ba9e-3830d3ccb1e6,TCGA-CC-A7IL_diagnosis,asian,not reported,Liver,TCGA-CC-A7IL_treatment_1,29a33a3b-fea7-595a-8fe0-f117de8cabb6,no,,,Liver,released,not reported,2019-04-28T13:25:13.523846-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-CC-A7IL_treatment,,,no,2019-04-28T13:25:13.523846-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:58.071505-05:00,released,61b29ace-425b-5b5d-a182-2dafe0b69ff4\\r\\n,TCGA-DD-A1EG_demographic,5755a41a-7d49-54ee-9bb1-59aa3b05e3be,8170/3,TCGA-DD-A1EG,,\"Hepatocellular carcinoma, NOS\",6c79f64b-63fe-46f5-bf7b-77208231b0f2,released,2019-04-28T13:20:58.310688-05:00,yes,28108,1931,,,male,not reported,not reported,6c79f64b-63fe-46f5-bf7b-77208231b0f2,2019-04-28T13:20:58.310688-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,9bec5f4c-ae0f-578b-a4a4-6f546c27d502,TCGA-DD-A1EG_diagnosis,white,not reported,Liver,TCGA-DD-A1EG_treatment,158560c6-156d-5bd8-8f68-b849f97902f4,no,2010,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A1EG_treatment_1,,,no,2019-04-28T13:20:58.310688-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:19.490721-05:00,released,96b8deb2-528f-548e-802b-35bfa7ee06fc\\r\\n,TCGA-DD-AADF_demographic,68541836-9dd3-5013-ae56-b9d01d0b034a,8170/3,TCGA-DD-AADF,,\"Hepatocellular carcinoma, NOS\",70bb26b8-b38b-4e79-90e7-033a38405b00,released,,no,23614,1947,,,female,not reported,not reported,70bb26b8-b38b-4e79-90e7-033a38405b00,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:21:11.990374-05:00,stage i,9c34e76b-4986-5b73-8c83-98acc6aa7c3e,TCGA-DD-AADF_diagnosis,asian,not reported,Liver,TCGA-DD-AADF_treatment_1,f4deb0ab-a40b-5535-b1ba-fe92226389fb,no,2011,,Liver,released,not reported,2019-04-28T13:21:11.990374-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AADF_treatment,,,no,2019-04-28T13:21:11.990374-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:42.289685-05:00,released,05b453fa-5fb8-5420-8058-116ae03b2c00\\r\\n,TCGA-RC-A7S9_demographic,d2920470-e785-57da-9d46-4ac400c57539,8170/3,TCGA-RC-A7S9,,\"Hepatocellular carcinoma, NOS\",f5de6712-4de4-43de-8eb5-ec2a798c8438,released,2019-04-28T13:28:20.709796-05:00,no,17403,1965,,640,female,not reported,not reported,f5de6712-4de4-43de-8eb5-ec2a798c8438,2019-04-28T13:28:20.709796-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,79caa04b-6ab2-5c67-ab09-ffdd86f3909c,TCGA-RC-A7S9_diagnosis,asian,not reported,Liver,TCGA-RC-A7S9_treatment,062d05c2-1860-59de-9bd3-85f48ac05bd4,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-RC-A7S9_treatment_1,,,no,2019-04-28T13:28:20.709796-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:53.093878-05:00,released,171f32f0-8a10-5798-bd81-ecdd3cdb4f50\\r\\n,TCGA-GJ-A3OU_demographic,b46c5aac-5dd9-55ad-b05f-9427824c13ce,8174/3,TCGA-GJ-A3OU,,\"Hepatocellular carcinoma, clear cell type\",fb2abc2a-ecf1-4184-912f-26a649f861ff,released,,no,21671,1952,,879,male,not reported,not reported,fb2abc2a-ecf1-4184-912f-26a649f861ff,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:28:30.761401-05:00,stage i,7cf4a96a-e0cb-5b28-9738-6c5f9aa5640f,TCGA-GJ-A3OU_diagnosis,white,not reported,Liver,TCGA-GJ-A3OU_treatment_1,0dd82736-4500-57b6-8472-bd8ca6ec900c,no,,,Liver,released,not reported,2019-04-28T13:28:30.761401-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-GJ-A3OU_treatment,,,no,2019-04-28T13:28:30.761401-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:53.093878-05:00,released,50017a4f-56e6-559a-a23c-f45d374d8484\\r\\n,TCGA-ED-A7PZ_demographic,1a38ed35-9106-5001-af73-9e3f4c4d3a32,8170/3,TCGA-ED-A7PZ,,\"Hepatocellular carcinoma, NOS\",87750e70-3af7-452a-9aa5-375acd3843ea,released,,no,22601,1952,,6,male,not reported,not reported,87750e70-3af7-452a-9aa5-375acd3843ea,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:22:30.148874-05:00,stage ii,d4fad37d-93bb-5b1b-a523-242fa1efdf19,TCGA-ED-A7PZ_diagnosis,asian,not reported,Liver,TCGA-ED-A7PZ_treatment_1,6c100bbe-5976-58fd-a19f-ef5365a106f9,no,,,Liver,released,not reported,2019-04-28T13:22:30.148874-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-ED-A7PZ_treatment,,,no,2019-04-28T13:22:30.148874-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:05.743590-05:00,released,1869b0a5-847b-531c-8e07-80b6b12aba2f\\r\\n,TCGA-G3-A25W_demographic,a9b1b9ee-b601-59cf-897c-226fce8ff92d,8170/3,TCGA-G3-A25W,,\"Hepatocellular carcinoma, NOS\",06ac44e9-1226-4202-828b-6f224766d7ac,released,,no,29018,1931,,935,female,not reported,not reported,06ac44e9-1226-4202-828b-6f224766d7ac,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:14:12.879088-05:00,stage iiib,c2487ef4-f8d1-5045-8307-ad5fae81aeee,TCGA-G3-A25W_diagnosis,white,not reported,Liver,TCGA-G3-A25W_treatment_1,6f8eaa68-a08e-577f-98d0-c0beea5b1b7e,no,,,Liver,released,not reported,2019-04-28T13:14:12.879088-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-G3-A25W_treatment,,,yes,2019-04-28T13:14:12.879088-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:27.936420-05:00,released,8247a7e2-d4eb-5182-bcb2-1874bfb5d6d5\\r\\n,TCGA-EP-A2KB_demographic,16127f9c-b088-51e7-8b8a-b7a606972a3f,8170/3,TCGA-EP-A2KB,,\"Hepatocellular carcinoma, NOS\",18c08546-bed3-4ed9-b223-479afe633c8e,released,2019-04-28T13:15:22.372778-05:00,no,16835,1965,,334,female,not reported,not reported,18c08546-bed3-4ed9-b223-479afe633c8e,2019-04-28T13:15:22.372778-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,1e163eb2-4bc1-5d78-b48f-9513316d15ab,TCGA-EP-A2KB_diagnosis,white,not reported,Liver,TCGA-EP-A2KB_treatment,a3ab57c4-5062-5e33-88f7-777ea976c5d5,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-EP-A2KB_treatment_1,,,no,2019-04-28T13:15:22.372778-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:27.936420-05:00,released,f6eca0e4-a762-50b1-ae7f-f9ed18f4e09c\\r\\n,TCGA-MI-A75H_demographic,1d42a256-f16a-5f0e-b41b-7fcac0b50055,8170/3,TCGA-MI-A75H,,\"Hepatocellular carcinoma, NOS\",f3f6ba92-c68f-4313-99f4-0281272e02b6,released,2019-04-28T13:28:16.105426-05:00,no,28371,1935,,747,male,not reported,not reported,f3f6ba92-c68f-4313-99f4-0281272e02b6,2019-04-28T13:28:16.105426-05:00,released,2019-05-03T14:06:23.922205-05:00,not reported,c2a18921-da5f-54ce-abc5-29a3c41e293a,TCGA-MI-A75H_diagnosis,white,not reported,Liver,TCGA-MI-A75H_treatment,acbf4bdc-e76d-5982-a94a-0f55762b05b4,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-MI-A75H_treatment_1,,,yes,2019-04-28T13:28:16.105426-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:53.093878-05:00,released,188f8e84-29f7-561f-bdc5-36f724d08afd\\r\\n,TCGA-NI-A8LF_demographic,e8ca9118-d072-5c22-8b33-69d582ff5b7a,8170/3,TCGA-NI-A8LF,,\"Hepatocellular carcinoma, NOS\",420dc176-e9a8-484b-bfa3-1b84e039c26b,released,,no,27162,1938,,799,male,not reported,not reported,420dc176-e9a8-484b-bfa3-1b84e039c26b,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:18:07.068471-05:00,stage i,ac7f8d03-4539-5080-80e8-cc24276f8666,TCGA-NI-A8LF_diagnosis,white,not reported,Liver,TCGA-NI-A8LF_treatment_1,2afdda48-0d03-5dc4-8c16-381514b8c73c,no,,,Liver,released,not reported,2019-04-28T13:18:07.068471-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-NI-A8LF_treatment,,,no,2019-04-28T13:18:07.068471-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:53.093878-05:00,released,17f41b78-8357-5a6a-813c-054a8f0b9938\\r\\n,TCGA-BW-A5NQ_demographic,c88606b6-e730-50a2-a4c8-c09e7770dafb,8170/3,TCGA-BW-A5NQ,,\"Hepatocellular carcinoma, NOS\",c7f1b389-aec7-4993-8afb-b7a56064f8fc,released,2019-04-28T13:26:23.796827-05:00,not reported,23353,1947,,0,male,not reported,not reported,c7f1b389-aec7-4993-8afb-b7a56064f8fc,2019-04-28T13:26:23.796827-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,ad7d17aa-d0dc-5ed3-a0c5-a659a68e2967,TCGA-BW-A5NQ_diagnosis,white,not reported,Liver,TCGA-BW-A5NQ_treatment,6e05fd03-0959-5a3a-b8be-ef2bb491449c,not reported,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-BW-A5NQ_treatment_1,,,yes,2019-04-28T13:26:23.796827-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:58.071505-05:00,released,b3fe93ae-31a9-5816-a9d0-b052100b0c4d\\r\\n,TCGA-DD-AACT_demographic,c7de235b-032d-5487-8e3a-f5f7af8a53b9,8170/3,TCGA-DD-AACT,,\"Hepatocellular carcinoma, NOS\",3ea084c5-3783-4fde-b341-5914d2edb977,released,2019-04-28T13:17:49.780163-05:00,no,25292,1941,,1562,female,not reported,not reported,3ea084c5-3783-4fde-b341-5914d2edb977,2019-04-28T13:17:49.780163-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,79a7ef0f-e470-5f20-a540-6e60afb3d0b3,TCGA-DD-AACT_diagnosis,asian,not reported,Liver,TCGA-DD-AACT_treatment,a8a10330-5c63-52ec-9221-2e72266a5f75,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AACT_treatment_1,,,no,2019-04-28T13:17:49.780163-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:42.289685-05:00,released,40109fa7-49a5-55fb-a2f6-3fb5ddccfe51\\r\\n,TCGA-DD-AAE1_demographic,af9ef590-26cc-5fc6-beef-eaaaccce4c84,8170/3,TCGA-DD-AAE1,,\"Hepatocellular carcinoma, NOS\",3bbff405-dae4-4dc9-985a-33e7ac9cb2dd,released,2019-04-28T13:17:35.490966-05:00,no,19073,1961,,552,male,not reported,not reported,3bbff405-dae4-4dc9-985a-33e7ac9cb2dd,2019-04-28T13:17:35.490966-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,dd4ea1d4-ebe2-5d93-bad3-86eb7495dd9f,TCGA-DD-AAE1_diagnosis,asian,not reported,Liver,TCGA-DD-AAE1_treatment,e5dde667-a6e7-5ec8-90b5-e5649a76d535,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AAE1_treatment_1,,,no,2019-04-28T13:17:35.490966-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:05.743590-05:00,released,5fe2df73-af0b-5555-833a-34c043f8223e\\r\\n,TCGA-ED-A7PX_demographic,cc3de161-2289-57b1-824d-f81cd04fcd68,8170/3,TCGA-ED-A7PX,,\"Hepatocellular carcinoma, NOS\",470d52b8-3d74-4789-b714-b9869a96657b,released,2019-04-28T13:18:35.040645-05:00,not reported,17638,1965,,6,female,not reported,not reported,470d52b8-3d74-4789-b714-b9869a96657b,2019-04-28T13:18:35.040645-05:00,released,2019-05-03T14:06:23.922205-05:00,stage ii,adaa279c-dbb6-556b-86d9-6c9e43721540,TCGA-ED-A7PX_diagnosis,asian,not reported,Liver,TCGA-ED-A7PX_treatment,af6bd9bd-6232-51b8-8c11-7c345d02f36d,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-ED-A7PX_treatment_1,,,no,2019-04-28T13:18:35.040645-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:05.743590-05:00,released,b5a8058e-0cfb-5d7d-b1cb-a3a2d67951ce\\r\\n,TCGA-2V-A95S_demographic,0a79774f-a25f-5425-b83c-004e4b752701,8170/3,TCGA-2V-A95S,,\"Hepatocellular carcinoma, NOS\",2c041473-eaaa-4b7c-9b2e-b9da3543ad18,released,2019-04-28T13:16:37.754023-05:00,no,,,,,male,not reported,not reported,2c041473-eaaa-4b7c-9b2e-b9da3543ad18,2019-04-28T13:16:37.754023-05:00,released,2019-05-03T14:06:23.922205-05:00,stage ii,f561d034-67b3-5563-a2a3-e4497a5df2cd,TCGA-2V-A95S_diagnosis,asian,not reported,Liver,TCGA-2V-A95S_treatment,7c505805-781d-5617-81bf-c32bb12b4a48,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-2V-A95S_treatment_1,,,no,2019-04-28T13:16:37.754023-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:35.448559-05:00,released,d88b47ad-02d9-5dbf-92c6-36cdbe3bfa24\\r\\n,TCGA-DD-AAE4_demographic,c0f7f3d0-1c2e-50fe-947d-301159d7bd9d,8170/3,TCGA-DD-AAE4,,\"Hepatocellular carcinoma, NOS\",c797d6ad-05d4-4322-bad2-29801a986b4e,released,2019-04-28T13:26:21.297947-05:00,no,18009,1964,,608,female,not reported,not reported,c797d6ad-05d4-4322-bad2-29801a986b4e,2019-04-28T13:26:21.297947-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,b04a00d7-decc-56fd-ada9-9085aea2bd96,TCGA-DD-AAE4_diagnosis,asian,not reported,Liver,TCGA-DD-AAE4_treatment,af2ca6e1-a68c-587e-926c-4c811e7d91b9,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AAE4_treatment_1,,,no,2019-04-28T13:26:21.297947-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:05.743590-05:00,released,613b7601-e6f7-5b22-a7ad-cbbe2291b8fc\\r\\n,TCGA-RC-A6M4_demographic,990c9dee-e5f2-5410-b2e8-6c5f20d98a90,8170/3,TCGA-RC-A6M4,,\"Hepatocellular carcinoma, NOS\",2d1dc64d-27de-4c83-a7fa-88da5b48bf24,released,,not reported,27327,1936,,22,female,not reported,not reported,2d1dc64d-27de-4c83-a7fa-88da5b48bf24,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:16:47.629296-05:00,stage iiia,f5949f94-831d-5590-87f6-18162aa51493,TCGA-RC-A6M4_diagnosis,white,not reported,Liver,TCGA-RC-A6M4_treatment_1,33d64106-6d59-57cc-8232-72229061c463,not reported,,,Liver,released,not reported,2019-04-28T13:16:47.629296-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-RC-A6M4_treatment,,,no,2019-04-28T13:16:47.629296-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:53.093878-05:00,released,2025d5ea-e9fe-5170-aaf3-b0588009a7ef\\r\\n,TCGA-2Y-A9H5_demographic,e9f866f0-e917-5366-bd65-f14114e2dc7f,8170/3,TCGA-2Y-A9H5,,\"Hepatocellular carcinoma, NOS\",51810579-e20d-4f08-93e7-891d645931db,released,,no,21818,1951,,,female,not reported,not reported,51810579-e20d-4f08-93e7-891d645931db,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:19:11.449722-05:00,stage i,f5fcd2e7-fcbf-50bb-b85c-1bdfe7f09a6a,TCGA-2Y-A9H5_diagnosis,white,not reported,Liver,TCGA-2Y-A9H5_treatment_1,01b002ec-01e8-5367-87f9-1b992ff0f58a,no,2011,,Liver,released,not reported,2019-04-28T13:19:11.449722-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-2Y-A9H5_treatment,,,no,2019-04-28T13:19:11.449722-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:35.448559-05:00,released,d3800426-d919-55de-958e-323ab2403a61\\r\\n,TCGA-ZS-A9CE_demographic,63114e37-7023-573b-9b67-8e2afd74ab25,8170/3,TCGA-ZS-A9CE,,\"Hepatocellular carcinoma, NOS\",7bdc5f86-4d7d-4f1f-bc23-ab51fa9fb947,released,,no,29051,1932,,1241,female,not reported,not reported,7bdc5f86-4d7d-4f1f-bc23-ab51fa9fb947,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:21:46.813505-05:00,stage ii,f61e0427-db78-565a-946f-90c56d30fbbc,TCGA-ZS-A9CE_diagnosis,white,not reported,Liver,TCGA-ZS-A9CE_treatment_1,d3d510bd-8237-5748-bfce-ae3fc95a18d0,no,,,Liver,released,not reported,2019-04-28T13:21:46.813505-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-ZS-A9CE_treatment,,,yes,2019-04-28T13:21:46.813505-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:38:16.668337-05:00,released,50e5b3ac-c3f9-5ca6-b3e0-1fae2eee1c85\\r\\n,TCGA-DD-AAEA_demographic,ba385f27-7380-5226-bb93-9e6946edc638,8170/3,TCGA-DD-AAEA,,\"Hepatocellular carcinoma, NOS\",ad9657aa-34e9-48b1-ba63-916fe7bd14bb,released,2019-04-28T13:24:44.619517-05:00,no,24027,1947,,575,male,not reported,not reported,ad9657aa-34e9-48b1-ba63-916fe7bd14bb,2019-04-28T13:24:44.619517-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,f6d2c4c3-6dbf-5740-b1f4-27ebb3694b3e,TCGA-DD-AAEA_diagnosis,asian,not reported,Liver,TCGA-DD-AAEA_treatment,5a0c639e-97bd-5aea-b620-f63919f11078,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AAEA_treatment_1,,,yes,2019-04-28T13:24:44.619517-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:05.743590-05:00,released,d6b0f9dc-90a8-5fee-ab5d-4b605add8d74\\r\\n,TCGA-2Y-A9GS_demographic,c742cca9-d6d7-55c5-a8ab-c40287db9781,8170/3,TCGA-2Y-A9GS,,\"Hepatocellular carcinoma, NOS\",95b97198-1a1b-4f01-90f3-6c66638371d1,released,2019-04-28T13:23:28.813942-05:00,no,21318,1948,,,male,not reported,not reported,95b97198-1a1b-4f01-90f3-6c66638371d1,2019-04-28T13:23:28.813942-05:00,released,2019-05-03T14:06:23.922205-05:00,not reported,f6d84f3f-e450-5489-ab59-338ed932bc2a,TCGA-2Y-A9GS_diagnosis,white,not reported,Liver,TCGA-2Y-A9GS_treatment,419ef6d9-9ccf-5016-a250-501f4e0cbdc2,no,2007,,Liver,released,not reported,,,hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-2Y-A9GS_treatment_1,,,no,2019-04-28T13:23:28.813942-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:35.448559-05:00,released,ec926521-7362-5d69-a254-637fb819657a\\r\\n,TCGA-CC-5261_demographic,f07403e4-54ac-5513-966a-3d6bb3b85390,8170/3,TCGA-CC-5261,,\"Hepatocellular carcinoma, NOS\",1ad7f17e-b3b8-40e9-aab8-5a17e0aec408,released,,no,16373,1966,,12,male,not reported,not reported,1ad7f17e-b3b8-40e9-aab8-5a17e0aec408,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:15:31.984191-05:00,stage ii,769c38dc-8d72-5617-98df-8b4614758d0d,TCGA-CC-5261_diagnosis,asian,not reported,Liver,TCGA-CC-5261_treatment_1,e23947f1-3dca-5956-8d4a-d57bffb9a7b5,no,,,Liver,released,not reported,2019-04-28T13:15:31.984191-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-CC-5261_treatment,,,no,2019-04-28T13:15:31.984191-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:58.071505-05:00,released,140ffd01-28f7-528c-a71d-bb013387cf94\\r\\n,TCGA-XR-A8TC_demographic,4917aff5-3678-5705-bd65-303140e3380b,8170/3,TCGA-XR-A8TC,,\"Hepatocellular carcinoma, NOS\",4db9de75-9297-46e5-acc5-9275f52a642a,released,2019-04-28T13:19:02.362606-05:00,no,15817,1968,,1339,female,not reported,not reported,4db9de75-9297-46e5-acc5-9275f52a642a,2019-04-28T13:19:02.362606-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,7709cb67-8318-5f17-8e94-756f13eb273a,TCGA-XR-A8TC_diagnosis,white,not reported,Liver,TCGA-XR-A8TC_treatment,75a14875-74d3-5e6c-ab23-fc48b74acc31,no,,,Liver,released,not reported,,,hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-XR-A8TC_treatment_1,,,yes,2019-04-28T13:19:02.362606-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:38:16.668337-05:00,released,e350e78c-ebd3-5810-8967-ee7d5bda845a\\r\\n,TCGA-CC-A3MC_demographic,b79bb429-6370-5d94-a1cf-3e052c92edd5,8170/3,TCGA-CC-A3MC,,\"Hepatocellular carcinoma, NOS\",0277f393-3743-47d6-a96f-155baec9eb49,released,2019-04-28T13:14:00.991766-05:00,no,20067,1957,,363,male,not reported,not reported,0277f393-3743-47d6-a96f-155baec9eb49,2019-04-28T13:14:00.991766-05:00,released,2019-05-03T14:06:23.922205-05:00,stage iiia,1f9012a2-66d5-569c-bb1f-751ef77d04b0,TCGA-CC-A3MC_diagnosis,asian,not reported,Liver,TCGA-CC-A3MC_treatment,8907c55f-56af-5f58-978e-2f537d5f76b1,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-CC-A3MC_treatment_1,,,no,2019-04-28T13:14:00.991766-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:58.071505-05:00,released,b31e6299-91ab-541a-972f-673e343d9901\\r\\n,TCGA-DD-AAVW_demographic,9cb7ec80-d03e-55dd-a964-3176e3305cb4,8170/3,TCGA-DD-AAVW,,\"Hepatocellular carcinoma, NOS\",11823a8a-194f-4e6b-a373-ef5a3fc7d2b9,released,,no,12986,1973,,2317,male,not reported,not reported,11823a8a-194f-4e6b-a373-ef5a3fc7d2b9,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:15:00.346227-05:00,stage i,10b7f826-5ab9-58e1-a1b5-8b10ac49c837,TCGA-DD-AAVW_diagnosis,asian,not reported,Liver,TCGA-DD-AAVW_treatment_1,db7c1a7c-4175-53b1-a512-8457d410dd53,no,,,Liver,released,not reported,2019-04-28T13:15:00.346227-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AAVW_treatment,,,no,2019-04-28T13:15:00.346227-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:05.743590-05:00,released,f0f4bfd8-2400-5967-a631-67efd81b7594\\r\\n,TCGA-DD-AACW_demographic,daa0ded0-9c64-500d-bac7-96c53cf260e7,8170/3,TCGA-DD-AACW,,\"Hepatocellular carcinoma, NOS\",67a00f5f-c753-48f9-bc24-8287f50ec776,released,2019-04-28T13:20:48.696174-05:00,no,15872,1967,,1424,male,not reported,not reported,67a00f5f-c753-48f9-bc24-8287f50ec776,2019-04-28T13:20:48.696174-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,af3376bc-f990-5594-abe6-0efb9c839d33,TCGA-DD-AACW_diagnosis,asian,not reported,Liver,TCGA-DD-AACW_treatment,0267a1e6-7054-59c9-a210-c81c62027579,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AACW_treatment_1,,,no,2019-04-28T13:20:48.696174-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:42.289685-05:00,released,4a4aa6e2-19d5-5f90-8292-a576441895bf\\r\\n,TCGA-DD-A115_demographic,bddd0c26-e678-5b1f-91a8-25b3315aaa09,8170/3,TCGA-DD-A115,,\"Hepatocellular carcinoma, NOS\",45b566d7-f120-471c-a94a-be7936889f2d,released,,no,19697,1949,,,male,not reported,not reported,45b566d7-f120-471c-a94a-be7936889f2d,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:18:27.408988-05:00,stage iiia,80481ba2-cad9-5415-b92d-327c0c6b2429,TCGA-DD-A115_diagnosis,white,not reported,Liver,TCGA-DD-A115_treatment_1,5e7ef6f5-7360-5baf-a65b-3a6792b13368,yes,2008,,Liver,released,not reported,2019-04-28T13:18:27.408988-05:00,,not reported,released,Adenomas and Adenocarcinomas,TCGA-DD-A115_treatment,,,no,2019-04-28T13:18:27.408988-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:58.071505-05:00,released,41000d11-ee33-52a0-a8c1-6c80f5e5c0be\\r\\n,TCGA-DD-AAED_demographic,89e36e64-481a-52d8-a6f4-7b837b04a133,8170/3,TCGA-DD-AAED,,\"Hepatocellular carcinoma, NOS\",527d2bc3-7fdd-4b08-839d-67e2f246db04,released,2019-04-28T13:19:20.492059-05:00,no,18722,1961,,763,male,not reported,not reported,527d2bc3-7fdd-4b08-839d-67e2f246db04,2019-04-28T13:19:20.492059-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,523442f5-24bd-529e-98df-e6d616391b26,TCGA-DD-AAED_diagnosis,asian,not reported,Liver,TCGA-DD-AAED_treatment,1fef8539-5fb7-558e-be18-a41e463c9107,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AAED_treatment_1,,,no,2019-04-28T13:19:20.492059-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:05.743590-05:00,released,03fb6b5d-f5b7-506e-a302-0637bccbc5b0\\r\\n,TCGA-DD-A73G_demographic,6f026ef1-336f-5498-82c0-134418cc73db,8170/3,TCGA-DD-A73G,,\"Hepatocellular carcinoma, NOS\",4774367c-5d8f-4b23-934a-e6d33a89dca8,released,2019-04-28T13:18:37.373040-05:00,no,26949,1932,,3478,female,not reported,not reported,4774367c-5d8f-4b23-934a-e6d33a89dca8,2019-04-28T13:18:37.373040-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,80d25bdf-6946-5213-be2a-6f6c34c8a3ae,TCGA-DD-A73G_diagnosis,white,not reported,Liver,TCGA-DD-A73G_treatment,d6239f82-2599-59b1-9e17-4c03188b2e09,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A73G_treatment_1,,,no,2019-04-28T13:18:37.373040-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:42.289685-05:00,released,6cc92718-ee3f-54d4-98f2-7569a17c302a\\r\\n,TCGA-DD-AADJ_demographic,b71cce13-1da8-5a0d-bce2-7b5eb3ebe979,8170/3,TCGA-DD-AADJ,,\"Hepatocellular carcinoma, NOS\",1d880aea-9efe-4a43-8a6a-6a81801da9e0,released,2019-04-28T13:15:49.208119-05:00,no,25863,1941,,1066,female,not reported,not reported,1d880aea-9efe-4a43-8a6a-6a81801da9e0,2019-04-28T13:15:49.208119-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,81111509-8c0f-5129-a5ee-c815c519b690,TCGA-DD-AADJ_diagnosis,asian,not reported,Liver,TCGA-DD-AADJ_treatment,752d9398-4bd7-5cbe-ab20-1b63dfd80e89,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AADJ_treatment_1,,,no,2019-04-28T13:15:49.208119-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:42.289685-05:00,released,be0e100c-2b57-5ded-993e-7d14142eab8c\\r\\n,TCGA-DD-AAVX_demographic,03c1b88d-7ca4-5480-844d-1f77ccbb9205,8170/3,TCGA-DD-AAVX,,\"Hepatocellular carcinoma, NOS\",afcb9708-92b3-4727-9c0d-63e7ff22d87b,released,2019-04-28T13:24:58.888224-05:00,yes,14016,1970,,1718,male,not reported,not reported,afcb9708-92b3-4727-9c0d-63e7ff22d87b,2019-04-28T13:24:58.888224-05:00,released,2019-05-03T14:06:23.922205-05:00,stage ii,c482969f-3019-5ef1-a48e-d7b719061d51,TCGA-DD-AAVX_diagnosis,asian,not reported,Liver,TCGA-DD-AAVX_treatment,9efc0266-f7e1-511c-bef5-32f32e9c3ea8,yes,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AAVX_treatment_1,,,no,2019-04-28T13:24:58.888224-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:05.743590-05:00,released,8af9c87c-0f3c-5ae2-9e48-480d224385c1\\r\\n,TCGA-ZS-A9CF_demographic,820c7baf-6e82-535e-8372-65cb956a5753,8170/3,TCGA-ZS-A9CF,,\"Hepatocellular carcinoma, NOS\",7fe5e2d9-c514-47bc-8387-3f940f7a822d,released,2019-04-28T13:22:01.189228-05:00,no,23510,1944,,2412,male,not reported,not reported,7fe5e2d9-c514-47bc-8387-3f940f7a822d,2019-04-28T13:22:01.189228-05:00,released,2019-05-03T14:06:23.922205-05:00,stage ii,1f9fd7d4-23ec-5f95-ab97-0bd3964ada88,TCGA-ZS-A9CF_diagnosis,white,not reported,Liver,TCGA-ZS-A9CF_treatment,848e21ae-932c-500a-9bb7-a46b96bf51bf,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-ZS-A9CF_treatment_1,,,no,2019-04-28T13:22:01.189228-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:38:16.668337-05:00,released,02ff719e-c5a6-5404-a5ff-ed0d79f331d9\\r\\n,TCGA-DD-A39Z_demographic,6b9076cc-5c08-5fa6-af8a-aa5280add163,8170/3,TCGA-DD-A39Z,,\"Hepatocellular carcinoma, NOS\",42cb60f0-1a9e-4f59-8e2e-50c25e85cb98,released,,not reported,15930,1953,,,female,not reported,not reported,42cb60f0-1a9e-4f59-8e2e-50c25e85cb98,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:18:14.402254-05:00,stage ii,2531e8c6-27c2-5a38-928e-144065b40fdd,TCGA-DD-A39Z_diagnosis,not reported,not reported,Liver,TCGA-DD-A39Z_treatment_1,760e64c9-3c83-5bbc-b602-ca298fa0f5e1,not reported,1997,,Liver,released,not reported,2019-04-28T13:18:14.402254-05:00,,not reported,released,Adenomas and Adenocarcinomas,TCGA-DD-A39Z_treatment,,,no,2019-04-28T13:18:14.402254-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:19.490721-05:00,released,5e2cda53-665c-54b9-8b62-b22d2bdb150f\\r\\n,TCGA-RC-A7SF_demographic,1a92518d-600e-5bff-a064-cbd38dd03ec8,8170/3,TCGA-RC-A7SF,,\"Hepatocellular carcinoma, NOS\",714a6878-ed2a-47f3-9755-b705ac144d68,released,,no,24432,1946,,579,male,not reported,not reported,714a6878-ed2a-47f3-9755-b705ac144d68,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:21:14.615460-05:00,stage i,072b3198-76a5-59d7-9ab1-de3f95ec137c,TCGA-RC-A7SF_diagnosis,asian,not reported,Liver,TCGA-RC-A7SF_treatment_1,e3faf8ce-4f43-5a7d-8869-da82ecb4a455,no,,,Liver,released,not reported,2019-04-28T13:21:14.615460-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-RC-A7SF_treatment,,,no,2019-04-28T13:21:14.615460-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:53.093878-05:00,released,288af713-648c-5f9c-9e0f-53f7189d2e7e\\r\\n,TCGA-DD-AADG_demographic,bdaa042c-8c47-573d-992a-6d6b607f93b2,8170/3,TCGA-DD-AADG,,\"Hepatocellular carcinoma, NOS\",89d1261c-6d93-4298-a2af-b5ff52be0cb6,released,,no,25887,1941,,1145,male,not reported,not reported,89d1261c-6d93-4298-a2af-b5ff52be0cb6,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:22:46.676028-05:00,stage iiia,be471824-8949-5c86-b43e-89425a52f944,TCGA-DD-AADG_diagnosis,asian,not reported,Liver,TCGA-DD-AADG_treatment_1,d71cf2e8-6ee5-5edc-981d-0c2cbbde33dd,no,,,Liver,released,not reported,2019-04-28T13:22:46.676028-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AADG_treatment,,,no,2019-04-28T13:22:46.676028-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:42.289685-05:00,released,1a151bf3-c874-5aad-aff6-aa9578863fc1\\r\\n,TCGA-DD-A73F_demographic,fd52f9d1-0c50-5053-9a2a-7c3068930a65,8170/3,TCGA-DD-A73F,,\"Hepatocellular carcinoma, NOS\",870c86e7-d6e1-4f9d-bb0b-bd1c66d6bcde,released,,no,28234,1933,,1085,female,not reported,not reported,870c86e7-d6e1-4f9d-bb0b-bd1c66d6bcde,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:22:27.799288-05:00,stage i,6dd80b81-b4bd-5334-934c-dd3456d46d53,TCGA-DD-A73F_diagnosis,white,not reported,Liver,TCGA-DD-A73F_treatment_1,a568b5bf-83b4-58e7-a631-3d06b4b33e70,no,,,Liver,released,not reported,2019-04-28T13:22:27.799288-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A73F_treatment,,,no,2019-04-28T13:22:27.799288-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:19.490721-05:00,released,46fbdc06-7500-556a-9b62-9c186a8c2cc6\\r\\n,TCGA-BD-A3EP_demographic,47b407a1-18eb-5505-b45f-0ccf1a6bbe10,8170/3,TCGA-BD-A3EP,,\"Hepatocellular carcinoma, NOS\",de302b98-250d-42fe-9945-11e1b2bbd3c6,released,,no,27756,1935,,409,female,not reported,not reported,de302b98-250d-42fe-9945-11e1b2bbd3c6,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:27:29.815491-05:00,stage i,a6643770-d005-5be6-a1cb-fda458e647cc,TCGA-BD-A3EP_diagnosis,black or african american,not reported,Liver,TCGA-BD-A3EP_treatment_1,10597541-ae09-5bab-843d-f721dfc42b5c,no,,,Liver,released,not reported,2019-04-28T13:27:29.815491-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-BD-A3EP_treatment,,,no,2019-04-28T13:27:29.815491-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:58.071505-05:00,released,2355ea39-b633-5b37-af84-95e9f59cd968\\r\\n,TCGA-2Y-A9GX_demographic,2f02c3f4-4311-57ca-88f3-cf6d2287f346,8170/3,TCGA-2Y-A9GX,,\"Hepatocellular carcinoma, NOS\",d6c2c6ce-3483-4fe5-aef6-e40419f728cf,released,,no,24963,1939,,2442,male,not reported,not reported,d6c2c6ce-3483-4fe5-aef6-e40419f728cf,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:27:15.135172-05:00,stage i,5fa47b6c-82da-561f-be26-b072e4b2c567,TCGA-2Y-A9GX_diagnosis,white,not reported,Liver,TCGA-2Y-A9GX_treatment_1,dfe87fd0-2350-543a-9622-75696a2e66cc,no,,,Liver,released,not reported,2019-04-28T13:27:15.135172-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-2Y-A9GX_treatment,,,no,2019-04-28T13:27:15.135172-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:35.448559-05:00,released,1e44f05d-8f42-5c0b-b87a-0a99b0fecb1c\\r\\n,TCGA-DD-A73B_demographic,5954a18c-d3d2-5c4b-8366-07b5c4cdc96d,8170/3,TCGA-DD-A73B,,\"Hepatocellular carcinoma, NOS\",5449c232-56f1-4e03-9421-aba3ae180107,released,,no,26390,1940,,,female,not reported,not reported,5449c232-56f1-4e03-9421-aba3ae180107,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:19:30.414205-05:00,stage i,735ac2ba-a808-5075-987e-aa75e39426d8,TCGA-DD-A73B_diagnosis,white,not reported,Liver,TCGA-DD-A73B_treatment_1,99570655-63e7-59ea-ae37-ea5c80f7c1d8,no,2012,,Liver,released,not reported,2019-04-28T13:19:30.414205-05:00,,hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A73B_treatment,,,no,2019-04-28T13:19:30.414205-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:19.490721-05:00,released,9c5e8b3d-d5e0-5b6d-9c32-569e08f9b59f\\r\\n,TCGA-DD-A73D_demographic,e80e8a22-ed16-5f03-81f1-b504f32684c4,8170/3,TCGA-DD-A73D,,\"Hepatocellular carcinoma, NOS\",24170a77-94e0-4002-9d3e-a46c84e84fca,released,,no,24941,1944,,693,female,not reported,not reported,24170a77-94e0-4002-9d3e-a46c84e84fca,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:16:15.343829-05:00,stage ii,138489e0-ec40-5776-b9c1-cc671500cb03,TCGA-DD-A73D_diagnosis,white,not reported,Liver,TCGA-DD-A73D_treatment_1,bffcc459-c221-5fc4-9d2a-6c9370fc4b39,no,,,Liver,released,not reported,2019-04-28T13:16:15.343829-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A73D_treatment,,,no,2019-04-28T13:16:15.343829-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:19.490721-05:00,released,0c327217-62b9-5e99-87a7-eb39e331886c\\r\\n,TCGA-UB-A7MA_demographic,1d4f1903-4986-5782-aeb3-e4fda6cc95f3,8180/3,TCGA-UB-A7MA,,Combined hepatocellular carcinoma and cholangiocarcinoma,10179efc-a091-4119-8ec2-30db6269d674,released,,no,22843,1951,,848,female,not reported,not reported,10179efc-a091-4119-8ec2-30db6269d674,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:14:50.830180-05:00,stage ii,56fb6457-93fb-5e0b-ac1e-b84482478286,TCGA-UB-A7MA_diagnosis,white,not reported,Liver,TCGA-UB-A7MA_treatment_1,0f3d62ed-4319-592e-ad99-734d01cdc101,yes,,,Liver,released,not reported,2019-04-28T13:14:50.830180-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-UB-A7MA_treatment,,,no,2019-04-28T13:14:50.830180-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:53.093878-05:00,released,d3966fad-6e2c-5cbd-b245-4e97caabba53\\r\\n,TCGA-G3-A7M5_demographic,b671e081-1e0a-5eb2-b819-eb55d371067f,8170/3,TCGA-G3-A7M5,,\"Hepatocellular carcinoma, NOS\",869f8a17-bced-4002-bd60-99df84a03b93,released,2019-04-28T13:22:25.390983-05:00,no,27963,1937,,447,male,not reported,not reported,869f8a17-bced-4002-bd60-99df84a03b93,2019-04-28T13:22:25.390983-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,85f253fc-0bd9-54de-85e4-ed3cf4a8d075,TCGA-G3-A7M5_diagnosis,asian,not reported,Liver,TCGA-G3-A7M5_treatment,e429a666-3777-52b6-99e9-dcf40d5da392,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-G3-A7M5_treatment_1,,,no,2019-04-28T13:22:25.390983-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:27.936420-05:00,released,b5083b7e-110d-5bf0-846c-e008d2dc55b6\\r\\n,TCGA-2Y-A9GY_demographic,daa0a695-ef27-59d5-9200-d09348d895b1,8170/3,TCGA-2Y-A9GY,,\"Hepatocellular carcinoma, NOS\",75030b63-59af-4705-86e7-3a431b7cf65a,released,,no,23435,1943,,,female,not reported,not reported,75030b63-59af-4705-86e7-3a431b7cf65a,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:21:24.846050-05:00,stage ii,c5e4ec82-2342-5eed-a751-2cf22030a7b0,TCGA-2Y-A9GY_diagnosis,white,not reported,Liver,TCGA-2Y-A9GY_treatment_1,10c84bc8-9b57-599a-9e80-2018b0d26cae,no,2009,,Liver,released,not reported,2019-04-28T13:21:24.846050-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-2Y-A9GY_treatment,,,no,2019-04-28T13:21:24.846050-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:35.448559-05:00,released,664622da-fa94-5053-8b47-683f1f85dffc\\r\\n,TCGA-BC-A10Z_demographic,8f281926-ea8f-552c-bdd2-5be8ab9604d8,8170/3,TCGA-BC-A10Z,,\"Hepatocellular carcinoma, NOS\",709f1e4d-f5e8-4a0b-8254-23f037f4bae7,released,,no,22913,1941,,,female,not reported,not reported,709f1e4d-f5e8-4a0b-8254-23f037f4bae7,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:21:07.396438-05:00,stage i,bff2643f-6fb9-556c-9bcb-b6a9f0d91f69,TCGA-BC-A10Z_diagnosis,white,not reported,Liver,TCGA-BC-A10Z_treatment_1,bb23023f-782a-51c3-bb36-ed7952793897,no,2003,,Liver,released,not reported,2019-04-28T13:21:07.396438-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-BC-A10Z_treatment,,,no,2019-04-28T13:21:07.396438-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:35.448559-05:00,released,19a30c64-abf7-560f-a1e1-e06e2109bb17\\r\\n,TCGA-DD-AAC9_demographic,20b21ab7-f9bf-5fb8-8776-f4a03156bdaa,8170/3,TCGA-DD-AAC9,,\"Hepatocellular carcinoma, NOS\",ac6a1e0c-dba0-4b21-b12b-a501ed796bec,released,,no,18911,1957,,347,male,not reported,not reported,ac6a1e0c-dba0-4b21-b12b-a501ed796bec,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:24:39.862702-05:00,stage i,138c0d42-3dcb-52a0-957a-7e1bfb169160,TCGA-DD-AAC9_diagnosis,asian,not reported,Liver,TCGA-DD-AAC9_treatment_1,c031bd4a-7e0b-54b6-972d-322ed7399f8b,no,,,Liver,released,not reported,2019-04-28T13:24:39.862702-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AAC9_treatment,,,no,2019-04-28T13:24:39.862702-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:42.289685-05:00,released,c6618598-9de9-57bf-a3c7-792157d79480\\r\\n,TCGA-DD-AAD3_demographic,69199fab-a68b-52ec-a4f1-65e572f1e5fd,8170/3,TCGA-DD-AAD3,,\"Hepatocellular carcinoma, NOS\",0d13229a-304a-48a6-a761-12e68e94a4b4,released,2019-04-28T13:14:38.545766-05:00,no,15706,1968,,1295,male,not reported,not reported,0d13229a-304a-48a6-a761-12e68e94a4b4,2019-04-28T13:14:38.545766-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,452fae1e-bf14-5590-a5f8-0957a96176cd,TCGA-DD-AAD3_diagnosis,asian,not reported,Liver,TCGA-DD-AAD3_treatment,82332c6d-d5e4-5529-873f-45bd6e1d72cb,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AAD3_treatment_1,,,no,2019-04-28T13:14:38.545766-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:42.289685-05:00,released,4be1f0af-dbf9-50c3-9af4-50dc420972c9\\r\\n,TCGA-DD-AACM_demographic,efce1219-65c7-58d2-87aa-b3e2004df13c,8170/3,TCGA-DD-AACM,,\"Hepatocellular carcinoma, NOS\",173088ed-6bc0-4ccf-80e7-c647028cccd6,released,,no,17590,1961,,1769,male,not reported,not reported,173088ed-6bc0-4ccf-80e7-c647028cccd6,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:15:14.619199-05:00,stage ii,a844a1a5-84ed-52ce-8dff-2ad0fc7ab5dd,TCGA-DD-AACM_diagnosis,asian,not reported,Liver,TCGA-DD-AACM_treatment_1,1f6cebd3-49be-5937-a400-e954a622e861,no,,,Liver,released,not reported,2019-04-28T13:15:14.619199-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AACM_treatment,,,no,2019-04-28T13:15:14.619199-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:42.289685-05:00,released,e3e9ef51-9cce-5333-8fad-12d1b93ec32c\\r\\n,TCGA-DD-AADD_demographic,3f44ef01-acec-5924-a81a-488d25fd090a,8170/3,TCGA-DD-AADD,,\"Hepatocellular carcinoma, NOS\",b44f664c-444c-4c64-a407-52fd9b55f178,released,,no,18752,1960,,1231,male,not reported,not reported,b44f664c-444c-4c64-a407-52fd9b55f178,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:25:08.549315-05:00,stage i,46e42878-9806-5929-8236-2c610eace239,TCGA-DD-AADD_diagnosis,asian,not reported,Liver,TCGA-DD-AADD_treatment_1,bb2c804e-f198-570e-9e51-533c2b8a7125,no,,,Liver,released,not reported,2019-04-28T13:25:08.549315-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AADD_treatment,,,no,2019-04-28T13:25:08.549315-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:42.289685-05:00,released,f15f1f24-0a27-5b52-bc11-4be3af5ae3a5\\r\\n,TCGA-DD-AACV_demographic,6f71e462-7db6-538f-8968-81f8a0df757d,8170/3,TCGA-DD-AACV,,\"Hepatocellular carcinoma, NOS\",8e79ea29-787e-4a33-8465-9891776f47ed,released,,no,19660,1957,,1531,male,not reported,not reported,8e79ea29-787e-4a33-8465-9891776f47ed,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:22:58.534619-05:00,stage i,6a31c939-b07c-51c7-b570-f80c4f709ee2,TCGA-DD-AACV_diagnosis,asian,not reported,Liver,TCGA-DD-AACV_treatment_1,5b99f699-79c3-5312-872d-6072ece76fe1,no,,,Liver,released,not reported,2019-04-28T13:22:58.534619-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AACV_treatment,,,no,2019-04-28T13:22:58.534619-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:42.289685-05:00,released,9534432f-5dce-529e-b8be-138825b11a85\\r\\n,TCGA-QA-A7B7_demographic,bf095257-ede1-5aa0-9ef4-6f9d402bfd1a,8170/3,TCGA-QA-A7B7,,\"Hepatocellular carcinoma, NOS\",b0952fd6-62ee-44ef-9a2a-e5262ed4721a,released,2019-04-28T13:25:01.280949-05:00,no,17636,1965,,94,male,not reported,not reported,b0952fd6-62ee-44ef-9a2a-e5262ed4721a,2019-04-28T13:25:01.280949-05:00,released,2019-05-03T14:06:23.922205-05:00,stage ii,86d4c282-bf2c-55ac-afad-bd17600fe760,TCGA-QA-A7B7_diagnosis,black or african american,not reported,Liver,TCGA-QA-A7B7_treatment,2a8ce8d9-6238-56be-aab2-eb2703e5b69d,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-QA-A7B7_treatment_1,,,no,2019-04-28T13:25:01.280949-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:53.093878-05:00,released,493da4da-97b5-5214-8298-f2ba922ac332\\r\\n,TCGA-RC-A7SH_demographic,abc07694-9dce-5863-a7c6-6008ad0ef0a8,8174/3,TCGA-RC-A7SH,,\"Hepatocellular carcinoma, clear cell type\",32a98b3d-4cbd-4dcc-ac71-428fafc5e1c3,released,,no,15560,1970,,468,male,not reported,not reported,32a98b3d-4cbd-4dcc-ac71-428fafc5e1c3,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:16:59.406028-05:00,stage ii,cdcfe3e9-5381-5ce5-8aeb-265dd78dfe04,TCGA-RC-A7SH_diagnosis,asian,not reported,Liver,TCGA-RC-A7SH_treatment_1,91103ae7-b037-5d3c-a3d8-e1ee96e86983,yes,,,Liver,released,not reported,2019-04-28T13:16:59.406028-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-RC-A7SH_treatment,,,no,2019-04-28T13:16:59.406028-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:53.093878-05:00,released,8fcae704-3ad3-560b-85f6-e57d1334d0a2\\r\\n,TCGA-DD-A11A_demographic,f44ad2d1-7794-5942-9e06-239049fca86a,8170/3,TCGA-DD-A11A,,\"Hepatocellular carcinoma, NOS\",609c82fd-eb3a-46d7-8c09-0cde281a50b3,released,,not reported,24646,1937,,79,male,not reported,not reported,609c82fd-eb3a-46d7-8c09-0cde281a50b3,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:20:14.717632-05:00,stage i,87696326-e4ca-5eea-bc6f-37bab4e03549,TCGA-DD-A11A_diagnosis,black or african american,not reported,Liver,TCGA-DD-A11A_treatment_1,88ead5d2-db40-5913-8675-ada85007c3f2,not reported,,,Liver,released,not reported,2019-04-28T13:20:14.717632-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A11A_treatment,,,no,2019-04-28T13:20:14.717632-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:58.071505-05:00,released,339501de-3a0b-5b9c-b7a6-e7175c2b1f88\\r\\n,TCGA-2Y-A9H9_demographic,982687d0-9c05-56dc-9122-ab994752b558,8170/3,TCGA-2Y-A9H9,,\"Hepatocellular carcinoma, NOS\",efc3e5e4-0d8e-4bef-a259-29f8ed21684f,released,,no,25670,1941,,697,male,not reported,not reported,efc3e5e4-0d8e-4bef-a259-29f8ed21684f,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:28:06.383311-05:00,stage i,88020936-8e46-5821-9268-50599a85b42f,TCGA-2Y-A9H9_diagnosis,white,not reported,Liver,TCGA-2Y-A9H9_treatment_1,49298ff4-8b2b-5191-9639-aa3d3b2b8be6,yes,,,Liver,released,not reported,2019-04-28T13:28:06.383311-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-2Y-A9H9_treatment,,,no,2019-04-28T13:28:06.383311-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:35.448559-05:00,released,6ac7bded-7033-5085-80c4-0aa5c13f9df0\\r\\n,TCGA-FV-A495_demographic,9e52e4f0-3539-5983-a4b4-9aad0cf91639,8170/3,TCGA-FV-A495,,\"Hepatocellular carcinoma, NOS\",bd48fa5e-0152-46f0-a4fa-8cf723ff2dcd,released,,not reported,18740,1961,,1,female,not reported,not reported,bd48fa5e-0152-46f0-a4fa-8cf723ff2dcd,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:25:45.197711-05:00,stage ii,89d758b6-b3b5-59a8-a771-d151e4e0239a,TCGA-FV-A495_diagnosis,white,not reported,Liver,TCGA-FV-A495_treatment_1,49c4511c-5a3a-5922-b283-40b97e8cf947,not reported,,,Liver,released,not reported,2019-04-28T13:25:45.197711-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-FV-A495_treatment,,,no,2019-04-28T13:25:45.197711-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:27.936420-05:00,released,6fc25754-e068-5055-9415-c5c4998833ea\\r\\n,TCGA-WX-AA46_demographic,4d2efd8f-1bb4-56bc-a3c8-4bcba702e477,8170/3,TCGA-WX-AA46,,\"Hepatocellular carcinoma, NOS\",02c41e28-cf14-42e2-9e15-f43248ae16e0,released,,no,22639,1951,,756,male,not reported,not reported,02c41e28-cf14-42e2-9e15-f43248ae16e0,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:14:05.656868-05:00,stage ii,8a4d36ff-b609-5195-870c-62f8ce57ffe2,TCGA-WX-AA46_diagnosis,white,not reported,Liver,TCGA-WX-AA46_treatment_1,230aff98-3b37-5045-9d99-00d0a97dac8b,no,,,Liver,released,not reported,2019-04-28T13:14:05.656868-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-WX-AA46_treatment,,,no,2019-04-28T13:14:05.656868-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:38:16.668337-05:00,released,2890b424-9da5-5bd4-a7fe-fa4ca13ef8fe\\r\\n,TCGA-DD-A39X_demographic,f84bf328-9e82-57c1-9f91-0136dcd101c1,8170/3,TCGA-DD-A39X,,\"Hepatocellular carcinoma, NOS\",0d0a10b4-7b99-4043-a129-89844f258156,released,,no,28528,1920,,,female,not reported,not reported,0d0a10b4-7b99-4043-a129-89844f258156,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:14:35.955179-05:00,stage i,14285756-ee92-5321-baf4-7baeb57fcd3d,TCGA-DD-A39X_diagnosis,white,not reported,Liver,TCGA-DD-A39X_treatment_1,d4d14df0-f983-59a7-960a-6ba4c4ba534b,no,2002,,Liver,released,not reported,2019-04-28T13:14:35.955179-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A39X_treatment,,,no,2019-04-28T13:14:35.955179-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:19.490721-05:00,released,21ec3225-d38b-5553-b8da-600fa798c93d\\r\\n,TCGA-DD-AAVV_demographic,34112f34-2e0c-5714-a700-922ec228fe37,8170/3,TCGA-DD-AAVV,,\"Hepatocellular carcinoma, NOS\",915f531b-8448-41c7-9dfb-9c83062b906e,released,,no,20751,1951,,2455,male,not reported,not reported,915f531b-8448-41c7-9dfb-9c83062b906e,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:23:06.012957-05:00,stage ii,c01dd726-4fab-5ae4-bfff-895f0a481bcb,TCGA-DD-AAVV_diagnosis,asian,not reported,Liver,TCGA-DD-AAVV_treatment_1,2873da34-451b-58c2-8641-0ad02da0da6a,no,,,Liver,released,not reported,2019-04-28T13:23:06.012957-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AAVV_treatment,,,no,2019-04-28T13:23:06.012957-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:05.743590-05:00,released,3362c47f-03c1-5430-a68b-a39e5c212d8e\\r\\n,TCGA-CC-A3MA_demographic,9c105fe9-f28a-5e89-98ea-99dbf7f8d006,8170/3,TCGA-CC-A3MA,,\"Hepatocellular carcinoma, NOS\",613ddb95-14d7-4941-b374-fb5cd344d1bb,released,2019-04-28T13:20:19.800627-05:00,no,22375,1950,,2,male,not reported,not reported,613ddb95-14d7-4941-b374-fb5cd344d1bb,2019-04-28T13:20:19.800627-05:00,released,2019-05-03T14:06:23.922205-05:00,stage iiia,c086678d-23f7-5bdc-aaed-a04203dda6e5,TCGA-CC-A3MA_diagnosis,asian,not reported,Liver,TCGA-CC-A3MA_treatment,e63cf1ba-c70d-5103-9d2e-9aeb32f2af0c,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-CC-A3MA_treatment_1,,,no,2019-04-28T13:20:19.800627-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:58.071505-05:00,released,3211ef1e-4cf3-59e7-81fc-25a5653b9f8d\\r\\n,TCGA-BD-A2L6_demographic,4d2ad91a-b2e5-5896-a429-8e45238063b5,8170/3,TCGA-BD-A2L6,,\"Hepatocellular carcinoma, NOS\",13a97cee-76b0-46a1-b728-d87b2248311e,released,2019-04-28T13:15:05.220740-05:00,yes,25489,1942,,1363,male,not reported,not reported,13a97cee-76b0-46a1-b728-d87b2248311e,2019-04-28T13:15:05.220740-05:00,released,2019-05-03T14:06:23.922205-05:00,not reported,f01e182f-75b1-5175-8300-f88362eaf7f8,TCGA-BD-A2L6_diagnosis,white,not reported,Liver,TCGA-BD-A2L6_treatment,7d79704f-013a-5cd8-8b88-5e628c48e98c,no,,,Liver,released,not reported,,,not reported,released,Adenomas and Adenocarcinomas,TCGA-BD-A2L6_treatment_1,,,no,2019-04-28T13:15:05.220740-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:58.071505-05:00,released,3c88b7c6-5a66-5208-a63a-772cdb17d7a9\\r\\n,TCGA-ES-A2HS_demographic,c635775b-a557-5f40-a3d8-4ceba8b33402,8170/3,TCGA-ES-A2HS,,\"Hepatocellular carcinoma, NOS\",728aedb3-551a-4c16-9be3-7733a9539e9e,released,,not reported,29268,1928,,,male,not reported,not reported,728aedb3-551a-4c16-9be3-7733a9539e9e,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:21:19.604584-05:00,stage i,f096ed9b-394b-562e-a1fd-4c5e5ad12025,TCGA-ES-A2HS_diagnosis,white,not reported,Liver,TCGA-ES-A2HS_treatment_1,ac787945-9ff5-5d5a-9519-be024b613b9c,not reported,2009,,Liver,released,not reported,2019-04-28T13:21:19.604584-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-ES-A2HS_treatment,,,yes,2019-04-28T13:21:19.604584-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:27.936420-05:00,released,0c6132d7-2dd7-5a52-8016-3e58a895e260\\r\\n,TCGA-2Y-A9H3_demographic,9a33c592-f976-5c75-a337-102c3f1cbc73,8170/3,TCGA-2Y-A9H3,,\"Hepatocellular carcinoma, NOS\",9b69d7f9-38eb-48e1-bdc0-a092a53bc709,released,2019-04-28T13:23:43.843367-05:00,no,16443,1965,,1516,male,not reported,not reported,9b69d7f9-38eb-48e1-bdc0-a092a53bc709,2019-04-28T13:23:43.843367-05:00,released,2019-05-03T14:06:23.922205-05:00,stage ii,8bc31039-d1df-5913-89d3-785c410e20be,TCGA-2Y-A9H3_diagnosis,white,not reported,Liver,TCGA-2Y-A9H3_treatment,0b94912a-d1e8-5a02-a067-bc00c4629294,no,,,Liver,released,not reported,,,hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-2Y-A9H3_treatment_1,,,no,2019-04-28T13:23:43.843367-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:35.448559-05:00,released,16a1c699-da5b-5f3a-a2bf-5c8b7312254c\\r\\n,TCGA-DD-AADV_demographic,ce3b7c8d-1ad4-56d2-98de-4a054082ad52,8170/3,TCGA-DD-AADV,,\"Hepatocellular carcinoma, NOS\",4c78b999-4797-4e19-8bc5-9ffd01cf768a,released,2019-04-28T13:18:57.078851-05:00,no,18300,1963,,574,male,not reported,not reported,4c78b999-4797-4e19-8bc5-9ffd01cf768a,2019-04-28T13:18:57.078851-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,778d7ca6-3919-59bc-a86d-399fbb8aab2d,TCGA-DD-AADV_diagnosis,asian,not reported,Liver,TCGA-DD-AADV_treatment,7f1e65cb-1149-52fd-b821-1412fb47eea3,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AADV_treatment_1,,,yes,2019-04-28T13:18:57.078851-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:05.743590-05:00,released,10246dd2-3101-5b91-b5cb-92bf89f1ba6f\\r\\n,TCGA-DD-AAD1_demographic,3e3754e3-7fe0-51f3-834c-f89117e3ce43,8170/3,TCGA-DD-AAD1,,\"Hepatocellular carcinoma, NOS\",1f482810-433a-4d46-b81b-f7909fff8c09,released,,no,18794,1959,,564,female,not reported,not reported,1f482810-433a-4d46-b81b-f7909fff8c09,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:15:56.343125-05:00,stage i,f15ce944-83d8-507b-ba1a-06bda29fc550,TCGA-DD-AAD1_diagnosis,asian,not reported,Liver,TCGA-DD-AAD1_treatment_1,40281c77-f336-5a40-bba3-d3caa131802e,no,,,Liver,released,not reported,2019-04-28T13:15:56.343125-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AAD1_treatment,,,no,2019-04-28T13:15:56.343125-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:42.289685-05:00,released,12e352e9-2a1d-5f2c-a0e5-ab7dde6984e3\\r\\n,TCGA-5C-A9VG_demographic,b98a532e-fbf2-52ca-acbf-125e68b933d7,8170/3,TCGA-5C-A9VG,,\"Hepatocellular carcinoma, NOS\",073e51f9-fb79-4a5f-9ba0-2c9af03c0b85,released,2019-04-28T13:14:15.466124-05:00,no,21273,1955,,328,male,not reported,not reported,073e51f9-fb79-4a5f-9ba0-2c9af03c0b85,2019-04-28T13:14:15.466124-05:00,released,2019-05-03T14:06:23.922205-05:00,stage ii,8bdfdcb9-fb08-56ef-8853-e18adc16d27b,TCGA-5C-A9VG_diagnosis,white,not reported,Liver,TCGA-5C-A9VG_treatment,c639e546-4512-599f-b557-d5a58db480f7,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-5C-A9VG_treatment_1,,,no,2019-04-28T13:14:15.466124-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:35.448559-05:00,released,8b7cabfd-f835-5ec8-aab5-b8d7bdecbd18\\r\\n,TCGA-DD-AACN_demographic,3c6b1028-4ccb-5fd2-a79f-ae71f07087a0,8170/3,TCGA-DD-AACN,,\"Hepatocellular carcinoma, NOS\",0afd4283-7311-4d69-a2f5-779628da45fc,released,,no,12007,1977,,1302,male,not reported,not reported,0afd4283-7311-4d69-a2f5-779628da45fc,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:14:30.878300-05:00,stage i,f1d82c1b-24ac-5d83-abbf-0d45a0878557,TCGA-DD-AACN_diagnosis,asian,not reported,Liver,TCGA-DD-AACN_treatment_1,77bcde49-705c-596a-9568-51d2051be197,no,,,Liver,released,not reported,2019-04-28T13:14:30.878300-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AACN_treatment,,,no,2019-04-28T13:14:30.878300-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:42.289685-05:00,released,9188136b-c61d-5f22-a05c-3edcbad09118\\r\\n,TCGA-EP-A26S_demographic,a5240fac-a33a-5f14-b927-0d6ea82002ae,8170/3,TCGA-EP-A26S,,\"Hepatocellular carcinoma, NOS\",b7d6621c-8bce-4a01-8588-9d7761d9372b,released,2019-04-28T13:25:23.603057-05:00,no,25677,1941,,608,male,not reported,not reported,b7d6621c-8bce-4a01-8588-9d7761d9372b,2019-04-28T13:25:23.603057-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,f20d4db1-449f-59f2-96a1-f6f3a36077a8,TCGA-EP-A26S_diagnosis,white,not reported,Liver,TCGA-EP-A26S_treatment,b04764ed-fadf-5f28-aefc-ba455bbdd1bb,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-EP-A26S_treatment_1,,,no,2019-04-28T13:25:23.603057-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:27.936420-05:00,released,a2de1238-94b5-5d52-8181-80bdcc58079f\\r\\n,TCGA-DD-A113_demographic,b6c5c4dd-1297-5411-a868-a52f0f6e5d0a,8170/3,TCGA-DD-A113,,\"Hepatocellular carcinoma, NOS\",aeb17d2b-fa8c-4989-bf3a-d2c74b785455,released,,no,20188,1951,,2425,female,not reported,not reported,aeb17d2b-fa8c-4989-bf3a-d2c74b785455,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:24:52.008980-05:00,stage ii,8d334800-c998-53b0-aef0-1d38d31b7cc5,TCGA-DD-A113_diagnosis,white,not reported,Liver,TCGA-DD-A113_treatment_1,ffe4bce7-2bf3-5406-a014-04becdc91140,no,,,Liver,released,not reported,2019-04-28T13:24:52.008980-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A113_treatment,,,no,2019-04-28T13:24:52.008980-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:58.071505-05:00,released,45b4c855-7106-5443-8d8b-9ea54487c01d\\r\\n,TCGA-ZS-A9CD_demographic,4dc9899e-b05f-5da7-86a4-a69e24a5adfe,8170/3,TCGA-ZS-A9CD,,\"Hepatocellular carcinoma, NOS\",9197ca4c-e48c-43af-ba61-d894faf3cc24,released,2019-04-28T13:23:11.029260-05:00,no,26915,1937,,,male,not reported,not reported,9197ca4c-e48c-43af-ba61-d894faf3cc24,2019-04-28T13:23:11.029260-05:00,released,2019-05-03T14:06:23.922205-05:00,stage ii,f23ec093-178d-58d7-8ab2-523af687f18c,TCGA-ZS-A9CD_diagnosis,white,not reported,Liver,TCGA-ZS-A9CD_treatment,83d5c6f2-dcb9-52a9-a26e-fce6d7606dc1,no,2013,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-ZS-A9CD_treatment_1,,,no,2019-04-28T13:23:11.029260-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:38:16.668337-05:00,released,283a3b0b-e2d6-5d1a-b72c-cd771b4601e5\\r\\n,TCGA-DD-A3A2_demographic,e8e11166-5d08-517a-93c0-a6f78dd7282d,8170/3,TCGA-DD-A3A2,,\"Hepatocellular carcinoma, NOS\",357c1c08-f368-4cae-8f20-9be241b30479,released,2019-04-28T13:17:16.035452-05:00,no,27930,1922,,,female,not reported,not reported,357c1c08-f368-4cae-8f20-9be241b30479,2019-04-28T13:17:16.035452-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,8dcd4cdd-cf30-56b9-b51c-de453b9238a1,TCGA-DD-A3A2_diagnosis,white,not reported,Liver,TCGA-DD-A3A2_treatment,05abf7b4-1b17-5a89-bb20-822e6774c375,no,2003,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A3A2_treatment_1,,,no,2019-04-28T13:17:16.035452-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:19.490721-05:00,released,eb96e3e2-a930-5945-9c10-0d75aa9be49e\\r\\n,TCGA-DD-A3A1_demographic,e898b5c8-acba-5e06-bad8-6ca6db03ac44,8170/3,TCGA-DD-A3A1,,\"Hepatocellular carcinoma, NOS\",877b9f6b-9b34-40ed-933f-8fef204edf21,released,,no,24046,1936,,,male,not reported,not reported,877b9f6b-9b34-40ed-933f-8fef204edf21,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:22:34.942331-05:00,stage iiia,f3156e8e-02cf-517e-b665-40bcf923c69c,TCGA-DD-A3A1_diagnosis,not reported,not reported,Liver,TCGA-DD-A3A1_treatment_1,cf4d5896-daef-5ce7-bfa1-87a1d9bb7006,no,2001,,Liver,released,not reported,2019-04-28T13:22:34.942331-05:00,,not reported,released,Adenomas and Adenocarcinomas,TCGA-DD-A3A1_treatment,,,no,2019-04-28T13:22:34.942331-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:36:19.490721-05:00,released,5a4fc3a9-7086-575c-8a92-018f730fd31b\\r\\n,TCGA-ZP-A9D4_demographic,44a4d44e-d41e-59d7-8735-7c4d4d4aa336,8170/3,TCGA-ZP-A9D4,,\"Hepatocellular carcinoma, NOS\",4244912d-8527-410c-a084-a56c55eb1f82,released,2019-04-28T13:18:09.471305-05:00,no,23656,1948,,395,female,not reported,not reported,4244912d-8527-410c-a084-a56c55eb1f82,2019-04-28T13:18:09.471305-05:00,released,2019-05-03T14:06:23.922205-05:00,not reported,163831a0-3a6c-55bf-b7b0-a14b238ad5b9,TCGA-ZP-A9D4_diagnosis,white,not reported,Liver,TCGA-ZP-A9D4_treatment,3accafd5-6f9e-5607-94c4-da1eeff531a2,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-ZP-A9D4_treatment_1,,,no,2019-04-28T13:18:09.471305-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:38:16.668337-05:00,released,b5bbe886-025f-5e6e-9b5e-783e71e33feb\\r\\n,TCGA-ED-A5KG_demographic,61e120d0-3e8b-5d3a-a700-ef8b9107cf34,8170/3,TCGA-ED-A5KG,,\"Hepatocellular carcinoma, NOS\",cebdafee-8ffd-4ee2-8dd1-9225e06623c2,released,,no,22258,1952,,854,female,not reported,not reported,cebdafee-8ffd-4ee2-8dd1-9225e06623c2,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:26:43.489337-05:00,stage ii,ce28c953-29d2-5bf2-8d95-f8ecfa88c4b3,TCGA-ED-A5KG_diagnosis,asian,not reported,Liver,TCGA-ED-A5KG_treatment_1,4a2e4625-e86b-5c4e-91a1-8c27b84b816e,no,,,Liver,released,not reported,2019-04-28T13:26:43.489337-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-ED-A5KG_treatment,,,no,2019-04-28T13:26:43.489337-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:05.743590-05:00,released,616dc2a1-c1d8-5a97-9571-f9f75abdfc00\\r\\n,TCGA-CC-A3MB_demographic,b5978097-00e7-5737-b3a6-6058063d49ea,8170/3,TCGA-CC-A3MB,,\"Hepatocellular carcinoma, NOS\",2c53d48d-e3bc-49f3-bbe0-2eee24252b4c,released,,no,13255,1975,,3,male,not reported,not reported,2c53d48d-e3bc-49f3-bbe0-2eee24252b4c,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:16:40.169407-05:00,stage iiia,a88283d9-97ac-5553-9859-893f0fba8ba6,TCGA-CC-A3MB_diagnosis,asian,not reported,Liver,TCGA-CC-A3MB_treatment_1,8f63c79a-bb1a-5084-9065-995f4106783f,no,,,Liver,released,not reported,2019-04-28T13:16:40.169407-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-CC-A3MB_treatment,,,no,2019-04-28T13:16:40.169407-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:58.071505-05:00,released,146ff9ae-1d18-5ac0-bd6d-5903d5cdd830\\r\\n,TCGA-CC-A7IE_demographic,eed112c7-6efe-5028-b495-96da9e078409,8170/3,TCGA-CC-A7IE,,\"Hepatocellular carcinoma, NOS\",220f75d7-08a4-4936-b4b2-0750e87ccdf5,released,2019-04-28T13:16:05.980056-05:00,no,20985,1955,,0,male,not reported,not reported,220f75d7-08a4-4936-b4b2-0750e87ccdf5,2019-04-28T13:16:05.980056-05:00,released,2019-05-03T14:06:23.922205-05:00,stage iiia,2b503dc8-156a-5d28-bcd0-c8d45cde600a,TCGA-CC-A7IE_diagnosis,asian,not reported,Liver,TCGA-CC-A7IE_treatment,27e03db3-1b04-5a70-b2cc-f3df86f4a423,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-CC-A7IE_treatment_1,,,no,2019-04-28T13:16:05.980056-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:58.071505-05:00,released,95697307-934b-5779-91cf-fddd4a1cf3bf\\r\\n,TCGA-DD-AADQ_demographic,eb5ad258-996e-5fc9-be89-3a7e322c5878,8170/3,TCGA-DD-AADQ,,\"Hepatocellular carcinoma, NOS\",485d283a-552c-485a-84fb-3abdb98dc797,released,,no,21756,1954,,436,male,not reported,not reported,485d283a-552c-485a-84fb-3abdb98dc797,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:18:42.293199-05:00,stage ii,8fdb447a-5ad3-5028-8d10-bb3968df1008,TCGA-DD-AADQ_diagnosis,asian,not reported,Liver,TCGA-DD-AADQ_treatment_1,1cf84435-457c-5168-b1c5-38265983b8db,no,,,Liver,released,not reported,2019-04-28T13:18:42.293199-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AADQ_treatment,,,no,2019-04-28T13:18:42.293199-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:05.743590-05:00,released,1cc25911-88ca-5952-93ce-2f470964b055\\r\\n,TCGA-KR-A7K8_demographic,5bcd6913-4137-58f3-88fa-6636b5e48c57,8170/3,TCGA-KR-A7K8,,\"Hepatocellular carcinoma, NOS\",4b0e544c-4090-4ebb-b3e5-2623aa91356c,released,2019-04-28T13:18:51.969934-05:00,no,20914,1955,,906,male,not reported,not reported,4b0e544c-4090-4ebb-b3e5-2623aa91356c,2019-04-28T13:18:51.969934-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,5406aa28-ca22-5b48-a1ae-8d25c1b8d1d0,TCGA-KR-A7K8_diagnosis,not reported,not reported,Liver,TCGA-KR-A7K8_treatment,383ab90e-3bdd-5eb6-ad11-f752b062787a,no,,,Liver,released,not reported,,,not reported,released,Adenomas and Adenocarcinomas,TCGA-KR-A7K8_treatment_1,,,no,2019-04-28T13:18:51.969934-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:53.093878-05:00,released,5d00b529-0e89-581c-b51e-6a0223e8699f\\r\\n,TCGA-DD-AAW3_demographic,fcfb6d92-4761-5a9d-b6a0-1153f0bf381c,8170/3,TCGA-DD-AAW3,,\"Hepatocellular carcinoma, NOS\",564b4f4d-3c18-40d5-9d95-916774df600c,released,,no,25254,1940,,1633,male,not reported,not reported,564b4f4d-3c18-40d5-9d95-916774df600c,2019-05-03T14:06:23.922205-05:00,released,2019-04-28T13:19:40.113809-05:00,stage i,903f5e59-d587-5e6f-84f3-55704a5e628a,TCGA-DD-AAW3_diagnosis,asian,not reported,Liver,TCGA-DD-AAW3_treatment_1,369ba736-5109-5b44-a78e-e7ae45c73f57,no,,,Liver,released,not reported,2019-04-28T13:19:40.113809-05:00,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AAW3_treatment,,,no,2019-04-28T13:19:40.113809-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:05.743590-05:00,released,3b2bf89c-d479-5b23-8fa1-6c2c2149445e\\r\\n,TCGA-DD-AAVS_demographic,fd3a0556-8f6d-5500-acdc-9481f0588b1c,8170/3,TCGA-DD-AAVS,,\"Hepatocellular carcinoma, NOS\",9fc30c21-2c78-4843-a658-fe84a64b8fad,released,2019-04-28T13:23:51.044821-05:00,no,20586,1951,,1823,male,not reported,not reported,9fc30c21-2c78-4843-a658-fe84a64b8fad,2019-04-28T13:23:51.044821-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,90faead5-648b-520b-a775-ff57cf782f3c,TCGA-DD-AAVS_diagnosis,asian,not reported,Liver,TCGA-DD-AAVS_treatment,d8195d86-674c-539f-831a-5d3cf248b568,no,,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-AAVS_treatment_1,,,no,2019-04-28T13:23:51.044821-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:37:05.743590-05:00,released,cfdb5ea1-0bdc-5d21-ac75-222ba8a3ecac\\r\\n,TCGA-DD-A1E9_demographic,15319954-3dfe-5ebc-aa9c-cf5b252ba6f8,8170/3,TCGA-DD-A1E9,,\"Hepatocellular carcinoma, NOS\",8153a862-0790-4a33-80db-ed47fedcd4ef,released,2019-04-28T13:22:10.841143-05:00,no,25808,1932,,,male,not reported,not reported,8153a862-0790-4a33-80db-ed47fedcd4ef,2019-04-28T13:22:10.841143-05:00,released,2019-05-03T14:06:23.922205-05:00,stage i,90ff2170-0d7d-592c-a1b1-616cc191cad0,TCGA-DD-A1E9_diagnosis,white,not reported,Liver,TCGA-DD-A1E9_treatment,00756a7d-2aaf-5b86-be98-078ceaf16a70,no,2009,,Liver,released,not reported,,,not hispanic or latino,released,Adenomas and Adenocarcinomas,TCGA-DD-A1E9_treatment_1,,,no,2019-04-28T13:22:10.841143-05:00,Liver and intrahepatic bile ducts,,2019-05-01T12:35:58.071505-05:00,released,c5e2522d-c8c5-5581-9304-0e08e7f67d57\\r\\n'\n"
     ]
    }
   ],
   "source": [
    "cases_endpt = 'https://api.gdc.cancer.gov/cases'\n",
    "proj_endpt = 'https://api.gdc.cancer.gov/projects/TCGA-LIHC?expand=summary,summary.experimental_strategies,summary.data_categories&pretty=true'\n",
    "\n",
    "# The 'fields' parameter is passed as a comma-separated string of single names.\n",
    "fields = [\n",
    "    \"submitter_id\",\n",
    "    \"case_id\",\n",
    "    \"primary_site\",\n",
    "    \"disease_type\",\n",
    "    \"vital_status\",\n",
    "    'cases.diagnoses.state',\n",
    "    'state',\n",
    "    'demographic.created_datetime',\n",
    "'demographic.demographic_id',\n",
    "'demographic.ethnicity',\n",
    "'demographic.gender',\n",
    "'demographic.race',\n",
    "'demographic.state',\n",
    "'demographic.submitter_id',\n",
    "'demographic.updated_datetime',\n",
    "'demographic.year_of_birth',\n",
    "'demographic.year_of_death',\n",
    "'diagnoses.age_at_diagnosis',\n",
    "'diagnoses.classification_of_tumor',\n",
    "'diagnoses.created_datetime',\n",
    "'diagnoses.days_to_birth',\n",
    "'diagnoses.days_to_death',\n",
    "'diagnoses.days_to_last_follow_up',\n",
    "'diagnoses.days_to_last_known_disease_status',\n",
    "'diagnoses.days_to_recurrence',\n",
    "'diagnoses.diagnosis_id',\n",
    "'diagnoses.last_known_disease_status',\n",
    "'diagnoses.morphology',\n",
    "'diagnoses.primary_diagnosis',\n",
    "'diagnoses.prior_malignancy',\n",
    "'diagnoses.progression_or_recurrence',\n",
    "'diagnoses.site_of_resection_or_biopsy',\n",
    "'diagnoses.state',\n",
    "'diagnoses.submitter_id',\n",
    "'diagnoses.tissue_or_organ_of_origin',\n",
    "'diagnoses.tumor_grade',\n",
    "'diagnoses.tumor_stage',\n",
    "'diagnoses.updated_datetime',\n",
    "'diagnoses.vital_status',\n",
    "'diagnoses.treatments.created_datetime',\n",
    "'diagnoses.treatments.days_to_treatment',\n",
    "'diagnoses.treatments.state',\n",
    "'diagnoses.treatments.submitter_id',\n",
    "'diagnoses.treatments.therapeutic_agents',\n",
    "'diagnoses.treatments.treatment_id',\n",
    "'diagnoses.treatments.treatment_intent_type',\n",
    "'diagnoses.treatments.treatment_or_therapy',\n",
    "'diagnoses.treatments.updated_datetime',\n",
    "    ]\n",
    "\n",
    "fields = ','.join(fields)\n",
    "\n",
    "filters = {\n",
    "    \"op\": \"and\",\n",
    "    \"content\":[\n",
    "        {\n",
    "        \"op\": \"in\",\n",
    "        \"content\":{\n",
    "            \"field\": \"cases.project.primary_site\",\n",
    "            \"value\": [\"Liver and intrahepatic bile ducts\"]\n",
    "            }\n",
    "        },\n",
    "#         {\n",
    "#         \"op\": \"in\",\n",
    "#         \"content\":{\n",
    "#             \"field\": \"files.experimental_strategy\",\n",
    "#             \"value\": [\"RNA-Seq\"]\n",
    "#             }\n",
    "#         },\n",
    "        {\n",
    "        \"op\": \"in\",\n",
    "        \"content\":{\n",
    "            \"field\": \"cases.project.project_id\",\n",
    "            \"value\": [\"TCGA-LIHC\"]\n",
    "            }\n",
    "        }\n",
    "    ]\n",
    "}\n",
    "\n",
    "params = {\n",
    "    \"filters\": json.dumps(filters),\n",
    "    \"fields\": fields,\n",
    "    \"format\": \"csv\",\n",
    "    \"size\": \"1000\",\n",
    "    }\n",
    "\n",
    "\n",
    "response = requests.get(cases_endpt, params = params)\n",
    "\n",
    "print(response.content)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 78,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>diagnoses.days_to_recurrence</th>\n",
       "      <th>demographic.submitter_id</th>\n",
       "      <th>diagnoses.treatments.treatment_id</th>\n",
       "      <th>diagnoses.morphology</th>\n",
       "      <th>submitter_id</th>\n",
       "      <th>diagnoses.treatments.treatment_intent_type</th>\n",
       "      <th>diagnoses.primary_diagnosis</th>\n",
       "      <th>id</th>\n",
       "      <th>diagnoses.treatments.state</th>\n",
       "      <th>diagnoses.treatments.created_datetime</th>\n",
       "      <th>...</th>\n",
       "      <th>diagnoses.treatments.submitter_id</th>\n",
       "      <th>demographic.created_datetime</th>\n",
       "      <th>diagnoses.treatments.treatment_intent_type</th>\n",
       "      <th>diagnoses.prior_malignancy</th>\n",
       "      <th>demographic.updated_datetime</th>\n",
       "      <th>primary_site</th>\n",
       "      <th>diagnoses.treatments.therapeutic_agents</th>\n",
       "      <th>diagnoses.updated_datetime</th>\n",
       "      <th>demographic.state</th>\n",
       "      <th>diagnoses.treatments.treatment_id</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>TCGA-DD-AADM_demographic</td>\n",
       "      <td>d2011ad3-bbca-5f2a-a646-4c39ab7f6e50</td>\n",
       "      <td>8170/3</td>\n",
       "      <td>TCGA-DD-AADM</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Hepatocellular carcinoma, NOS</td>\n",
       "      <td>62c02da8-e4b4-4294-9923-8992d187fc7b</td>\n",
       "      <td>released</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>TCGA-DD-AADM_treatment</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>no</td>\n",
       "      <td>2019-04-28T13:20:26.737322-05:00</td>\n",
       "      <td>Liver and intrahepatic bile ducts</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2019-05-01T12:36:42.289685-05:00</td>\n",
       "      <td>released</td>\n",
       "      <td>fa555b9e-bfc5-5c0e-9e23-c71a219985cc</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>TCGA-MR-A520_demographic</td>\n",
       "      <td>e4c42bee-c60c-55e3-ab8a-b0466b7800d3</td>\n",
       "      <td>8170/3</td>\n",
       "      <td>TCGA-MR-A520</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Hepatocellular carcinoma, NOS</td>\n",
       "      <td>25e893ad-a0fd-45ae-9aa9-9bcd7c2ec8e5</td>\n",
       "      <td>released</td>\n",
       "      <td>2019-04-28T13:16:22.558732-05:00</td>\n",
       "      <td>...</td>\n",
       "      <td>TCGA-MR-A520_treatment_1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>no</td>\n",
       "      <td>2019-04-28T13:16:22.558732-05:00</td>\n",
       "      <td>Liver and intrahepatic bile ducts</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2019-05-01T12:37:53.093878-05:00</td>\n",
       "      <td>released</td>\n",
       "      <td>e318f368-87c5-5de7-8ca3-c799aeeb0cdd</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2</td>\n",
       "      <td>NaN</td>\n",
       "      <td>TCGA-DD-AAW2_demographic</td>\n",
       "      <td>a4ac4bf7-2759-5302-91d3-a0b1d7324c02</td>\n",
       "      <td>8170/3</td>\n",
       "      <td>TCGA-DD-AAW2</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Hepatocellular carcinoma, NOS</td>\n",
       "      <td>03df105e-a005-4577-bfdb-9644758d778e</td>\n",
       "      <td>released</td>\n",
       "      <td>2019-04-28T13:14:08.134677-05:00</td>\n",
       "      <td>...</td>\n",
       "      <td>TCGA-DD-AAW2_treatment_1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>no</td>\n",
       "      <td>2019-04-28T13:14:08.134677-05:00</td>\n",
       "      <td>Liver and intrahepatic bile ducts</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2019-05-01T12:37:05.743590-05:00</td>\n",
       "      <td>released</td>\n",
       "      <td>9bd0e639-14db-5b89-b0a4-f4784e34bc2e</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>3</td>\n",
       "      <td>NaN</td>\n",
       "      <td>TCGA-2Y-A9GZ_demographic</td>\n",
       "      <td>2e637e2b-6f22-5a1c-91cf-c925926755a0</td>\n",
       "      <td>8170/3</td>\n",
       "      <td>TCGA-2Y-A9GZ</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Hepatocellular carcinoma, NOS</td>\n",
       "      <td>0e8c3831-def9-4efa-9f93-8942072d6a77</td>\n",
       "      <td>released</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>TCGA-2Y-A9GZ_treatment</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>no</td>\n",
       "      <td>2019-04-28T13:14:41.005191-05:00</td>\n",
       "      <td>Liver and intrahepatic bile ducts</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2019-05-01T12:35:35.448559-05:00</td>\n",
       "      <td>released</td>\n",
       "      <td>fae58ba4-ab4b-5145-8e0f-be4a51af8e7d</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>4</td>\n",
       "      <td>NaN</td>\n",
       "      <td>TCGA-LG-A6GG_demographic</td>\n",
       "      <td>6fe0674b-d337-5cc1-8132-67a443930c31</td>\n",
       "      <td>8170/3</td>\n",
       "      <td>TCGA-LG-A6GG</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Hepatocellular carcinoma, NOS</td>\n",
       "      <td>c618da6d-3c66-4a6a-8832-3526a3b75410</td>\n",
       "      <td>released</td>\n",
       "      <td>2019-04-28T13:26:16.469340-05:00</td>\n",
       "      <td>...</td>\n",
       "      <td>TCGA-LG-A6GG_treatment_1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>yes</td>\n",
       "      <td>2019-04-28T13:26:16.469340-05:00</td>\n",
       "      <td>Liver and intrahepatic bile ducts</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2019-05-01T12:37:53.093878-05:00</td>\n",
       "      <td>released</td>\n",
       "      <td>4d1b37ee-01fd-5145-8848-1ab507e09597</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>372</td>\n",
       "      <td>NaN</td>\n",
       "      <td>TCGA-DD-AADQ_demographic</td>\n",
       "      <td>eb5ad258-996e-5fc9-be89-3a7e322c5878</td>\n",
       "      <td>8170/3</td>\n",
       "      <td>TCGA-DD-AADQ</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Hepatocellular carcinoma, NOS</td>\n",
       "      <td>485d283a-552c-485a-84fb-3abdb98dc797</td>\n",
       "      <td>released</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>TCGA-DD-AADQ_treatment</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>no</td>\n",
       "      <td>2019-04-28T13:18:42.293199-05:00</td>\n",
       "      <td>Liver and intrahepatic bile ducts</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2019-05-01T12:37:05.743590-05:00</td>\n",
       "      <td>released</td>\n",
       "      <td>1cc25911-88ca-5952-93ce-2f470964b055</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>373</td>\n",
       "      <td>NaN</td>\n",
       "      <td>TCGA-KR-A7K8_demographic</td>\n",
       "      <td>5bcd6913-4137-58f3-88fa-6636b5e48c57</td>\n",
       "      <td>8170/3</td>\n",
       "      <td>TCGA-KR-A7K8</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Hepatocellular carcinoma, NOS</td>\n",
       "      <td>4b0e544c-4090-4ebb-b3e5-2623aa91356c</td>\n",
       "      <td>released</td>\n",
       "      <td>2019-04-28T13:18:51.969934-05:00</td>\n",
       "      <td>...</td>\n",
       "      <td>TCGA-KR-A7K8_treatment_1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>no</td>\n",
       "      <td>2019-04-28T13:18:51.969934-05:00</td>\n",
       "      <td>Liver and intrahepatic bile ducts</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2019-05-01T12:37:53.093878-05:00</td>\n",
       "      <td>released</td>\n",
       "      <td>5d00b529-0e89-581c-b51e-6a0223e8699f</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>374</td>\n",
       "      <td>NaN</td>\n",
       "      <td>TCGA-DD-AAW3_demographic</td>\n",
       "      <td>fcfb6d92-4761-5a9d-b6a0-1153f0bf381c</td>\n",
       "      <td>8170/3</td>\n",
       "      <td>TCGA-DD-AAW3</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Hepatocellular carcinoma, NOS</td>\n",
       "      <td>564b4f4d-3c18-40d5-9d95-916774df600c</td>\n",
       "      <td>released</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>TCGA-DD-AAW3_treatment</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>no</td>\n",
       "      <td>2019-04-28T13:19:40.113809-05:00</td>\n",
       "      <td>Liver and intrahepatic bile ducts</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2019-05-01T12:37:05.743590-05:00</td>\n",
       "      <td>released</td>\n",
       "      <td>3b2bf89c-d479-5b23-8fa1-6c2c2149445e</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>375</td>\n",
       "      <td>NaN</td>\n",
       "      <td>TCGA-DD-AAVS_demographic</td>\n",
       "      <td>fd3a0556-8f6d-5500-acdc-9481f0588b1c</td>\n",
       "      <td>8170/3</td>\n",
       "      <td>TCGA-DD-AAVS</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Hepatocellular carcinoma, NOS</td>\n",
       "      <td>9fc30c21-2c78-4843-a658-fe84a64b8fad</td>\n",
       "      <td>released</td>\n",
       "      <td>2019-04-28T13:23:51.044821-05:00</td>\n",
       "      <td>...</td>\n",
       "      <td>TCGA-DD-AAVS_treatment_1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>no</td>\n",
       "      <td>2019-04-28T13:23:51.044821-05:00</td>\n",
       "      <td>Liver and intrahepatic bile ducts</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2019-05-01T12:37:05.743590-05:00</td>\n",
       "      <td>released</td>\n",
       "      <td>cfdb5ea1-0bdc-5d21-ac75-222ba8a3ecac</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>376</td>\n",
       "      <td>NaN</td>\n",
       "      <td>TCGA-DD-A1E9_demographic</td>\n",
       "      <td>15319954-3dfe-5ebc-aa9c-cf5b252ba6f8</td>\n",
       "      <td>8170/3</td>\n",
       "      <td>TCGA-DD-A1E9</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Hepatocellular carcinoma, NOS</td>\n",
       "      <td>8153a862-0790-4a33-80db-ed47fedcd4ef</td>\n",
       "      <td>released</td>\n",
       "      <td>2019-04-28T13:22:10.841143-05:00</td>\n",
       "      <td>...</td>\n",
       "      <td>TCGA-DD-A1E9_treatment_1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>no</td>\n",
       "      <td>2019-04-28T13:22:10.841143-05:00</td>\n",
       "      <td>Liver and intrahepatic bile ducts</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2019-05-01T12:35:58.071505-05:00</td>\n",
       "      <td>released</td>\n",
       "      <td>c5e2522d-c8c5-5581-9304-0e08e7f67d57</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>377 rows  51 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "     diagnoses.days_to_recurrence  demographic.submitter_id  \\\n",
       "0                             NaN  TCGA-DD-AADM_demographic   \n",
       "1                             NaN  TCGA-MR-A520_demographic   \n",
       "2                             NaN  TCGA-DD-AAW2_demographic   \n",
       "3                             NaN  TCGA-2Y-A9GZ_demographic   \n",
       "4                             NaN  TCGA-LG-A6GG_demographic   \n",
       "..                            ...                       ...   \n",
       "372                           NaN  TCGA-DD-AADQ_demographic   \n",
       "373                           NaN  TCGA-KR-A7K8_demographic   \n",
       "374                           NaN  TCGA-DD-AAW3_demographic   \n",
       "375                           NaN  TCGA-DD-AAVS_demographic   \n",
       "376                           NaN  TCGA-DD-A1E9_demographic   \n",
       "\n",
       "        diagnoses.treatments.treatment_id diagnoses.morphology  submitter_id  \\\n",
       "0    d2011ad3-bbca-5f2a-a646-4c39ab7f6e50               8170/3  TCGA-DD-AADM   \n",
       "1    e4c42bee-c60c-55e3-ab8a-b0466b7800d3               8170/3  TCGA-MR-A520   \n",
       "2    a4ac4bf7-2759-5302-91d3-a0b1d7324c02               8170/3  TCGA-DD-AAW2   \n",
       "3    2e637e2b-6f22-5a1c-91cf-c925926755a0               8170/3  TCGA-2Y-A9GZ   \n",
       "4    6fe0674b-d337-5cc1-8132-67a443930c31               8170/3  TCGA-LG-A6GG   \n",
       "..                                    ...                  ...           ...   \n",
       "372  eb5ad258-996e-5fc9-be89-3a7e322c5878               8170/3  TCGA-DD-AADQ   \n",
       "373  5bcd6913-4137-58f3-88fa-6636b5e48c57               8170/3  TCGA-KR-A7K8   \n",
       "374  fcfb6d92-4761-5a9d-b6a0-1153f0bf381c               8170/3  TCGA-DD-AAW3   \n",
       "375  fd3a0556-8f6d-5500-acdc-9481f0588b1c               8170/3  TCGA-DD-AAVS   \n",
       "376  15319954-3dfe-5ebc-aa9c-cf5b252ba6f8               8170/3  TCGA-DD-A1E9   \n",
       "\n",
       "     diagnoses.treatments.treatment_intent_type  \\\n",
       "0                                           NaN   \n",
       "1                                           NaN   \n",
       "2                                           NaN   \n",
       "3                                           NaN   \n",
       "4                                           NaN   \n",
       "..                                          ...   \n",
       "372                                         NaN   \n",
       "373                                         NaN   \n",
       "374                                         NaN   \n",
       "375                                         NaN   \n",
       "376                                         NaN   \n",
       "\n",
       "       diagnoses.primary_diagnosis                                    id  \\\n",
       "0    Hepatocellular carcinoma, NOS  62c02da8-e4b4-4294-9923-8992d187fc7b   \n",
       "1    Hepatocellular carcinoma, NOS  25e893ad-a0fd-45ae-9aa9-9bcd7c2ec8e5   \n",
       "2    Hepatocellular carcinoma, NOS  03df105e-a005-4577-bfdb-9644758d778e   \n",
       "3    Hepatocellular carcinoma, NOS  0e8c3831-def9-4efa-9f93-8942072d6a77   \n",
       "4    Hepatocellular carcinoma, NOS  c618da6d-3c66-4a6a-8832-3526a3b75410   \n",
       "..                             ...                                   ...   \n",
       "372  Hepatocellular carcinoma, NOS  485d283a-552c-485a-84fb-3abdb98dc797   \n",
       "373  Hepatocellular carcinoma, NOS  4b0e544c-4090-4ebb-b3e5-2623aa91356c   \n",
       "374  Hepatocellular carcinoma, NOS  564b4f4d-3c18-40d5-9d95-916774df600c   \n",
       "375  Hepatocellular carcinoma, NOS  9fc30c21-2c78-4843-a658-fe84a64b8fad   \n",
       "376  Hepatocellular carcinoma, NOS  8153a862-0790-4a33-80db-ed47fedcd4ef   \n",
       "\n",
       "    diagnoses.treatments.state diagnoses.treatments.created_datetime  ...  \\\n",
       "0                     released                                   NaN  ...   \n",
       "1                     released      2019-04-28T13:16:22.558732-05:00  ...   \n",
       "2                     released      2019-04-28T13:14:08.134677-05:00  ...   \n",
       "3                     released                                   NaN  ...   \n",
       "4                     released      2019-04-28T13:26:16.469340-05:00  ...   \n",
       "..                         ...                                   ...  ...   \n",
       "372                   released                                   NaN  ...   \n",
       "373                   released      2019-04-28T13:18:51.969934-05:00  ...   \n",
       "374                   released                                   NaN  ...   \n",
       "375                   released      2019-04-28T13:23:51.044821-05:00  ...   \n",
       "376                   released      2019-04-28T13:22:10.841143-05:00  ...   \n",
       "\n",
       "    diagnoses.treatments.submitter_id  demographic.created_datetime  \\\n",
       "0              TCGA-DD-AADM_treatment                           NaN   \n",
       "1            TCGA-MR-A520_treatment_1                           NaN   \n",
       "2            TCGA-DD-AAW2_treatment_1                           NaN   \n",
       "3              TCGA-2Y-A9GZ_treatment                           NaN   \n",
       "4            TCGA-LG-A6GG_treatment_1                           NaN   \n",
       "..                                ...                           ...   \n",
       "372            TCGA-DD-AADQ_treatment                           NaN   \n",
       "373          TCGA-KR-A7K8_treatment_1                           NaN   \n",
       "374            TCGA-DD-AAW3_treatment                           NaN   \n",
       "375          TCGA-DD-AAVS_treatment_1                           NaN   \n",
       "376          TCGA-DD-A1E9_treatment_1                           NaN   \n",
       "\n",
       "     diagnoses.treatments.treatment_intent_type  diagnoses.prior_malignancy  \\\n",
       "0                                           NaN                          no   \n",
       "1                                           NaN                          no   \n",
       "2                                           NaN                          no   \n",
       "3                                           NaN                          no   \n",
       "4                                           NaN                         yes   \n",
       "..                                          ...                         ...   \n",
       "372                                         NaN                          no   \n",
       "373                                         NaN                          no   \n",
       "374                                         NaN                          no   \n",
       "375                                         NaN                          no   \n",
       "376                                         NaN                          no   \n",
       "\n",
       "         demographic.updated_datetime                       primary_site  \\\n",
       "0    2019-04-28T13:20:26.737322-05:00  Liver and intrahepatic bile ducts   \n",
       "1    2019-04-28T13:16:22.558732-05:00  Liver and intrahepatic bile ducts   \n",
       "2    2019-04-28T13:14:08.134677-05:00  Liver and intrahepatic bile ducts   \n",
       "3    2019-04-28T13:14:41.005191-05:00  Liver and intrahepatic bile ducts   \n",
       "4    2019-04-28T13:26:16.469340-05:00  Liver and intrahepatic bile ducts   \n",
       "..                                ...                                ...   \n",
       "372  2019-04-28T13:18:42.293199-05:00  Liver and intrahepatic bile ducts   \n",
       "373  2019-04-28T13:18:51.969934-05:00  Liver and intrahepatic bile ducts   \n",
       "374  2019-04-28T13:19:40.113809-05:00  Liver and intrahepatic bile ducts   \n",
       "375  2019-04-28T13:23:51.044821-05:00  Liver and intrahepatic bile ducts   \n",
       "376  2019-04-28T13:22:10.841143-05:00  Liver and intrahepatic bile ducts   \n",
       "\n",
       "    diagnoses.treatments.therapeutic_agents        diagnoses.updated_datetime  \\\n",
       "0                                       NaN  2019-05-01T12:36:42.289685-05:00   \n",
       "1                                       NaN  2019-05-01T12:37:53.093878-05:00   \n",
       "2                                       NaN  2019-05-01T12:37:05.743590-05:00   \n",
       "3                                       NaN  2019-05-01T12:35:35.448559-05:00   \n",
       "4                                       NaN  2019-05-01T12:37:53.093878-05:00   \n",
       "..                                      ...                               ...   \n",
       "372                                     NaN  2019-05-01T12:37:05.743590-05:00   \n",
       "373                                     NaN  2019-05-01T12:37:53.093878-05:00   \n",
       "374                                     NaN  2019-05-01T12:37:05.743590-05:00   \n",
       "375                                     NaN  2019-05-01T12:37:05.743590-05:00   \n",
       "376                                     NaN  2019-05-01T12:35:58.071505-05:00   \n",
       "\n",
       "    demographic.state     diagnoses.treatments.treatment_id  \n",
       "0            released  fa555b9e-bfc5-5c0e-9e23-c71a219985cc  \n",
       "1            released  e318f368-87c5-5de7-8ca3-c799aeeb0cdd  \n",
       "2            released  9bd0e639-14db-5b89-b0a4-f4784e34bc2e  \n",
       "3            released  fae58ba4-ab4b-5145-8e0f-be4a51af8e7d  \n",
       "4            released  4d1b37ee-01fd-5145-8848-1ab507e09597  \n",
       "..                ...                                   ...  \n",
       "372          released  1cc25911-88ca-5952-93ce-2f470964b055  \n",
       "373          released  5d00b529-0e89-581c-b51e-6a0223e8699f  \n",
       "374          released  3b2bf89c-d479-5b23-8fa1-6c2c2149445e  \n",
       "375          released  cfdb5ea1-0bdc-5d21-ac75-222ba8a3ecac  \n",
       "376          released  c5e2522d-c8c5-5581-9304-0e08e7f67d57  \n",
       "\n",
       "[377 rows x 51 columns]"
      ]
     },
     "execution_count": 78,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df = pd.read_csv(io.BytesIO(response.content))\n",
    "df.columns = [col.replace('.0', '').replace('.1', '') for col in df.columns]\n",
    "df"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Clinical data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 84,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['bcr_patient_uuid', 'bcr_patient_barcode', 'form_completion_date',\n",
       "       'prospective_collection', 'retrospective_collection', 'gender',\n",
       "       'height_cm_at_diagnosis', 'weight_kg_at_diagnosis', 'race', 'ethnicity',\n",
       "       'history_other_malignancy', 'history_neoadjuvant_treatment',\n",
       "       'tumor_status', 'vital_status', 'family_history_cancer_indicator',\n",
       "       'family_history_cancer_number_relatives',\n",
       "       'history_hepato_carcinoma_risk_factors',\n",
       "       'other_hepato_carcinoma_risk_factors', 'viral_hepatitis_serology',\n",
       "       'radiation_treatment_adjuvant', 'pharmaceutical_tx_adjuvant',\n",
       "       'ablation_embolization_tx_adjuvant', 'histologic_diagnosis',\n",
       "       'definitive_surgical_procedure', 'tumor_grade', 'residual_tumor',\n",
       "       'ajcc_staging_edition', 'ajcc_tumor_pathologic_pt',\n",
       "       'ajcc_nodes_pathologic_pn', 'ajcc_metastasis_pathologic_pm',\n",
       "       'ajcc_pathologic_tumor_stage', 'vascular_invasion',\n",
       "       'child_pugh_classification', 'alpha_fetoprotien_at_procurement',\n",
       "       'alpha_fetoprotien_norm_range_lower',\n",
       "       'alpha_fetoprotien_norm_range_upper', 'platelet_count_preresection',\n",
       "       'platelet_norm_range_lower', 'platelet_norm_range_upper',\n",
       "       'prothrombin_time_INR_at_procurement',\n",
       "       'prothrom_time_INR_norm_range_lower',\n",
       "       'prothrombin_time_norm_range_upper', 'serum_albumin_preresection',\n",
       "       'serum_albumin_norm_range_lower', 'serum_albumin_norm_range_upper',\n",
       "       'bilirubin_total_norm_range_upper', 'bilirubin_total_norm_range_lower',\n",
       "       'bilirubin_total', 'creatinine_level_preresection',\n",
       "       'creatinine_norm_range_lower', 'creatinine_norm_range_upper',\n",
       "       'ishak_fibrosis_score', 'hepatic_inflammation_adj_tissue', 'ecog_score',\n",
       "       'new_tumor_event_dx_indicator', 'age_at_diagnosis', 'birth_days_to',\n",
       "       'clinical_M', 'clinical_N', 'clinical_T', 'clinical_stage',\n",
       "       'days_to_initial_pathologic_diagnosis', 'death_days_to', 'disease_code',\n",
       "       'extranodal_involvement', 'icd_10', 'icd_o_3_histology', 'icd_o_3_site',\n",
       "       'informed_consent_verified', 'last_contact_days_to', 'patient_id',\n",
       "       'project_code', 'stage_other', 'tissue_source_site',\n",
       "       'tumor_tissue_site', 'year_of_initial_pathologic_diagnosis'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 84,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "clinpat = pd.read_csv('/Users/mattheweng/Downloads/TCGA-LIHC Clinical Data 1516/nationwidechildrens.org_clinical_patient_lihc.txt', sep='\\t')\n",
    "clinpat.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 100,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0        days_to_death\n",
       "1       CDE_ID:3165475\n",
       "2     [Not Applicable]\n",
       "3                   91\n",
       "4                  770\n",
       "            ...       \n",
       "62    [Not Applicable]\n",
       "63                 373\n",
       "64                   9\n",
       "65                2456\n",
       "66    [Not Applicable]\n",
       "Name: death_days_to, Length: 67, dtype: object"
      ]
     },
     "execution_count": 100,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "clinpat.death_days_to.apply(lambda x: 5000 if x == ')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 101,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0     5000\n",
       "1     5000\n",
       "2     5000\n",
       "3       91\n",
       "4      770\n",
       "      ... \n",
       "62    5000\n",
       "63     373\n",
       "64       9\n",
       "65    2456\n",
       "66    5000\n",
       "Name: death_days_to, Length: 67, dtype: int64"
      ]
     },
     "execution_count": 101,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 102,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 864x576 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Histogram of survival data\n",
    "days_to_death = clinpat.death_days_to.apply(lambda x: int(x) if x not in ['days_to_death', '[Not Applicable]', 'CDE_ID:3165475'] else 5000)\n",
    "\n",
    "fig = plt.figure(figsize=(12,8))\n",
    "plt.hist(days_to_death)\n",
    "plt.xticks(rotation=90);"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 124,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Text(0.5, 1.0, 'Surviving patients x days after diagnoses')"
      ]
     },
     "execution_count": 124,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 720x432 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Survival scatterplot\n",
    "def f(x):\n",
    "    days_to_death = clinpat.death_days_to.apply(lambda x: int(x) if x not in ['days_to_death', '[Not Applicable]', 'CDE_ID:3165475'] else 5000)\n",
    "    return sum(days_to_death >= x)\n",
    "\n",
    "x = np.arange(3500)\n",
    "y = np.array(list(map(f, x)))\n",
    "\n",
    "fig = plt.figure(figsize=(10,6))\n",
    "plt.scatter(x, y)\n",
    "plt.xlabel('Days')\n",
    "plt.ylabel('Num patients')\n",
    "plt.title('Surviving patients x days after diagnoses')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# RNA-seq data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "env-tcga",
   "language": "python",
   "name": "env-tcga"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.6.7"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
